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Abstract 
The strong 1H NMR signals from water and fat impose significant limitations to 
magnetic resonance spectroscopic imaging in vivo.! Herein, novel paramagnetic 
lanthanide probes for 1H magnetic resonance imaging and spectroscopy studies are 
described, in which a tert-butyl reporter group is incorporated and placed about 6 to 7 Å 
from a lanthanide(III) ion in a kinetically stable macrocyclic complex. At such a 
distance, the tert-butyl reporter is shifted to a 1H NMR window that is well removed 
from the diamagnetic range, allowing its selective observation. Additionally, prudent 
selection of the lanthanide(III) ion, in accord with magnetic field strength, leads to an 
enhancement in the longitudinal relaxation rates, R1, permitting faster data acquisition 
per unit time in spectroscopy and imaging protocols. Further sensitivity gains are 
achieved by selecting a tert-butyl reporter group, within which the number of 
magnetically equivalent nuclei is maximised. 
 
As a result, the development of 1H PARASHIFT probes with carboxylate chelating 
arms possess tert-butyl groups that are shifted up to 25 ppm away from the water signal. 
At such frequencies, the enhanced sensitivity associated with the zero-background 
signal in vivo, allows the detection of these complexes in live mice, and due to the 
achievement of the required R1 values, data acquisition occurs within a few minutes 
following tail vein injection of well-tolerated doses that are of the same size as 
clinically administered contrast agents (0.1 mmol kg-1).  
 
Remarkable tert-butyl chemical shift enhancements up to 85 ppm away from the water 
signal are observed for 1H PARASHIFT probes possessing phosphinate chelating arms, 
moving the goal posts further still for 1H MRS studies. Such a shift magnitude means 
that larger spectral imaging bandwidths (such as 20 kHz) can be used, to further reduce 
data acquisition times. 
 
Minimal structural modifications, in the 4-position of the coordinated pyridyl moiety, 
have led to the development of ‘smart’ pH responsive 1H PARASHIFT probes, and also 
a covalently bound high-molecular weight glycol chitosan adduct. In the latter case, a 
strategy for increasing the retention time of these complexes is presented.
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Chapter One: Introduction 
1.1 Magnetic Resonance Imaging: a historical overview 
In 1937, Columbia University Professor Isidor I. Rabi first observed the quantum 
phenomenon renowned to be nuclear magnetic resonance (NMR). Within a decade, 
NMR spectroscopy was adopted for the analysis of substances by chemists, but a 
remarkable 30 years elapsed before the advent of nuclear medical imaging (renamed 
MRI in 1984). 
 
Those three decades saw many investigations into both non-biological and biological 
samples within the field of NMR spectroscopy, but without doubt the most notable 
discovery came from the work of physician Raymond Damadian. In 1970, spurred on 
by his own medical non-diagnoses, Damadian surmised that the 1H NMR signal of 
water in cancerous tissue might be different from that of healthy tissue, because the 
tumour contained more water. Despite his weak reasoning, he found that the 
longitudinal relaxation time (T1) of the 1H NMR signal of water in malignant tumour 
tissue (1.08 ± 0.08 s) was markedly longer than in healthy tissue (0.37 ± 0.08 s), and 
with it he had found ‘the ultimate technology to detect cancer’.1,2 In 1972, he filed a 
patent claim for the idea, entitled ‘Apparatus and Method for Detecting Cancer in 
Tissue’.3 All of the NMR experiments carried out until then were one-dimensional, with 
no mention made of a technique or method capable of using NMR spectroscopy to scan 
the human body. 
 
It was at the same time, that Paul C. Lauterbur and Peter Mansfield, unaware of each 
other’s work, concurrently described the answer: using magnetic field gradients and 
mathematical analyses for the two-dimensional spatial localisation of NMR signals.4 
Lauterbur christened his imaging technique zeugmatography (Greek for ‘I excite’) and 
persevered to publish the first ever proof-of-concept NMR image of two capillary tubes 
of H2O, in a background of D2O (Figure 1.0).5 
 
Whilst Lauterbur’s gradient approach gathered followers, Damadian set about building 
his large-scale human scanner. In 1977, the instrument named Indomitable carried out 
the world’s first human MRI scan, of a graduate student’s chest, and became the first 
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MRI machine prototype.6 The technology’s success was ashamedly short-lived, 
however, with detractors favouring Lauterbur’s approach soon, and forever after. 
 
1.1.1 1H MRI and MRS 
Almost forty years on, 1H MRI is widely regarded as one of the most significant tools in 
clinical diagnostics, with 6 MRI units per million population and nearly 42 MRI exams 
being carried out per thousand population every year, in the UK, according to the 
OECD (Organisation for Economic Co-operation and Development) Health Data 2013.7 
It is a powerful diagnostic technique, generating detailed three-dimensional anatomical 
images with impressive sub-millimetre resolution (Figure 1.0). The non-invasive nature 
of the technique also negates the use of harmful ionising radiation, typically associated 
with other imaging modalities, such as X-radiography.8 Following its rapid rise to 
universal importance, the 2003 Nobel Prize in Physiology or Medicine was jointly 
awarded to Lauterbur and Mansfield for their pioneering efforts, with 12 additional 
Nobel Prizes being directly and indirectly linked to the advent of MRI.9 
 
 
 
Figure 1.0 1H MRI images then and now: left Lauterbur’s ‘zeugmatogram’ of two H2O-filled capillary 
tubes and right A) vertical section through a human; B) horizontal section through the head of a pig; C) 
horizontal section through the head of a human; and D) horizontal image through an alligator.5,10,11!
 
1H MRI utilises the strong 1H NMR signal of water in living systems to generate 
images, after deconvolution and reconstruction. Protons have a spin angular momentum, 
I = ½, and a magnetic moment, µ, due to a positively charged nucleus. When protons 
are placed inside an external magnetic field, the nuclear spins orientate themselves in 
discrete directions, either parallel (+½) or anti-parallel (-½) to the field, and precess 
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around B0 at the Larmor frequency (Figure 1.1A). The difference in energy between 
these spin states is directly proportional to the strength of the external magnetic field, 
with the majority of spins adopting the more energetically favourable parallel 
orientation. The resulting net magnetisation vector, M0, arising from the sum of the 
magnetic moments, is aligned along the z-axis, so that Mz is non-zero (Figure 1.1B). 
Following the application of a 90° radiofrequency (RF)-pulse along the x-axis, the spins 
in the low energy state absorb energy and adopt the high energy state, causing Mz to tilt 
into the xy plane (Figure 1.1C and D).  
 
 
 
Figure 1.1 (A) The magnetic moment, µ, of each proton precesses around B0 at the Larmor frequency. 
(B)! The sum of magnetic moments generates a net macroscopic magnetisation, M0, along the z-axis. (C) 
Application of an RF pulse along the x-axis causes Mz to tilt away from the z-axis. (D) Assuming a 
90° pulse, the net magnetisation will lie in the xy plane. (E) Over time, the magnetisation recovers to its 
equilibrium value. This relaxation process is characterised by the time constants T1 and T2.12 
 
When the RF-pulse is removed, the thermodynamic instability attributed to the 
perturbed magnetic states is such that the net magnetisation relaxes back to its 
equilibrium alignment in the z-direction (Figure 1.1E). This relaxation process is 
characterised by the time constants T1 and T2. The spin-lattice relaxation time, T1, 
corresponds to the random processes whereby the excited spin states achieve stimulated 
emission of energy via interactions with proximal fluctuating magnetic fields within the 
lattice. The recovery of M0 occurs exponentially such that at t = T1, 63% of the original 
net magnetisation value has been recovered, with virtually 100% recovery at t = 5 × 
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T1.13 The spin-spin relaxation time, T2, refers to the loss of phase of the nuclear spins, 
arising from inhomogeneities in the local magnetic field they experience as a result of 
interactions with each other, following a 90° RF-pulse. Lauterbur first discovered that 
the protons of water molecules in different tissue types relaxed back to equilibrium at 
different rates and it is these differences in T1 and T2 that form the basis of 1H MRI, 
whereby image contrast is achieved and the detailed elucidation of soft tissue 
morphology is made possible. 
 
The modest sensitivity associated with low clinical field strengths, typically 1.5 or 3 T, 
led to the rapid introduction of contrast agents; a class of synthetic agents responsible 
for increasing signal intensity in MRI by either shortening T1 (increasing R1 since R1 = 
1/T1), or shortening T2 (increasing R2 since R2 = 1/T1). This shortening of T1 and T2 
arises due to the dipolar interaction between the nuclear magnetic moment of the water 
protons and the electronic magnetic moment of the contrast agent. A contrast agent can 
be classified as a T1 or T2 agent, depending on the relaxation time it affects 
predominantly.14 The majority of commercially available contrast agents are T1 agents, 
and induce positive image contrast. The use of T2 agents is less common, owed largely 
to the inherent reduction in signal intensity and negative image contrast. 
 
Gadolinium(III) based contrast agents represent the largest class of lanthanide T1 agents 
currently in clinical use, with 40% of MRI scans typically using a 0.1 mM kg-1 body 
weight dose of contrast agent.15 The Gd(III) ion might be considered an obvious choice, 
because it possesses the highest spin paramagnetism of any stable ion, but both 
dysprosium(III) and holmium(III) display larger magnetic moments due to orbital 
contributions to electron angular momentum. The isotropic nature of the electron 
distribution in Gd(III) means that it has a slower electronic relaxation time than the 
asymmetric Dy(III) and Ho(III), and so is more in tune with the proton Larmor 
frequency of water, leading to enhanced relaxation times.16,17 The free Gd(III) ion is 
toxic, however, with an LD50 value of around 0.1 mM kg-1, and so must be encapsulated 
within a multidentate ligand forming a complex that is kinetically and 
thermodynamically stable with respect to metal ion dissociation, if it is to be 
administered as an MRI contrast agent.18,19 In 1988, the first Gd(III)-based contrast 
agent, [Gd(DTPA)(H2O)]2-(officially marketed as Magnevist®), was approved for 
clinical use (logKML thermodynamic stability constant 22.2).17,20 Since then, eight 
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additional Gd(III)-based contrast agents have been approved for MRI applications 
(Figure 1.2). 
 
 
 
Figure 1.2 Structures of selected clinically approved Gd(III)-based contrast agents.!
 
Recently, the cause of the debilitating disease nephrogenic system fibrosis (NSF) has 
been linked to the premature dissociation of Gd(III) ions from DTPA-based systems, 
especially the diamide species Omniscan®, in renal system compromised patients.21 
Earlier conclusive works had in fact highlighted such stark differences in stability 
between DTPA-based ligands and macrocyclic DOTA-based ligands,22,23 and revised 
guidance warning radiographers about the use of contrast agents in patients with slow 
renal clearance was issued by the FDA in December 2010.24 
  
Magnetic resonance spectroscopy (MRS) is the clinically appropriate name for NMR 
spectroscopy. It is markedly different from MRI, in that it acquires an NMR spectrum 
of a region of interest (ROI), which can range in size from a 2 cm3 section to a single 1 
mm3 voxel, for example. MRS has been vying for commercial exploitation with MRI 
since the 1970’s, but the emergence of stable magnetic fields, wide-bore magnets and 
contrast agents has made MRI the pre-eminent clinical imaging technique. Despite the 
scope for targeted and higher relaxivity contrast agents, economic and health risk 
factors have contributed to a plateau in their development. MRS offers inherently richer 
information content, but the prevalent reason why MRS has not been more widely 
utilised can be attributed to the intrinsically low sensitivity of the NMR experiment. 
MRI uses the intense proton signal from water in vivo, which is present at a 
concentration of 55 M.14 The presence of other endogenous analytes typically lies in the 
millimolar range so their direct detection is problematic. 
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1.1.2 Heteronuclear MRI and MRS 
An alternative approach, using heteronuclei, presents one possible means of improving 
sensitivity in MRS because there is no endogenous background signal. Among the 
earliest reported work in the field of MRS is the use of 31P magnetic resonance. 31P is 
considered an attractive nucleus due to its 100% natural abundance, favourable nuclear 
spin, large NMR shift range and biological relevance (Table 1.0). 
 
Table 1.0 Comparison between 1H, 31P and 19F nuclei. !
 1H 31P 19F 
Spin, I ½ ½ ½ 
Natural abundance (%) 100 100 100 
Atomic abundance in humansa (%) 63 0.14 0.0012 
NMR shift range (ppm) 12 430 700 
Gyromagnetic ratio, γ (MHz T-1) 42.6 17.2 40.1 
NMR Sensitivity, relative to 1H 1 0.00663 0.83 
 
(a) As a percentage of the total atoms.25,26  
 
Moon and Richards first reported the non-invasive determination of intracellular pH 
using 31P MRS.27 The separation between the two 31P chemical shifts of 2,3-
diphosphoglycerate (2,3-DPG, Figure 1.3A) is dependent on pH, with a maximum shift 
difference of 1 ppm around pH 6.5. Typical physiological concentrations of 5 mM, in 
human red blood cells, and 7 mM, in rabbit red blood cells, coupled with a zero 
background signal means that 2,3-DPG is easily visible by 31P MRS. Although 
relatively agreeable pH results were presented in carbon monoxide treated rabbit blood 
and rabbit hemolysate, the authors cautiously warned how using 2,3-DPG as a pH probe 
is problematic, given that its strong interaction with deoxyhaemoglobin affects the 
chemical shift significantly. Therefore, 2,3-DPG can never be used in a living system. 
 
The utility of phenylphosphonic acid (PPA, Figure 1.3B) as a 31P MRS extracellular pH 
indicator has been demonstrated in perfused tissues.28 The resonant frequency of PPA 
occurs at higher frequency relative to other cellular phosphorus-containing compounds 
and allows easy detection by NMR. It is pH sensitive with a shift of 1.12 ppm/ pH unit 
over the 6.4 to 7.6 range. However, phosphoryl containing compounds, namely ATP 
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and sugar phosphates, have displayed chemical shifts which are dependent on ionic 
effects from divalent cations and salt, and so absolute calibration and certain 
identification remains difficult.29,30  
 
3-Aminopropylphosphonate (3-APP, Figure 1.3C) has also been used to measure the 
extracellular pH of tumours, by 31P MRS.31 Promising in vitro studies suggest the 
resonant frequency of 3-APP is not significantly affected by temperature or ionic 
strength, and the pH sensitivity of 1.5 ppm/ pH unit falls within the physiological range. 
Nevertheless, their in vivo work is restricted to the analysis of large tissue volumes, 
owing to the distinct lack of sensitivity associated with the multitude of endogenous 31P 
NMR signals. 
 
 
 
Figure 1.3 Structures of selected 31P-MRS indicators, from left to right: (A) 2,3-DPG, (B) PPA and (C) 
3-APP.27,28,31 
 
Over the last thirty years, in an effort to overcome sensitivity limitations, the focus has 
moved away from imaging heteronuclei that are biologically prevalent and has 
promoted interest in those that have a zero background signal in living systems.32–34 The 
leading example is 19F, due to its 100% natural abundance, favourable nuclear spin, 
high NMR sensitivity and trace existence in vivo (Table 1.0).35 Of course, there are 
higher concentrations of fluorinated salts in the bone and teeth, but a very short T2 
means it is not visible by conventional MRI methods. Also, the high gyromagnetic ratio 
of 19F (only 6% lower than 1H) means that spectral acquisition can occur on existing 
instrumentation, with minimal retuning of the RF coil. However, in order to produce an 
image of comparable quality to those produced in 1H MRI, whose signal comprises 
almost two-thirds of all the atoms present in the body, a high density of 19F nuclei is 
necessary. 
 
Perfluorocarbons (PFCs) are simple organic compounds, in which all of the hydrogen 
atoms have been substituted with fluorine. Their potential was first recommended in the 
1970’s, when human 1H MRI was in its infancy, after which they became one of the 
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earliest examples of contrast agents and the most prominent class of 19F MRI agents to 
date.36,37 The first documented example was perfluorotributylamine (PFTA, Figure 
1.4).38 
 
 
 
Figure 1.4 Structure of PFTA (left) and the first 19F MRI image from 1977 (right), of a star-shaped 
‘Union Jack’ phantom made from 2 and 6 mm tubes containing PFTA. The image took 400 s to acquire at 
0.7 T using a steady-state free-precession (SSFP) MRI sequence, with a repetition time (TR) of the order 
of several ms.38  
 
Almost a decade later, tumour detection by 19F MRS was carried out using 
perfluorooctylbromide (PFOB, Figure 1.5).39 Liquid PFCs typically have poor water 
solubility and must therefore be emulsified for clinical applications. Following 
intravenous administration of a PFOB suspension, leakage occurs through the tumour 
vascular endothelium, so that PFOB accumulates in the extracellular space. Since the 
local concentration of fluorine in the extracellular space is high, 19F MRS can be used to 
detect the 19F NMR signal. It is important to note that due to the inequivalent nature of 
the 19F nuclei, more than one 19F NMR signal is observed for PFOB. Therefore, 
chemical shift artefacts are observed, as the chemical shift and spatial frequency 
encoding information becomes entangled, so that the use of such agents is restricted. 
There is precedence for re-combining spatially close signals in the literature with the 
addition of selective excitation refocusing signals in Point RESolved Spectroscopy 
(PRESS)40 and STimulated Echo Acquisition Mode (STEAM)41 sequences. More recent 
examples have focused on the use of perfluoropolyethers, because the equivalence of 
the 19F nuclei gives rise to one sharp resonance in the 19F NMR.36,42  
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Figure 1.5 The chemical structure of PFOB (top); a) 1H coronal image of a mouse, where the implanted 
tumour is indicated by an arrow; b) corresponding 19F image with identical orientation, following the 
intravenous injection of 10 g/ kg body weight of PFOB emulsion. PFOB accumulates in the liver (L), 
spleen (S) and tumour (T).39  
 
Despite dedicated imaging coils, this approach has achieved limited impact with only 
sporadic applications being reported. High 19F spin density agents still need to be used 
at remarkably high concentrations, locally injected as a suspension due to poor water 
solubility. Injecting high concentrations of any agent is problematic, regardless of its 
apparent inertness or characterised clearance profile (e.g. for a typical human weighing 
60 kg, 600 g of PFOB emulsion is required according to Ratner et al.). Additionally, the 
field relies heavily on stronger magnetic fields to increase the signal-to-noise ratio 
(SNR), but clinical operating fields are typically much lower than those reported. 
Despite these disadvantages, in 2005 Celsense Inc. developed a polymeric 
perfluorocarbon tracer agent, marketed as Cell Sense, which was used to label cells ex 
vivo, allowing for their visualisation by 19F MRI/MRS after transfer.43 Cell Sense was 
FDA approved in 2011, with its first clinical use in 2014, and represents the most 
successful PFC to date.44 
 
It was mentioned previously that a high spin density of 19F nuclei is essential and this is 
in some part due to the intrinsically slow relaxation rates of the 19F nucleus. The T1 of a 
19F nucleus, in a diamagnetic molecule, is typically 1 s, resulting in an R1 of the order of 
1 s-1.45 In an MRS experiment, it is obligatory to wait five times the magnitude of T1 
before applying another 90° pulse, in what is called the delay time (dt), so that full 
recovery of magnetisation in the z-direction (M0) occurs (Figure 1.6, left). This 
propagates into exceedingly long repetition times (TR) and total scan times, which are 
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not clinically viable. A T1 of this magnitude also means that the amount of ‘dead time’ 
in the experiment, the time where no data is being collected, is large (Figure 1.6, top 
right). 
 
 
 
Figure 1.6 (Left) Example of a typical MRS pulse sequence where at = acquisition time, dt = delay time 
and TR = repetition time. The total scan time is given by n(TR). (Right) Representation of the signal 
intensity gained in an MRS experiment, where T1 = 1 s-1 (top) and 4 ms-1 (bottom).46  
 
An obvious method therefore presents itself: increase the relaxation rates of the imaging 
nucleus so that a greater number of scans can be carried out in a given time frame, 
manifesting itself in a significantly reduced total scan time and increased signal 
intensity. Recently, 19F relaxation rate enhancements between 10 and 25-fold have been 
achieved, by placing a CF3 group in close proximity to a paramagnetic lanthanide(III) 
centre.45,47–52 As a result, the delay times for MRS protocols were in the ms range, 
limiting the amount of ‘dead time’ and increasing the number of scans in a given time 
frame by allowing fast pulsing to occur (Figure 1.6, bottom right). Obvious therefore, is 
the requirement for an R1 of the order of 100 to 200 s-1 at 7 T. However, the successes 
of 19F MRI and MRS are limited, due to the far from trivial use in conventional 1H MR 
operating systems. The work detailed within this thesis focuses on this methodology, 
but without the use of heteronuclei, offers a novel approach to alleviate the major 
disadvantages plaguing the fields of MRI and MRS, presented so far. 
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1.1.3 A novel approach to 1H MRI and MRS: the use of PARASHIFT 
probes 
In general, 1H NMR chemical shifts for physiological compounds fall into the standard 
0-12 ppm range, with the majority of signal intensity representing water (4.7 ppm) and 
fat (1.3 ppm). In this case, the operating practicality of 1H MRI is its greatest drawback 
and so a method for circumventing the biological background signal has been devised. 
If the 1H NMR signal of a probe can be shifted away from the interfering water and fat 
signals in vivo, then it is feasible to image this resonance selectively, in a region where 
there is zero-background signal (Figure 1.7). This new approach allows the commercial 
availability of sensitive 1H MR imaging coils and the widespread understanding of 1H 
MRI to be exploited, negating the major disadvantages associated with imaging 
heteronuclear probes, whilst taking advantage of the zero-background signal. In theory, 
placing a paramagnetic lanthanide(III) centre close to a probe reporter group can attain 
such shift magnitude, with potential chemical shifts ranging between +500 and -500 
ppm. Herein derives the term PARASHIFT, meaning paramagnetically shifted. Before 
discussing applications further, the theoretical framework and practical aspects 
governing the design of these PARASHIFT probes should be addressed. 
 
 
 
Figure 1.7 A schematic representation showing the concept of shifting a 1H resonance outside the 
diamagnetic range, and away from the endogenous water and fat signals. 
1.2 Critical design features of PARASHIFT probes 
The design features of PARASHIFT probes, can be divided into two sub-sections, first, 
the physical theories that need to be considered in paramagnetic lanthanide(III) systems; 
and second, the practical features that need to be fulfilled when designing and 
synthesising PARASHIFT probes. 
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1.2.1 Theoretical considerations 
In the early days of NMR spectroscopy, paramagnetic lanthanide(III) probes were used 
as shift agents, enhancing the limited shift dispersion of the NMR spectrum, and 
relaxation agents, by enhancing relaxation rates by providing additional relaxation 
pathways.53–55 The following sub-section will explore the renowned theories 
underpinning the use of lanthanide(III) complexes as shift and relaxation agents. !
1.2.1.1 Shift: Bleaney’s theory of magnetic anisotropy 
Magnetic susceptibility describes the degree of magnetisation of a material in response 
to an applied magnetic field. All of the lanthanide(III) ions, display anisotropic 
magnetic susceptibilities, due to the asymmetry of their electron density distributions, 
except Gd(III) which is isotropic with seven 4f electrons. This arises due to the strong 
spin-orbit coupling giving large orbital contributions to the ground state, which is 
orientation dependent. This anisotropy directly affects the chemical shift in an NMR 
spectrum of a lanthanide(III) complex, in what is termed the lanthanide induced shift 
(LIS). In the presence of a magnetic field, the induced magnetic field changes intensity 
with molecular orientation and the average over all orientations is net zero and so a shift 
is induced. 
 
The LIS for a nucleus on a ligand that is coordinated to a lanthanide(III) ion can be 
explained as the sum of three contributions: a diamagnetic contribution (δd), the contact 
shift (δc) and the pseudocontact shift (δp) (Equation 1). 
 !!"# != !!! + !!! + !!!  (1) 
 
The diamagnetic contribution represents the change in shift of the ligand resonances 
upon coordination to a lanthanide(III) ion, typically arising from inductive effects, 
electrical field effects and conformational changes. These non-paramagnetic effects are 
negligible, typically, unless the nucleus is directly bound to the lanthanide(III) ion.56  
 
Both the contact and pseudocontact shifts arise from the anisotropy of the magnetic 
susceptibility and provide more significant contributions to the overall shift 
enhancement. The contact shift emanates from the through-bond transmission of 
unpaired electron density from the 4f orbital to the nucleus in question. This means that 
the magnitude of the contact shift falls away considerably as the number of bonds 
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between the lanthanide(III) ion and the nucleus increases, such that for nuclei more than 
5 Å or 3 bonds away from the lanthanide(III) ion the effect is usually near zero.  
 
The pseudocontact shift (Δp or PCS) is a magnetic field induced, through-space dipolar 
interaction between the nucleus and the unpaired electron. Arising from the sum of the 
electron magnetisation and the applied magnetic field, the interaction results in 
additional chemical shielding or deshielding of the nuclei. Bleaney’s theory of magnetic 
anisotropy has proved to be a reasonably reliable approximation for the PCS, defining it 
in terms of the ligand field, geometric coordinates, temperature and the nature of the 
lanthanide ion (Equation 2).54  
 
 (2) 
 
where CJ is the Bleaney coefficient for a specific lanthanide ion (Table 1.1), µB is the 
Bohr magneton, k is the Boltzmann constant, {θ and !} are the angles between the 
nucleus and the lanthanide(III) ion, r is the distance between the nucleus and the 
lanthanide(III) ion; and !!! and !!! are second order crystal field parameters. 
 
Bleaney’s theory presents us with three parameters to influence the overall PCS. For the 
work documented in this thesis, it is imperative to optimise these three parameters in 
order to induce a large PCS, and shift a reporter resonance outside the diamagnetic 
range. Firstly, through judicious lanthanide(III) ion selection, it is possible to influence 
both the direction and the magnitude of the PCS due to the varying values of the 
Bleaney coefficient (CJ) across selected lanthanide(III) ions (Table 1.1), and will be 
discussed later, in more detail (Section 1.2.2.1). 
 
Table 1.1 Overview of Bleaney coefficients (CJ) for selected lanthanide(III) ions. !
Ln(III) CJ CJ normaliseda 
Tb -157.5 -87 
Dy -181 -100 
Ho -71.2 -49 
Er 58.8 33 
Tm 95.3 53 
Yb 39.2 22 
(a) The normalised values (to Dy) are typically quoted. 
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The second way is to exploit the strong dependence of the PCS upon the positioning of 
the nucleus of interest with respect to the principal magnetic axis and the lanthanide(III) 
ion. For a given probe nucleus, the typical distribution of the PCS can be represented as 
a 3D scalar field (Figure 1.8). In practice, a conformational change 4 to 5 Å away from 
the lanthanide(III) ion can result in a chemical shift change of approximately 50 ppm.57 
This is shown in Figure 1.8, where different nuclei in the archetypal [Ln(DOTA)H2O]- 
complex can resonate in an area of strong positive PCS (red) or an area of strong 
negative PCS (blue). Depending upon their location, they can be shifted in opposite 
directions of the 1H NMR spectrum. 
 
 
 
Figure 1.8 Schematic representation of the PCS field distribution around an archetypal 
[Ln(DOTA)H2O]- complex, with predominant axial magnetic susceptibility; and the effect it has on the 
corresponding Eu 1H NMR spectrum (D2O, 298 K, 9.4 T). Taken and adapted from reference 51. 
 
The last variable that determines the PCS, relates to the local ligand field and is 
described by various crystal field splitting parameters, in the form !!!. As discussed 
previously, the PCS of a given nucleus occurs due to the magnetic anisotropy of the 
lanthanide(III) ion under investigation. The lanthanide(III) ion electron cloud is 
disturbed upon coordination to chelating ligands, resulting in splitting of the energy 
levels. Firstly, the electronic energy levels of the lanthanide(III) ions are split by 
electron-electron repulsions. These are then further divided into J energy levels, due to 
spin-orbit coupling; and finally, into 2J+1 magnetic states due to the crystal field. 
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Generally, the crystal field splitting is assumed to be smaller than the spin-orbit 
coupling, as defined by the Russell-Saunders coupling scheme (Figure 1.9).16 
 
 
 
Figure 1.9 A schematic representation of the electronic energy levels of a model Eu(III) complex. 
 
The crystal field states of lanthanide(III) complexes can be derived using the total 
Hamiltonian H = H0 + HCF, where H0 is the free-ion Hamiltonian and HCF is the crystal 
field Hamiltonian (Equation 3): 
 !!" = ! !!!!!!!"   (3) 
 
where !!! are the crystal field parameters and !!! are the spherical tensor operators of 
rank k, with components q.58  
 
Despite Bleaney’s theory being the basis for current understanding relating magnetic 
anisotropy and paramagnetic NMR shifts, subsequent discussions have questioned its 
applicability, citing three main assumptions and approximations. 
 
First, is the assumption that the electrons on the lanthanide(III) ion and the nucleus are 
point dipoles. A recent advance in the area by Charnock and Kuprov, describes a 
mathematical procedure to model the positions of the electrons on the lanthanide(III) 
ion as a non-point electron probability distribution, which is more realistic and can be 
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theoretically justified.59 This alteration primarily affects the quality of shift prediction 
for nuclei that are closest to the lanthanide(III) ion. 
 
Secondly, in his paper, Bleaney had assumed that the energy of the crystal field splitting 
of the lowest J state in a lanthanide complex, ∆!!", is smaller than !!! ie. ∆!!"!!! ≤ 1.54 
The theory has been found to conform to a number of experimental observations. 
Bleaney originally investigated aqua-complexes, with small crystal field splittings 
around 100 cm-1. However, at 295 K, !!! = 205 cm-1 and crystal field parameters 
exceeding this have been widely reported since, with a selection shown in Table 1.2. 
When the ∆!!"!!! < 1 condition is not fulfilled, the different J levels overlap and ‘J-
mixing’ occurs, so that J is no longer a good quantum number to describe the effects of 
spin-orbit coupling on the system. As a result, this has an impact on the validity of the 
CJ term in Equation 2. Clearly, Bleaney’s assumption does not hold true for all 
lanthanide(III) complexes and so further clarification is needed. 60,61  
 
Table 1.2 Overview of reported crystal field splitting parameters for Eu(III) complexes of selected 
ligands.51,62,63 !
Ligand !!! / cm-1 
aqua -133 
(DPA)3 -367 
NTA +200 
(NTA)2 +333 
EDTA -267 
DTPA -500 
CyDTA +300 
HEDTA +467 
NOTA +467 
DOTA -633 
TETA +767 
 
(a) Values of !!!  were estimated using the 
approximation !!! = ! !"! ∆! = 1  (vide infra).64 
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Lastly, only the second-rank crystal field splitting parameters, !!!  and !!! , are 
considered, but varying possible values of k and q mean that a large number of higher 
order crystal field splitting parameters exist. The rank tensor label, k, has allowed values 
of between 0 and 7. The even numbers represent the electrostatic interactions of 
electrons in specific orbitals, for example, k = 0 describes the s-orbital contribution. The 
odd numbers denote the intensities of induced electric-dipole transitions. The 
component tensor label, q, is defined by the point-group symmetry of the lanthanide(III) 
complex, which has allowed values between –k and k.65 The complexity of the crystal 
field splitting increases with reducing symmetry, such that higher order parameters play 
a more important role in low symmetry lanthanide(III) complexes. With up to 27 
parameters possible, the sign and magnitude of the crystal field splitting can vary 
dramatically.66,67 Bleaney’s theory, however, assumes that the main contribution to the 
crystal field splitting comes from the second-rank parameters, !!! and !!!, where !!! is 
found to be typically smaller than !!! (e.g. 20 cm-1 vs. 110 cm-1) and neglects these 
potentially large higher-rank parameters (where !!! < !!!!) .65,68 The works of 
McGarvey and Golding et al. extended Bleaney’s theory to include higher-rank 
parameters, albeit with limited impact.55,69 Definite in their conclusions, however, was 
the limited applicability of Bleaney’s theory to all lanthanide(III) systems, where it is 
clear the theory is violated. 
 
The splitting of energy levels can be directly observed, in some cases, through 
examination of lanthanide(III) emission spectra. Binnemans proposed a method for 
estimating a numerical value for the crystal field splitting, using the emission spectra of 
Eu(III) complexes.64,65 This, of course, assumes that the crystal field does not change 
between lanthanide(III) ions across an isostructural series. Excited Eu(III) ions emit 
visible light when energy is lost in transitions from the 5D0 excited state to various J 
levels of the ground state. The ∆! = 1 band, representing the 5D0 ! 7F1 transition, is 
split into a maximum of 3 bands in the presence of a ligand crystal field (Figure 1.10). 
In a Cn symmetric system, the 7F1 energy level splits into an A state and a doubly 
degenerate E state. The proportionality constant, x, relating the ∆! = 1!splitting value, 
ΔE, and the second-order crystal field parameter, !!! (Equation 4), is believed to be 
somewhere between 3.3 and 4.1. 
 !!! !≈ !!∆!  (4) 
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Figure 1.10 Energy level diagram, depicting the crystal field splitting of the 7F1 state, in the presence of a 
lanthanide crystal field, with Cn symmetry and the model ∆! = 1 bands.  
 
1.2.1.2 Relaxation: Solomon-Bloembergen-Morgan theory 
At the end of Section 1.1.2, the method of increasing the relaxation rates of the imaging 
nucleus using a paramagnetic lanthanide(III) ion was described, and a required R1 of the 
order of 100 to 200 s-1 at 7 T, was derived. The standard NMR experiment and classical 
relaxation theory are explained in detail in Section 1.1.1 vide supra, and elsewhere in 
standard NMR textbooks.35,70 For relaxation studies involving paramagnetic systems, 
the relaxation rates, R1 and R2, are typically analysed.  
 
The unpaired f electrons present in paramagnetic lanthanide(III) ions provide nuclei 
with additional relaxation mechanisms, leading to substantially enhanced relaxation 
rates compared with diamagnetic systems. In such systems, the observed relaxation rate 
(Riobs) can be expressed as the sum of the diamagnetic contribution (Rid) and the 
paramagnetic contribution (RiM) (Equation 5), where i = 1, 2. 
 !!"#$ = !!!" + !!!"  (5) 
 
The diamagnetic contribution represents the relaxation rate of solvent nuclei in the 
absence of a paramagnetic solute, and is found by comparison with diamagnetic 
complexes of La(III), Lu(III) and Y(III). The paramagnetic contribution occurs due to 
the electron-nuclear interaction between the fluctuating magnetic field, generated by the 
unpaired f electrons of the lanthanide ion, and the nuclear spins of the nucleus under 
study. This interaction is described as the sum of the contact contribution (Ricon), and the 
pseudocontact contribution, which is split into dipolar (Ridip) and Curie contributions 
(RiΧ) (Equation 6). 
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 !!" = !!!"#$ + !!!"!# + !!!"  (6) 
 
The contact contribution stems from fluctuating electron spin density located at the 
resonating nucleus. However, this contribution to relaxation is typically deemed 
insignificant for the lanthanide(III) ions (except Gd(III)), and is largely ignored.71 The 
pseudocontact contribution is the main contribution to relaxation, and describes two 
through-space relaxation mechanisms. Dipolar relaxation refers to the electronic 
relaxation of the nucleus due to fluctuations in the electronic magnetic field (Figure 
1.11a). Curie relaxation originates from the interaction between the nuclear spin and the 
thermal average of the electronic spin, and depends on the rotational motion of the 
complex (Figure 1.11b). 
 
 
 
Figure 1.11 Schematic diagrams showing the two components of the pseudocontact relaxation 
mechanism, where a) is the dipolar contribution and b) is the Curie contribution.  
 
The Solomon-Bloembergen-Morgan (SBM) equations (7 and 8), derived from Bloch-
Redfield-Wangsness (BRW) theory, best describe the R1 and R2 of resonances in 
paramagnetic lanthanide(III) complexes, representing a summation of the dipolar and 
Curie relaxation terms.72,73 These equations only apply within the limit that the energy 
of the coupling between the nucleus and the electrons, is smaller than the reciprocal of 
τR. This, the Redfield limit, is expressed as 1 / T1 << 1 / τR and all the lanthanide(III) 
complexes discussed within this thesis are expected to fall below it.51,53,74,75 
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where µ0 is the vacuum permeability, γN is the gyromagnetic ratio of the nucleus, µeff is 
the effective magnetic moment, r is the electron-nuclear distance, τr is the rotational 
correlation time, ωN is the nuclear Larmor frequency, T is the absolute temperature and 
k is the Boltzmann constant and the remaining symbols are defined as: 
 
where !!!""! = !!!!!!!!(! + 1), !!!! = (!!!! + !!!!!!)!!, !! = (!!!!ℏ )!! 
 
in which gJ is the effective electron g-factor, µB is the Bohr magneton, J(J+1) is the 
effective electron angular momentum, and T1e is the longitudinal relaxation time of the 
electron spin. 
 
In order to design a paramagnetic lanthanide(III) complex with desirable relaxation 
properties (R1 = 100 to 200 s-1), at a given field (7 T), there are four contributions to 
SBM theory that can be varied; the distance between the nucleus under observation and 
the lanthanide(III) ion, r, the effective magnetic moment of the lanthanide(III) ion, µeff, 
the rotational correlation time of the complex, τR, and the electronic longitudinal 
relaxation time, T1e. 
 
1.2.2 Practical considerations 
The aforementioned analyses of Bleaney’s theory of magnetic anisotropy and SBM 
theory present us with the following controllable practical design criteria for 1H 
PARASHIFT probes, defined within this thesis: 
• The choice of lanthanide(III) ion. 
• The nature of 1H reporter group. 
• The position of the 1H reporter group within the complex.  
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• And, the nature of the ligand framework. 
 
The following section will discuss the advantages of optimising these criteria, with 
reference to the theories relating to their derivation.  
 
1.2.2.1 Lanthanide(III) ion selection 
The choice of lanthanide(III) ion has perhaps the most influential impact because it 
affects both the shift and relaxation behaviour. The Bleaney constant gives a good 
indication regarding the sign and the magnitude of the pseudocontact shift (Table 1.3). 
For example, Dy(III), Tb(III) and Tm(III) are typically employed due to their large shift 
ranges, arising from their high magnetic susceptibilities. The Bleaney constant for 
Tm(III) is the largest positive value, +53, whereas Dy(III) possesses the largest negative 
value, normalised to -100. Due to the difference in sign and magnitude, we expect their 
resonances to be shifted in opposite directions, with the Dy(III) resonances typically 
being shifted further. The pseudocontact shift does not always follow the magnitude of 
the Bleaney coefficient, however, with some Tm(III) resonances being reported with 
larger shifts than expected.76,77 
 
Table 1.3 Magnetic and relaxation properties of selected lanthanide(III) ions, where the xenon core, [Xe], 
corresponds to 1s22s22p63s23p63d104s24p64d105s25p6. 
 
Ln(III) Electronic 
configuration 
Ground 
state term 
µeff/BMa  T1eb  (aqua 
ion, 2.1 T) / 
10-13 s  
CJc 
normalised 
Eu [Xe] 4f6 7F0 3.5 0.09 4.0 
Gd [Xe] 4f7 8S7/2 7.9 104-105 0 
Tb [Xe] 4f8 7F6 9.8 2.03 -87 
Dy [Xe] 4f9 6H15/2 10.3 2.99 -100 
Ho [Xe] 4f10 5I8 10.4 1.94 -39 
Er [Xe] 4f11 4I15/2 9.4 2.38 32 
Tm [Xe] 4f12 3H6 7.6 3.69 53 
Yb [Xe] 4f13 2F7/2 4.3 1.37 22 
 
(a) Taken from reference 78. (b) Taken from references 79–81. (c) As in Table 1.1. 
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The magnetic moment (Table 1.3) of the lanthanide(III) ion is also important when 
seeking to optimise nuclear relaxation rate enhancement. The higher the magnetic 
moment, the more significant effect it has on the nuclear relaxation, especially at high 
field (Figure 1.12). This renders Tm(III) a less attractive candidate than Dy(III), under 
normal circumstances. 
 
 
 
Figure 1.12 Simulation of the longitudinal relaxation rate, R1, of a hypothetical 1H resonance in an 
idealised system with the magnetic moment, µeff, at three different clinically relevant field strengths (B = 
1.5, 3.0 and 7.0 T) (295 K, T1e = 0.45 ps, r = 6.6 Å, τR = 250 ps). 
 
The electronic relaxation time, T1e, also features in SBM theory and varies amongst the 
lanthanide(III) ions (Table 1.3).82 Values of T1e tend to be ca. 10-12 to 10-13 s for fast 
relaxing lanthanide(III) complexes, except in the case of Gd(III).83 These values are 
deemed to be independent of magnetic field, and display small temperature 
dependencies, increasing slightly with decreasing T due to the small activation energy 
for the electron spin relaxation process. Fries and Belorizky summated that T1e can be 
interpreted as the fluctuation in the static and transient ligand fields because the strong 
spin-orbit coupling in lanthanide(III) complexes implies that such modulations promote 
electronic spin transitions.83  
 
For relaxation rates at low field, T1e has a significant impact. At low field, the dipolar 
term dominates the SBM equations (7 and 8), resulting in perturbation of the relaxation 
rates by almost one order of magnitude (Figure 1.13). This analysis highlights the 
importance of the consideration of T1e at clinically relevant field strengths (0.1 to 3.0 T) 
for MRI applications. Unfortunately, however, the physical basis of T1e is not properly 
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understood, and it is not yet possible to predict when designing a novel paramagnetic 
lanthanide(III) complex.  
 
 
 
Figure 1.13 Simulation of the dependence of R1 on T1e at a variety of fields (295 K, µeff = 10 BM, r = 6.5 
Å, τR = 250 ps).82  
 
1.2.2.2 Ligand design 
Any NMR based spectroscopic technique suffers from low SNR, and hence low 
sensitivity. Acquiring more scans is the most straightforward method for improving 
SNR, since SNR increases with the square root of the number of scans/transients (SNR 
~ !"), but is time consuming and therefore not clinically attractive. Recent advances in 
19F MRI (Section 1.1.2) saw a shift towards using high spin density perfluorinated 
probes, in an effort to increase signal intensity. Of those reported, the probes possessing 
a large number of magnetically equivalent nuclei were the most promising, affording a 
single sharp peak in the 19F NMR spectrum. Evidently, the number of magnetically 
equivalent nuclei contributing to the 1H reporter group in PARASHIFT probes should 
be optimised. 
 
The time limiting constraint hindering clinical acceptance can be alleviated, however, 
by enhancing the relaxation rates of the reporter group so that more signal intensity can 
be acquired in a shorter imaging time frame. This methodology has yielded sensitivity 
gains between 10 and 25-fold using lanthanide(III)-based systems in 19F MRI. In order 
to emulate these enhancements, the distance between the reporter nuclei and the 
lanthanide(III) ion, r, needs to be assessed. Since r appears on the denominator in the 
equations for both Bleaney and SBM theory (r-3 and r-6 respectively), the positioning of 
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the reporter group can have a dramatic impact on the shift and the relaxation behaviour, 
and warrants careful consideration. Consider the cases of Dy(III) and Tm(III), since 
they possess the largest pseudocontact shifts with opposing senses. Using literature 
values for the rotational correlation time, τR, and the electronic relaxation times,82 T1e, of 
Dy(III) and Tm(III) it is possible to simulate the rate of relaxation, R1, as a function of 
the internuclear distance, r, at varying field strengths (Figure 1.14). This analysis 
reveals that for a Dy(III) complex, a distance between 6 and 7 Å is required to achieve a 
100 to 200 s-1 enhancement in R1. For Tm(III), however, these R1 enhancements are 
only observed at shorter distances (5 Å at 4.7 T), due to its lower magnetic 
susceptibility. Similarly, the rate of transverse relaxation, R2, is enhanced with respect 
to distance and so a balance needs to be struck. When R2 increases, concomitant 
broadening of the NMR signal limits the sensitivity gain and inhibits signal detection. If 
the reporter nuclei are too close to the lanthanide(III) ion then line-broadening can be 
too severe; if they are too distant, then the effect on R1 will be much too small. 
Therefore, in an effort to maximise signal intensity, an R1/R2 ratio as close to unity as 
possible is desirable for PARASHIFT systems. 
 
 
 
Figure 1.14 Simulated variation of the 1H longitudinal relaxation rate, R1, with Ln3+-1H internuclear 
distance, r, at for Ln3+ = Dy3+ (upper, blue) and Tm3+ (lower, red) at three different magnetic field 
strengths (B = 4.7, dot; 7.0, dash; and 9.4 T, line) (295 K, T1e = 0.5 and 0.3 ps, τR = 250 ps).84  
 
Finally, the nature of the ligand framework must also be considered. The 4f lanthanide 
orbitals have a small radial extension and are shielded by the filled 5s and 5p orbitals. 
Their resulting ‘core-like’ nature means they are less available to form covalent bonds 
with ligands. As a result of this, and coupled with their large ionic radii, the 
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lanthanide(III) ions prefer higher coordination numbers of typically 8 or 9. In the 
majority of examples, macrocyclic multidentate ligands are used to satisfy such high 
coordination environments such as 12-N4 (1,4,7,10-tetraazacyclododecane) (Figure 
1.15). In the cases where the ligands do not fully saturate the lanthanide(III) ion, 
additional water molecules can coordinate. It is not uncommon for the hydration 
number to decrease across an isostructural series of lanthanide(III) complexes due to the 
decreasing coordinative demand brought about by the lanthanide contraction. The 
number of water molecules on a lanthanide(III) complex can be estimated and is 
represented with the hydration number, q. In order to maximise the affinity of the ligand 
for the hard positive lanthanide(III) ion, donor atoms such as oxygen and nitrogen are 
favoured. 
 
When designing a PARASHIFT probe for MR applications, it is imperative that the 
resulting lanthanide(III) complex is kinetically and thermodynamically stable with 
respect to metal ion dissociation. Much like free Gd(III) (LD50 = 0.1 mM kg-1), other 
free lanthanide(III) ions are toxic. In 2011, the chemistry and applications of DOTA had 
been published in over one thousand papers, reflecting its suitability for use in 
PARASHIFT systems.76 DOTA is a tetra-acetate modified 12-N4 system, possessing 
both nitrogen and oxygen donors (Figure 1.15). Its affinity for Y(III) was determined 
by Cox et al., with a thermodynamic binding constant, logKML, of 24.9.85 The 
PARASHIFT complexes in this discussion will be based on either H4DOTA or 
H4DOTPMe.  
 
 
 
Figure 1.15 Structures of 12-N4-based ligands reported in this thesis. 
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1.3 Applications of paramagnetic lanthanide(III) complexes in 
magnetic resonance: PARASHIFT and PARACEST 
The two main avenues of research, embracing paramagnetic lanthanide(III) complexes, 
are to be discussed in this section. The first is the focus of this thesis, and explores the 
idea of examining a shifted 1H reporter resonance on a paramagnetic lanthanide(III) 
complex (i.e. a PARASHIFT agent). There is some precedence in the literature 
regarding the development of 1H PARASHIFT probes, with early work focusing mainly 
on the Yb(III), Tm(III) and Pr(III) complexes of DOTMA, DOTP and MOE-DO3A 
(Figure 1.16). 
 
 
 
Figure 1.16 Previous examples of 1H PARASHIFT probes, in which the 1H reporter nuclei are 
highlighted in red (NB. all phosphinate arms in [Ln.DOTP]5- are equivalent; one is drawn as shown for 
clarity).86–93 
 
The first example of interest is the C4-symmetric complex [Yb.DOTMA]-, which 
possesses four equivalent methyl groups (Figure 1.16).86 The 12 magnetically 
equivalent methyl 1H nuclei resonate at -14.2 ppm (Figure 1.17). It was possible to 
observe this intense signal selectively, in a phantom imaging experiment, but it took 
over 6 h to observe a 3 mM aqueous solution of the complex at 4.7 T and 300 K. Under 
these conditions, R1 = 15 s-1 and R2 = 30 s-1. Evidently, the relaxation rate enhancement 
is too small to allow fast data acquisition, leading to clinically impractical acquisition 
times. Nevertheless, as a prototypical PARASHIFT probe, [Yb.DOTMA]- has 
demonstrated one of the aforementioned criteria: the high equivalent spin density of the 
1H reporter group. The pseudocontact shift exhibits a T-2 temperature dependency and 
as a result, all paramagnetic lanthanide(III)-based complexes possess T dependent 
chemical shifts. In light of this, the authors selected a pair of resonances and followed 
the chemical separation between them as a function of temperature. When looking at the 
change in chemical shift difference between an axial ring proton and a carboxylate arm 
         [Ln.DOTMA]-
where Ln = Yb and Tm
          [Ln.DOTP]5-
where Ln = Yb and Tm
[Pr.MOE-DO3A(H2O)]
N N
NN
P
O O
P
O P
OO
O Ln
-O
H2
H4
H1
H3
P
O
O-O
H5 H6
O- O-
N N
NN
O
O
O
O
O
O
O
O
Ln
H3C
CH3
CH3
H3C
N N
NN
O O
O
OO
O Pr
O CH3
OH2
Chapter One: Introduction !
! 27 
proton, a linear change of 0.41 ppm/K over the 308 to 318 K range was observed, in 
human serum. However, when observing the temperature dependence of the methyl 
signal under the same conditions, a meagre change of 0.04 ppm/K was found, the 
lowest of the resonances on [Yb.DOTMA]-. 
 
 
Figure 1.17 1H NMR spectrum of Na[Yb.DOTMA], where w and t-Bu refer to the solvent and the tert-
butyl reference, respectively (D2O, 300 K, pH 7.4).86 
 
Further responsive behaviour was sought and the same research group developed 
[Yb.DOTP]5-.87 The six ligand protons (highlighted in Figure 1.16 for clarity) are 
magnetically non-equivalent and result in six distinguishable resonances that resonate 
outside the diamagnetic range (Figure 1.18). Its pH dependent chemical shift behaviour 
was investigated by measuring the chemical shift separation between the ax1 (H1) and 
ac1 (H5) resonances as a function of pH. This allowed linear shift difference 
dependencies to be established, with an observed change of 7 ppm/pH unit, over the 
physiologically relevant 5 to 7.5 pH range. The main advantage of this work is that by 
using two probe signals the need for internal calibration is negated. However, 
calibration at different temperatures will need to be assessed before [Yb.DOTP]5- can 
be considered for in vivo applications, since the chemical shift is also very temperature 
sensitive. 
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Figure 1.18 1H NMR spectrum of Na5[Yb.DOTP], where w and r refer to the solvent and the tert-butyl 
reference, respectively (D2O, 312 K, pH 7.1, 90 MHz).87 
 
Concurrently, Frenzel and co-workers developed a similar approach towards a potential 
in vivo NMR thermometer.88,89 The methoxy group on [Pr.MOE-DO3A] (Figure 1.16) 
resonates at -24.1 ppm (relative to HOD), at 295 K. The change in chemical shift 
difference between the methoxy resonance and the water signal was measured in bovine 
serum, over the range 296 to 321 K, and a dependence of 0.13 ppm/K was established. 
The chemical shift remained unaffected by changes in pH between 5.6 and 9.6. 
However, an increase in linewidth was noted with increasing pH. A notable increase in 
linewidth is also evident when the NMR solvent is changed from D2O to plasma. 
Following this, however, the usefulness of [Pr.MOE-DO3A] as an NMR thermometer 
was successfully demonstrated in vivo, reporting temperature increases in the livers of 
anaesthetised rats with an accuracy of ±1 K. The signal intensity was sufficient to obtain 
spectra 30 min after complex administration, but the methoxy signal becomes 
increasingly broad over time due to chemical exchange broadening. This is probably 
associated with protein side chain ligation of Asp and Glu resides, competing with 
displacement of the bound water and the weakly coordinated methoxy group. Also, the 
dose administered of 1 mmol/kg led the authors to admit it was rather high when 
compared with commercial Gd(III)-based MRI contrast agents (ca. 0.1 mmol/kg), 
although they argued that the LD50 of 12.5 mmol/kg gave them a margin of safety. An 
acquisition time of 2.7 min per spectrum was reported but it is clear that more time will 
be required if the signal intensity continues to decrease over time, and in the presence of 
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endogenous protein. Additionally, the R1 of the methoxy signal in plasma was reported 
to be 23 s-1, and offers no improvements on the relaxation rates observed with 
[Yb.DOTMA]-. Finally, the complex was injected directly into the liver, rather than the 
tail vein. If it is administered intraveneously, it is likely that the hydrophilic complex 
would clear more quickly via the kidneys, localising in the bladder within a few 
minutes. 
 
In more recent work, Bansal and co-workers examined the methyl shift at -102 ppm of 
the major isomer of [Tm.DOTMA]- (Figure 1.16).90 The magnitude of this shift, 
compared to the Yb(III) analogue, resulted in dramatic improvements in phantom 
imaging experiments. Selective imaging of the strong methyl signal took just over 4 min 
at 9.4 T, for a 0.5 mM solution (ca. 6 h for 3 mM of the Yb(III) analogue). Their 
previous studies had demonstrated that [Tm.DOTMA]- was a good candidate for MR 
thermometry, with a temperature coefficient of 0.57 ppm/K, and a chemical shift that 
remains unaffected by variations in pH, [Ca2+] or plasma protein levels.91 Following 
these promising results, temperature mapping studies were successfully carried out in 
vivo, using doses of 0.5-0.6 mmol/kg. Images were acquired in about 3 min but due to 
rapid kidney clearance, the rats were nephrectomised beforehand. [Tm.DOTMA]- is 
without doubt the leading example of a 1H PARASHIFT probe to date, but the work 
detailed in this publication is not without flaw. The authors themselves admit that little 
was done to modify the pulse sequence in order to optimise signal intensity acquisition. 
For example, because the methyl resonance is so far away from the H2O signal, a much 
larger bandwidth for imaging could have been used to increase the SNR. With no such 
detail reported, it is unclear how long the complex takes to clear in a non-
nephrectomised rat, but it is assumed to be too fast to allow practicable image 
acquisition. The nephrectomy approach used here limits the applicability of these 
studies. Another fundamental problem is that it is impossible to modify the structure of 
[Tm.DOTMA]- to incorporate a targeting or responsive moiety, without disturbing the 
magnetic equivalence of the four methyl groups. 
 
More practically, the feasibility of tracking [Tm.DOTMA]- in vivo using the principle 
of PARASHIFT MR imaging as an alternative to established cell-tracking methods, has 
been explored.94 Macrophages were directly and unambiguously detected, following 
labeling with [Tm.DOTMA]-, in a mouse model. Due to the shift magnitude of the 
methyl signal, the complex was successfully imaged without interference from the 
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background water signal in vivo, using excitation and acquisition bandwidths centred at 
the resonant frequency (Figure 1.19). The method was extended in vitro, to 
[Dy.DOTMA]-, and the practicality of imaging two separate resonant frequencies was 
demonstrated, without interference from the water signal or each other. 
 
 
 
Figure 1.19 Schematic demonstrating the principle of PARASHIFT MR imaging. The resonant 
frequency of the methyl groups of [Tm.DOTMA]- and [Dy.DOTMA]- can be excited and detected 
separately and independently from the tissue water signal and each other. Dark grey bars indicate the 
typical excitation bandwidth (EB) and light grey bars indicate the acquisition bandwidth (AB).94 
 
Related work by Hyder et al. demonstrated the use of [Tm.DOTP]5- to generate 
temperature and pH maps of rat brains in vivo.92 The H6 proton on [Tm.DOTP]5- 
(labeled in Figure 1.16), displays a temperature dependent chemical shift of 0.93 
ppm/K, which is a 2-fold improvement on the behaviour of the methyl resonance in 
[Tm.DOTMA]-.93 The work, described earlier, for the Yb(III) analogue means that the 
chemical shifts are also pH dependent. Hyder et al. have previously proved that 
[Tm.DOTP]5- accumulates in the brain’s extracellular space, presenting a potential 
method for temperature and pH mapping. The authors acknowledged that extensive 
calibration was required prior to in vivo studies, so they monitored the chemical shift of 
H1, H2, H3 and H6 as a function of temperature and pH (H4 and H5 were omitted due to 
their far removed resonant frequencies of +500 and -385 ppm, respectively). Each 
resonance showed a unique dependence towards both parameters. Subsequent in vivo 
studies, following the continuous infusion of complex over a 2 h period, allowed 
temperature and pH maps to be constructed of rat brains, with images taking ‘at most a 
few minutes’ to acquire. Although this work is thorough, there are a few drawbacks, 
! !
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which must be scrutinised. Firstly, the doses of complex used in vivo are five to ten 
times higher than related Gd(III)-based contrast agents. This high dosage is probably 
due to the fact that the reporter signals in [Tm.DOTP]5- only comprise four nuclei. 
Moreover, the rats used in these studies were nephrectomised to prevent complex 
clearance via the kidneys.  
 
Another example has reported the use of Dy(III), Tb(III) and Tm(III) tetra-propargyl 
amide complexes as potential candidates for MR thermometry (Figure 1.20).95 Due to 
the large Bleaney coefficients and the close proximity of the labeled nuclei to the 
lanathanide(III) ion, highly-shifted resonances are achieved: Dy (H4) at -333 ppm, Tb 
(H4) at -287 ppm, Tm (H4) at 224 ppm and Tm (H5) at -148 ppm. These same nuclei 
report high temperature dependencies, between 1.05 ppm/K (Tm (H5)) and 1.76 ppm/K 
(Dy (H4)), representing a 2 to 3-fold improvement in previously published examples. 
Unfortunately however, these promising results only got as far as being tested in vitro, 
where a slight decrease in the temperature dependence for the Tm(III) analogue was 
observed. Although the authors comment on negligible losses due to line-broadening, 
relaxation rates over 3000 s-1 were reported at 14.1 T and 308 K. Such fast rates are not 
surprising for resonances that are within 4 Å of the lanthanide(III) ion. Any attempts at 
in vivo studies will most certainly be hindered by the reactivity of the alkyne groups, 
supposedly present so that extension of the arms can be carried out using ‘click’ 
chemistry.  
 
 
 
Figure 1.20 Example of the tetra-propargyl DOTAM complex, where Ln= Tb, Dy or Tm, and protons 
under discussion are highlighted in red.95 
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Work by Caravan et al., sought to encapsulate [Yb.DOTMA]- inside liposomal nano-
carriers with the diamagnetic 1H shift probe, sodium 3-(trimethylsilyl)-1-
propanesulfonate (DSS) (Figure 1.21).96 Their aim was to demonstrate the potential for 
multiplex imaging using two different probes with chemical shift signatures (DSS at 0 
ppm, [Yb.DOTMA]- at 14 ppm), with the added benefit of paramagnetic relaxation 
enhancement, to improve the detection sensitivity of DSS. However, the publication 
showed no results regarding [Yb.DOTMA]-, seemingly noting it as a poor choice of 
relaxation agent, and opted for [Gd(HP-DO3A)(H2O)] instead. Whilst, their 
conclusions ascertained that a wide variety of 1H PARASHIFT probes can be used for 
this purpose, ultimately, this approach is completely invalidated because there are better 
examples of lanthanide(III)-based shift and relaxation agents in the literature. The only 
good idea to stem from this publication was to improve the biocompatibility of 
[Yb.DOTMA]- through encapsulation in a liposome, since without it; it has no specific 
biological target and is rapidly excreted. 
 
 
 
Figure 1.21 Schematic representation of the co-encapsulation of [Yb.DOTMA]- and DSS inside a 
liposome. 
 
The second area of research, is the extension of the chemical exchange saturation 
transfer (CEST) experiment to include the use of paramagnetic lanthanide(III) 
complexes. Aime and co-workers discovered that compounds containing exchangeable 
protons (typically OH or NH) can act as T2 agents, by reducing the water proton 
relaxation time via exchange processes.97 Following this, substantial improvements 
were demonstrated when the RF irradiating field was applied at the exact resonant 
frequency of the exchanging protons, leading to a net decrease in the bulk water signal 
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intensity due to a saturation transfer effect.98 In order for efficient saturation transfer to 
occur, the exchange rate between the mobile protons and the water, kex, must be 
optimised. This occurs as kex approaches the chemical shift separation between the two 
exchanging sites, Δv.99 Consequently, larger Δv values allow for larger kex values to be 
exploited, amounting in an enhanced CEST effect. The aforementioned research on 1H 
PARASHIFT probes perfectly demonstrates the feasibility of shifting a 1H resonance 
well away from the water signal and so offers an attractive class of probes for CEST 
applications, coined PARACEST.100,101  
 
Paramagnetic lanthanide(III) complexes, such as [Eu.DOTAM(H2O)] (Figure 1.22) 
and its variants, have been used as PARACEST agents.102,103 Although interest in 
PARACEST has been growing in the last decade, due to the indirect nature of the 
technique the major limitation remains the need to determine the absolute concentration 
of the probe. As a result, there are few examples documented in vivo, and even then 
most cases report direct injection into the tissue of interest and/or a high injected dose 
(ca. 2 mmol/kg).104,105 Following on from the successes regarding pH and temperature 
sensitivity, several 1H PARASHIFT probes have been evaluated for sensitivity towards 
different physiological parameters, but once again only triumphs in vitro have been 
described. The main problems inherent to PARACEST are: the need to radiate 
continuously at high frequency, casting doubts over safety issues, and the need to 
collect multiple scans, meaning that acquisition times are long. 
 
 
 
Figure 1.22 Structure of a common PARACEST agent, [Eu.DOTAM(H2O)]3+, where functionalisation 
can occur by appending different R groups. 
 
The examples of 1H PARASHIFT probes discussed in this review, reinstate the need for 
the work in this thesis, and confirm that strict design criteria are required if any 
improvements are to be made moving forward. Of paramount importance is a 1H 
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reporter resonance that is shifted well away from the diamagnetic range, so it can be 
imaged without interference from endogenous 1H signals in vivo. Bleaney’s theory of 
magnetic anisotropy proves that through careful lanthanide(III) ion selection (CJ and 
µeff), it is possible to influence the sign and magnitude of the paramagnetic shift. Most 
obvious, is the need for a strong signal, arising from more than one equivalent 1H 
nucleus, permitting increased sensitivity. Also a necessity, but an idea not fully 
considered in these examples, is the benefit of longitudinal relaxation rate enhancement, 
and the hindrance of transverse relaxation rate enhancement; and their strong 
dependence on the Ln-nuclear distance (r) and lanthanide ion selection (µeff and T1e), at 
a given magnetic field (B0) (Section 1.2.1.2). 
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1.4 Aims and Objectives 
The aim of this project is to synthesise and characterise novel 1H PARASHIFT probes, 
with the definitive aim of developing systems that can be used for in vivo 1H magnetic 
resonance imaging and spectroscopy studies. Therefore, it is important to improve on 
the successes and limitations of previous examples, detailed vide supra Section 1.3.  
 
The design of these 1H PARASHIFT probes must satisfy the following criteria:  
• The probe must possess a reporter group with high equivalent spin density, so 
that one large signal dominates the 1H NMR spectrum. 
• The reporter group must be located an appropriate distance away (r) from the 
lanthanide(III) ion to benefit longitudinal relaxation rate enhancement; too close 
and line-broadening dominates; too distant and the enhancement is too small, 
such that the ratio of R1/R2 is close to unity. 
• The probe must be based on a 12-N4 macrocyclic framework since it shows 
kinetic and thermodynamic stability with respect to lanthanide(III) ion 
dissociation.  
• The choice of lanthanide(III) ion must optimise the shift (CJ) and relaxation (µeff 
and T1e) behaviour of the reporter group. 
• The probe must possess the potential for functionalisation with minimal 
modification, so that responsive behaviour can be readily incorporated.  
 
Chapter 2 describes the design, synthesis and characterisation of a novel class of 1H 
PARASHIFT probes, based on the abovementioned criteria. In chapter 3, a series of pH 
responsive 1H PARASHIFT probes were synthesised in pursuit of non-invasive pH 
determination in vivo. Finally, chapter 4 focuses on increasing the retention times of 1H 
PARASHIFT probes in vivo, by altering their biodistributions and offering a longer 
period to image; as well as increasing local signal intensities, through the use of higher 
molecular weight materials. 
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Chapter Two: Parent 1H PARASHIFT Probes 
2.1 Introduction 
The criteria at the end of Chapter 1 outline key requirements for the design of 
PARASHIFT probes for 1H MRS studies. Fundamentally, the shift of the 1H reporter 
group needs to be well removed from the diamagnetic spectral window in order for it to 
be selectively imaged in 1H MRS in vivo studies. In order to utilise practicable imaging 
pulse sequences, a spectral width of more than 20 kHz is required, and therefore the 
observed resonance must occur at least 10 kHz away from the water or fat signals.1 
Consequently, a shift of < -34 ppm or > +44 ppm is essential, at a magnetic field of 7 T. 
Bleaney’s 40-year-old theory of magnetic anisotropy remains the most commonly used 
approximation for predicting paramagnetic lanthanide(III) induced shifts, and describes 
them in terms of the nature of the lanthanide(III) ion (CJ), the positioning of the reporter 
group (r, θ, φ) and the ligand field, assessed by the second order crystal field terms !!! 
and !!!.2  
 
Additionally, to enhance sensitivity in MRS protocols, the 1H reporter group must still 
possess the required relaxation characteristics such that R1 is in the 100 to 200 Hz range 
at 7 T, and minimal line broadening occurs so that the R1/R2 ratio is close to unity. The 
Solomon-Bloembergen-Morgan (SBM) equations,3–5 derived from Bloch-Redfield-
Wangsness (BRW) theory,6 model the relaxation rates as a function of the distance 
between the lanthanide(III) ion and the 1H reporter nuclei, r, the magnetic moment of 
the lanthanide(III) ion, µeff, the rotational correlation time of the complex, τr, and the 
electronic longitudinal relaxation time, T1e. The steep r-6 dependence for both R1 and R2 
means that strategic placement of the reporter group is a balance between being 
sufficiently close to induce sufficient R1 enhancement, but not so close such that R2 
increases and too much line broadening occurs. Furthermore, the number of 
magnetically equivalent nuclei in the 1H reporter group must be optimised, and one 
stereoisomeric complex must be preferred in solution, so that one large signal dominates 
the 1H NMR spectrum.  
 
With this background in mind, three target parent structures of 1H PARASHIFT probes 
have been designed (Figure 2.0). Each system possesses a tert-butyl reporter group, 
since it introduces the maximum amount of equivalent spin density, and is based on a 
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macrocyclic 12-N4-based ligand framework. Related work in the area estimates 
lanthanide(III) ion-reporter nuclei distances of about 6.5 Å, following inclusion of a 
reporter group on the meta-position of a coordinated pyridyl moiety.7 The tri-
carboxylate system, [Ln.L1(H2O)], is in keeping with the design of many DO3A 
derivatives and as a result, presents the most straightforward synthetic route. 
Substitution of one carboxylate arm for a tert-butyl labeled pyridyl moiety to yield the 
C2-symmetric system, [Ln.L2(H2O)]+, has two added benefits: first, the resulting 
cationic nature will influence its biodistribution; second, the signal intensity of the 1H 
reporter group will be doubled, providing that the tert-butyl groups are equivalent. 
Changing the chelating arms from carboxylate to phosphinate affords the PMe3 parent 
system, [Ln.L3]. Recent advances that incorporate such a structural change, have seen a 
reporter signal change from representing 50% of the total signal intensity, with 
carboxylate arms, to 87%, with the more sterically demanding phosphinate arms; along 
with remarkably large shift enhancements.8  
 
!
 
Figure 2.0 The target parent 1H PARASHIFT probes: the model system, [Ln.L1(H2O)] (left); the C2-
symmetric system, [Ln.L2(H2O)]+ (middle) and the phosphinate system, [Ln.L3] (right). 
2.2 A Model Probe: The Tri-carboxylate Parent System 
2.2.1 Synthetic procedure 
The 12-N4-based macrocyclic platform was synthesised following a literature method, 
using tert-butyl bromoacetate to alkylate 1,4,7,10-tetraazacyclododecane (cyclen) 
(Scheme 2.0).9 Recrystallisation of the sticky residue, from toluene, yielded the target 
tri-carboxylate compound, 1, as a white solid. 
 
Scheme 2.0 General procedure for the synthesis of the 12-N4-based macrocyclic platform, 1. 
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The synthesis of the tert-butyl labeled pyridyl moiety, 5, began with the introduction of 
the tert-butyl reporter group (Scheme 2.1), using a procedure adapted from the work of 
Bell and co-workers.10,11 A small amount of copper(I) cyanide was required to catalyse 
the reaction between tert-butyl magnesium chloride and 5-bromo-2-methylpyridine, in 
THF. However, this procedure continually resulted in poor yields due to loss of the 
volatile product, 2, when removing THF under reduced pressure. In seeking to improve 
the procedure, diethyl ether was added to the solvent mixture, and losses were 
minimised by continuing the synthesis with 2 as a crude mixture. Subsequent oxidation 
of the pyridine ring nitrogen was achieved using mCPBA, and isolation of the N-oxide, 
3, was achieved following purification by silica gel column chromotography.  
 
 
 
Scheme 2.1 General procedures for the synthesis of the model parent 1H PARASHIFT probes, 
[Ln.L1(H2O)], 7-14. 
 
Treatment of the N-oxide, 3, with trifluoroacetic anhydride induced a [3,3]-sigmatropic 
shift, resulting in the formation of a trifluoroacetate ester intermediate, identifiable by 
both 1H and 19F NMR spectroscopy. Clean ester hydrolysis was performed in situ, using 
a 1:1 mixture of ethanol and water, and the identity of the desired alcohol, 4, was 
confirmed by a shift to lower frequency of the CH2 resonance in the 1H NMR spectrum 
(Figure 2.1). Nucleophilic substitution between the alcohol and methane sulfonyl 
chloride, in the presence of triethylamine, led to the formation of the mesylate 
precursor, 5.  
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Figure 2.1 1H NMR spectrum of the trifluoroacetate intermediate (top) and the alcohol compound, 4 
(bottom) showing the change in shift of the allylic CH2 resonance (blue) (CDCl3, 295 K, 9.4 T). 
To avoid decomposition, the mesylate 5 was used immediately, in the N-alkylation of 
the secondary amine on 1. Purification by silica gel column chromatography allowed 
isolation of the protected ligand, 6. Removal of the tert-butyl protecting groups was 
achieved using a dilute mixture of trifluoroacetic acid and dichloromethane, and the 
resulting TFA salt was complexed in aqueous solution, held at pH 5.5, using the 
appropriate hydrated lanthanide(III) chloride. Preparative reverse-phase HPLC 
purification yielded the desired series of complex, [Ln.L1(H2O)], where Ln = Eu to Yb 
(7-14). 
2.2.2 Characterisation of the complexes 
Firstly, the purity of each complex was assessed by analytical reverse-phase HPLC. 
Complexes 7-14 possessed one peak in the UV chromatogram (268 nm), with retention 
times (tR) ranging between 8.3 and 9.3 min (Figure 2.2 shows [Yb.L1(H2O)]). It is 
expected that an isostructural series of complexes, such as this, should exhibit similar 
retention times. 
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Figure 2.2 Observed analytical reverse-phase HPLC UV chromatogram of [Yb.L1(H2O)] (λ= 268 nm, 
10-100% MeOH+0.1% formic acid in H2O+0.1% formic acid over 10 min, tR=8.4 min). 
Secondly, the identity of the desired complexes was confirmed by low-resolution 
electrospray and high-resolution mass spectrometry, aided by the fact that each 
lanthanide possesses a distinctive isotope pattern. In each case, a characteristic isotope 
pattern was observed for complexes 7-14 (Figure 2.3 shows the observed [M+H]+ 
pattern for [Dy.L1(H2O)]), which corresponded well to their simulated isotope patterns 
(errors ≤ 5 ppm). 
 
 
 
Figure 2.3 Observed ESI-HRMS (+) spectrum of [Dy.L1(H2O)]; where [C24H37O6N5160Dy]+ requires 
651.1990, found 651.1996, error 0.9 ppm. 
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The metal hydration state of a lanthanide(III) complex (q value) can be calculated by 
measuring the radiative lifetime of the emissive excited state, k, in both H2O and D2O.12 
The attenuation of the metal-based emission intensity over time will always occur more 
slowly in D2O than in H2O, due to inefficient energy transfer between the 
lanthanide(III) excited state and X-D oscillators, in comparison to X-H oscillators.12 In 
the cases of Eu(III) and Tb(III), the energy gap between the emissive state and the 
highest lying electronic energy level of the ground state manifold corresponds to 
emission in the visible region of the electromagnetic spectrum (Eu: 12,300 (5D0 → 7F6); 
Tb: 14,800 cm-1 (5D4 → 7F0)).13 Hence, the difference between the radiative lifetimes in 
H2O and D2O can be readily measured for Eu(III) and Tb(III) complexes and exploited 
when estimating the number of bound water molecules:12  
 !!" = 1.2 !!!! − !!!!! − 0.25   (1) 
 !!" = 5 !!!! − !!!!! − 0.06   (2) 
 
where !!!! and !!!! are the rate constants for the depopulation of the lanthanide(III) 
emissive excited state in each solvent (derived as the reciprocals of the luminescence 
lifetimes of the complex in each solvent, !!!! and !!!! respectively). 
 
In order to calculate the q value, the decay of the lanthanide(III)-based emission 
intensity was initially recorded in H2O, and subsequently in D2O, following two cycles 
of dissolving and removing D2O under reduced pressure. In each case, a mono-
exponential decay was observed, and rate constants for the depopulation of the 
lanthanide(III) emissive excited state were calculated for each complex in each solvent. 
Estimations of the hydration state for each of the complexes were obtained using 
equations 1 and 2 (Table 2.0). Based on ample literature precedent, the suggestion that 
the complexes in the [Ln.L1(H2O)] series possess one bound water molecule is 
expected for such carboxylate-12-N4-based systems. 
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Table 2.0 Experimentally determined radiative rate constants, k, and derived values of q (±20%) for 
[Eu.L1(H2O)] and [Tb.L1(H2O)] (295 K, pH 7.0). 
 
[Ln.L1(H2O)] !!!!/ ms-1 !!!!/ ms-1 q 
Eu 1.39 0.40 0.9 
Tb 0.69 0.40 1.2 
 
The hydration state of a lanthanide(III) complex can also be estimated from the 
relaxivity of the Gd(III) complex, i.e. its ability to enhance (1/T1) and (1/T2) of proximal 
nuclei per unit concentration, denoted by r1p or r2p respectively.14 The relationship in 
equation 3 allows the relaxivity to be calculated following the measurement of the 
relaxation rate, provided that the concentration of Gd(III) is known.14  
 !!!,!"# = ! !!!,! + !!!,! !"(!!!)  where i = 1, 2 (3) 
 
Relaxivity is most commonly used as a direct measure of the ability of a contrast agent 
to increase the rate of relaxation of the bulk water, where a large r1p value denotes good 
image contrast. The presence of Gd(III) creates a strong local magnetic field, which 
interacts with the water proton nuclear spins to provide three relaxation mechanisms. 
The total relaxivity is given by the sum of these contributions in equation 4.14,15 The 
first is inner-sphere relaxation (IS), and relates to relaxation enhancements due to the 
water molecule that is bound in the first coordination sphere of the Gd(III) ion (Figure 
2.4). If this water molecule is in fast exchange, kex, with the bulk outer-sphere (OS) 
water then propagation of the magnetic field interaction ensues and relaxivity is 
increased. As a result, relaxivity values are much higher when there is a bound water 
molecule on the Gd(III) complex (i.e. such that q = 1) and so provides a method for 
estimating the q value.  
 !!" = ! !!,! !" + ! !!,! !" + ! !!,! !! where i = 1, 2 (4) 
 
The other two contributions are not considered when approximating the complex 
hydration state because they relate to outer-sphere (OS) and second-sphere (SS) effects, 
and are beyond the scope of this work as a result. 
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Figure 2.4 Schematic representation of a Gd(III) contrast agent in the presence of water, highlighting the 
inner-sphere (IS), outer-sphere (OS) and second-sphere (SS) relaxation mechanisms, where kex is the 
exchange between the coordinated IS water and the bulk OS water. 
 
Using equation 3, the relaxivity of [Gd.L1(H2O)] was calculated to be 4.8±0.01 mM-1 s-
1. Such a value is consistent with the presence of one bound water molecule, based on 
analysis of numerous related DO3A-based Gd(III) complexes.15 This analysis also 
corroborates well with the q value obtained by previously measuring the radiative 
lifetimes of the Eu(III) and Tb(III) emissive excited states. 
2.2.3 1H NMR studies: shift behaviour 
An initial investigation into the chemical shift behaviour of the tert-butyl reporter group 
on each complex was carried out using 1H NMR spectroscopy (Figure 2.5). In each 
case, the tert-butyl reporter group gave rise to a strong sharp resonance, shifted away 
from the ligand tert-butyl resonance (1.5 ppm). In three of the complexes, this 
resonance possessed the required shift outside of the diamagnetic range, with an 
observed shift over 20 ppm away from the endogenous signals in vivo for the Dy(III) 
complex (Figure 2.5). 
 
However, in order to interpret the observed tert-butyl chemical shifts, it is necessary to 
recall the origins of the pseudocontact shift in paramagnetic lanthanide(III) complexes, 
as discussed in Section 1.2.1.1:  
 
 (5) 
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where CJ is the Bleaney coefficient characteristic to each lanthanide(III) ion, µB is the 
Bohr magneton, {θ and !} are the angles between the nucleus and the lanthanide(III) 
ion, r is the distance between the nucleus and the lanthanide(III) ion; and !!! and !!! are 
second order crystal field parameters. 
 
For an isostructural series of lanthanide(III) complexes, Bleaney theory assumes that the 
ligand crystal field is lanthanide(III) ion independent and invariant across the series. 
Therefore, if each 1H NMR spectrum is acquired at the same temperature, it is expected 
that the resonant frequency of a given nucleus on each complex will be almost entirely 
determined by the respective Bleaney coefficients, since the spherical coordinates and 
the distance should remain relatively unchanged. The 1H NMR spectra for complexes 9-
14 are shown superimposed in Figure 2.5. 
 
 
Figure 2.5 Superimposed 1H NMR spectra of C3 parent complexes, [Ln.L1(H2O)], highlighting the shift 
in the tert-butyl reporter resonance for Ln = Tm, Er, Yb, Ho, Tb and Dy (D2O, 9.4 T, 295 K), with 
respect to the corresponding Bleaney coefficients (CJ). The solvent water peak is omitted for clarity and * 
represents residual formate from HPLC purification and neutralisation. 
 
Following this analysis, it is evident that the chemical shift behaviour of the tert-butyl 
group follows the sign and magnitude of the Bleaney coefficients, with positive CJ 
values shifting to higher frequency and negative CJ values shifting to lower frequency. 
The Dy(III) and Tm(III) complexes display the largest shifts in opposite directions, 
with the Dy(III) tert-butyl resonating at -20.1 ppm (CJ = -100) and the Tm tert-butyl 
resonating at +10.5 ppm (CJ = +53). Whilst the shifts show a reasonable agreement to 
the relative ordering predicted by the Bleaney coefficients, the magnitude does not fit to 
a linear trend, with the Tb(III) complex being the biggest outlier (Figure 2.6). It has 
-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2026810121416182022
C3 Parent System Stack (Tb, Dy, Ho, Er, Tm, Yb)
+33
 Er
+53
Tm
+22
 Yb
-86
Tb
-100
  Dy
*
-39
 Ho
δH/	ppm
CJ:
Chapter Two: Parent 1H PARASHIFT Probes !
! 49 
been previously noted that Bleaney theory has limited applicability,16,17 and so a few 
more parameters need to be assessed for the [Ln.L1(H2O)] series, in order to gain a 
wider understanding. 
 
 
 
Figure 2.6 Relationship between the magnitude of the paramagnetic shift, |δpara|, of the tert-butyl reporter 
resonance for [Ln.L1(H2O)] and the Bleaney coefficients for each lanthanide(III) ion. N.B. All signs are 
positive for clarity, |δpara| is estimated by assuming the diamagnetic complex has a shift of 1.5 ppm and 
the line shown is a line of best-fit to the data. 
 
The temperature inside the NMR spectrometer was measured accurately after the 
acquisition of each NMR spectrum, using an ethylene glycol standard reference 
solution. Although, the distance between the lanthanide(III) ion and the tert-butyl 
reporter group, r, is likely to decrease slightly as a result of the lanthanide contraction, 
this variation would not contribute significantly to the overall shift (<0.05 Å across the 
series for the later lanthanide(III) ions).18 The polar coordinates, {θ and !}, cannot be 
properly alluded to without crystal structure information and knowledge of the principal 
axis. 
 
The assumption in Bleaney’s theory that the crystal field is constant for an isostructural 
series of lanthanide(III) complexes is not appropriate for many lanthanide(III) 
complexes. Research by Gruber and co-workers proved this, reporting an increase in !!! and a decrease in !!! from Tb(III) to Yb(III), for lanthanide(III) ions occupying the 
C3i sites of Y2O3.19 Owing to the work postulated by Binnemans, it is possible to 
roughly quantify !!!!by analysing the splitting in the ∆! = 1  band in the Eu(III) 
emission spectrum.20 Thus, the splitting of the ∆! = 1 manifold was estimated for 
[Eu.L1(H2O)], giving a !!!  value equal to -500 cm-1 (Figure 2.7). This value is 
comparable to related lanthanide(III) complexes, and provides further evidence to 
R² = 0.79796 
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nullify another assumption of Bleaney’s theory that the crystal field terms are much 
smaller than !!! (205 cm-1 at 295 K, addressed in Section 1.2.1.1). Further inspection 
of the Eu(III) emission spectrum, shows 3 bands in the ∆! = 1 manifold, implying that 
the E states are not degenerate. Such behaviour is not surprising when the low 
symmetry of the [Ln.L1(H2O)] complex series is considered, leading to a significant 
error margin when estimating the crystal field splitting. 
 !!!= - 500±40 cm-1 
 
 
Figure 2.7 Emission spectrum of [Eu.L1(H2O)] (D2O, 295 K, λexc= 270 nm), analysis of the ∆! = 1 
manifold at 590-595 nm allows the crystal field splitting parameter, !!!, to be estimated. 
 
Yb(III) complexes, possess relatively sharp and well defined 1H NMR spectra, although 
they do not allow considerable shifts to be achieved for the PARASHIFT work in this 
thesis. As a result, the 1H NMR spectrum of [Yb.L1(H2O)] has been fully assigned, 
using relaxation rate data and a structurally related example as a guide (Figure 2.8).21  
 
 
 
Figure 2.8 Annotated 1H NMR spectrum of [Yb.L1(H2O)] (D2O, 9.4 T, 295 K). The unassigned 
resonances correspond to the minor isomer, with twisted-square antiprismatic geometry. 
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The occurrence of isomers in solution can be seen from the 1H NMR spectrum of 
[Yb.L1(H2O)], and is a phenomenon expected for these pyridyl-based systems. The 
presence of isomers is not problematic, providing one species exists preferentially. This 
is indeed the case, with the major tert-butyl resonance accounting for over 80% of the 
observed signal intensity in each case.  
 
There are two main elements of chirality for systems based on the complex 
[Ln.DOTA(H2O)]-, associated with the NCCN and NCCO chelate rings (Figure 
2.9).22,23 Each NCCN ring can have a torsion angle of +60° or -60°, denoted by δ and λ 
respectively. Similarly, each NCCO ring can have a torsion angle of ca. +30° or -30°, 
corresponding to Δ and Λ respectively. As a result, the occurrence of four stereoisomers 
is possible in solution. The larger lanthanide(III) ions typically adopt square 
antiprismatic (SAP) geometries whereas, the smaller lanthanide(III) ions form twisted-
square antiprisms (TSAP).22,23 Such a trend across the series is a result of the ligand 
twisting in conformation to accommodate the smaller metal. As a result, it is thought 
that the isomers of [Dy.L1(H2O)] are SAP and [Tm.L1(H2O)] are TSAP. 
 
 
 
Figure 2.9 Schematic representation of the coordination geometries adopted by DOTA-based complexes, 
e.g. [Ln.L1(H2O)], through arm rotation and ring inversion: mono-capped square anti-prism (SAP) and 
twisted square anti-prism (TSAP). The bound water molecule has been omitted for clarity. 
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From this shift behaviour analysis, it can be surmised that [Dy.L1(H2O)] is a good 
candidate for a 1H PARASHIFT probe. It possesses a tert-butyl shift that is over 20 
ppm away from the biological window and should permit selective imaging. However, 
the relaxation behaviour must also be assessed before conclusions can be drawn 
concerning the suitability of this complex as a 1H PARASHIFT probe for MRS 
applications. 
2.2.4 1H NMR studies: relaxation behaviour 
The longitudinal relaxation rate, R1, for the major tert-butyl resonance of [Ln.L1(H2O)] 
was obtained using the inversion-recovery pulse sequence, at 6 different field strengths 
(Table 2.1). The complex characteristics detailed in Section 2.1 stressed the importance 
of paramagnetic relaxation enhancement, with desired R1 values of the order of 100 to 
200 s-1 at 7 T. It is evident from this data, that R1 exhibits the expected increase with 
increasing field, with enhancements most pronounced for the Dy(III) and Tb(III) 
complexes. In the case of Dy(III), the R1 value falls into the desired range. 
 
Table 2.1 Experimental longitudinal relaxation rate data for the major tert-butyl resonance of 
[Ln.L1(H2O)] at different magnetic field strengths (D2O, 295 Ka). 
 
Ln  R1/ s-1 (± error)  R1/R2b 
(9.4 T) 
 1.0 T 4.7 T 9.4 T 11.7 T 14.1 T 16.4 T  
Tb 56 (1) 72 (1) 104 (2) 128 (1) 146 (1) 169 (1) 0.59 
Dy 55 (2) 73 (1) 124 (1) 149 (1) 170 (1) 210 (2) 0.56 
Ho 28 (1) 45 (1) 89 (1) 118 (1) 144 (1) 169 (1) 0.58 
Er 21 (1) 29 (1) 59 (1) 80 (1) 97 (1) 120 (1) 0.55 
Tm 18 (2) 31 (1) 54 (1) 64 (1) 71 (1) 82 (1) 0.57 
Yb 6.1 (0.5) 6.4 (0.1) 7.6 (0.3) 8.6 (0.1) 9.5 (0.1) 10.7 (0.1) 0.12 
 
(a) Temperature was monitored accurately, calibrating against an ethylene glycol shift thermometer; (b) 
R2 values were estimated as (π × ω1/2), for a Lorentzian line fit. 
 
The variations in the measured R1 values are consistent with the magnitude predicted by 
the effective magnetic moments, µeff, listed on page 21. For example, the Dy(III) 
complex shows the largest R1 enhancement, with a µeff value of 10.3 BM, whereas the 
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corresponding Yb(III) complex has the smallest R1 enhancement, possessing a µeff value 
of 4.3 BM. 
 
Another important property when considering PARASHIFT probes for imaging 
applications is the relationship between the longitudinal relaxation rate, R1, and the 
transverse relaxation rate, R2. An increase in the latter results in an increase in 
linewidth, so it is imperative this is kept to a minimum. Therefore, it is suggested that in 
order to maximise signal intensity, the R1/R2 ratio should be as close to unity as 
possible, bearing in mind that R2 is always greater than R1. Values for R2 were estimated 
from the individual peak linewidths (at half-height), using a π × ω1/2 relationship in a 
Lorentzian fit. The data in Table 2.1 shows that the R1/R2 ratio is 0.6 for the 
[Ln.L1(H2O)] complexes, except for Yb(III). For a model system, this value is 
considered reasonable, but higher ratios have been reported for some other related CF3-
containing complexes and [Tm.DOTMA]-.8,24 The remarkably low value for Yb(III) 
can be attributed to the fast interconversion between the isomeric species in solution. 
 
In 2009, Kuprov developed an iterative global minimisation algorithm allowing the 
fitting of experimental nuclear relaxation rates, measured at different fields.25 The 
advantage of this is to enable the estimation of several useful parameters in the 
following SBM equation that are difficult to measure empirically i.e. µeff, T1e and τr:3–5   
 !! = ! !!" !!!! ! !!!!!""!!! ! !!!!!!!! !!!!!!! + ! !!!!!!!! !! !!!!! + !!! ! !!!! ! !!! !!""!!!" !!! ! !!!!!! !! !!!  (6) 
 
 
where µ0 is the vacuum permeability, γN is the gyromagnetic ratio of the nucleus, µeff is 
the effective magnetic moment, r is the electron-nuclear distance, τr is the rotational 
correlation time and ωN is the nuclear Larmor frequency.  
 
The algorithm uses a Levenberg-Marquardt minimisation technique, and allows 
individual parameters to be ‘fixed’ to a specified value. By fixing a parameter, and 
thereby eliminating it from the estimation process, the minimisation procedure is greatly 
simplified, but means that reliable values must be used. For example, the temperature is 
always a fixed value in this work (295 K) because it can be controlled and monitored 
accurately when acquiring an R1 measurement. The data can be fitted for each 
lanthanide(III) complex individually (single resonance fitting) or on a global level with 
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a common resonance across an isostructural series (global fitting), e.g. the tert-butyl 
resonance in this work. 
 
Using global minimisation methods for the complexes 9-14 simultaneously, the 
variation of experimental R1 data with field has been used to estimate the distance 
between the lanthanide(III) ion and the tert-butyl reporter group, r.26 Using fixed 
literature values of µeff,27 fitted data sets for each complex were allowed to converge to 
well-defined minima with an average r = 6.65±0.14 Å for the [Ln.L1(H2O)] series 
(Table 2.2 and Figure 2.10).  This correlates well with the predicted Dy(III)-1H reporter 
group distance range, proposed in Section 1.2.2.2, where simulations estimated r to be 
between 6 and 7 Å in order to achieve R1 values of the order of 100 to 200 s-1. 
 
Table 2.2 Calculated values for r (Å) obtained through fitting of experimental R1 values at 6 different 
magnetic fieldsa for [Ln.L1(H2O)] using a fixed value of µeffb
 
(BM) (D2O, 295 K). 
 
[Ln.L1(H2O)] µeff/ BM r/ Å 
Tb 9.8 6.63±0.01 
Dy 10.3 6.59±0.03 
Ho 10.4 6.80±0.02 
Er 9.4 6.68±0.01 
Tm 7.6 6.35±0.02 
Yb 4.3 6.34±0.01 
 Average 6.65±0.14 
 
(a) The fields are 1.0 T, 4.7 T, 9.4 T, 11.7 T, 14.1, 16.4 T; (b) µeff was fixed to literature values.27 
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Figure 2.10 1H NMR relaxation rates, R1/ s-1, for the tert-butyl resonance on [Ln.L1(H2O)] as a function 
of magnetic field, showing the fits (lines) to the experimental data points (circles) (295 K, D2O). 
 
The distance between the lanthanide(III) ion and the protons of the tert-butyl reporter 
group was further verified by calculating optimised geometries using ab initio and DFT 
methods without symmetry constraints, based on the yttrium analogue of a published X-
ray crystal structure (Figure 2.11), by Dr. Mark Fox.7,28 A mean r of 6.62 Å was 
obtained, once again agreeing with the estimations proposed in Section 1.2.2.2 for 
optimising the relaxation rates. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.11 DFT optimised structure of [Y.L1(H2O)]; left, view in the plane of the pyridine ring; right, 
view looking on top of the pyridine ring.28  
 
This relaxation behaviour analysis, further reinforces that the Dy(III) complex is a good 
1H PARASHIFT probe candidate from the [Ln.L1(H2O)] series, by fulfilling the criteria 
set out in Section 2.1. It possesses the required relaxation characteristics, with an R1 of 
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the order of 100 to 200 s-1 at 7 T, and an R1/R2 ratio of 0.6, in addition to its favourable 
tert-butyl chemical shift, over 20 ppm away from the diamagnetic signals in vivo. 
However, while these results are encouraging from a model system point-of-view, it is 
clear that further sensitivity improvements are required before in vivo protocols can be 
considered. Firstly, the observed R1 is at the lower end of the 100 to 200 s-1 range at 7 T, 
and the R1/R2 ratio is lower than for related examples. It is also proposed that the shift 
enhancement can be improved upon, given that the further away the reporter resonance 
is from the water and the fat signals, the better the sensitivity. By shortening the 
acquisition time, bigger bandwidths can be selected, i.e. 20 kHz rather than the 10 kHz 
demonstrated here. Also, due to its neutral charge it is thought that it will clear rapidly 
via the kidneys much like many of its 1H PARASHIFT predecessors.29–31  
2.3 Increasing the Signal Intensity: The Bis-carboxylate Parent System 
Before in vivo studies can be contemplated, improvements to the [Ln.L1(H2O)] series 
are necessary, with both relaxation rate enhancements and signal intensity gains sought 
after. However, care must be taken to ensure minimal structural modification occurs so 
that many of the favourable characteristics from the model [Ln.L1(H2O)] series are 
retained. The design of the C2-symmetric complex, [Ln.L2(H2O)]+ (Figure 2.0), was 
proposed to address these issues. First of all, it is predicted that the tert-butyl groups 
will be equivalent by C2-symmetry, resulting in a single 18 proton reporter resonance. 
The structural similarities between the proposed system and [Ln.L1(H2O)] has two 
advantages: the shift and relaxation behaviour will be comparable, and the synthetic 
route only requires minor modification. The resulting mono-cationic character of the 
[Ln.L2(H2O)]+ series will undoubtedly have affects on the clearance rate and the 
biodistribution profile in vivo. Despite exchanging a negatively charged hard oxygen 
donor for a less strongly coordinating pyridyl nitrogen donor, the overall stability of the 
[Ln.L2(H2O)]+ series is expected to be comparable to the [Ln.L1(H2O)] series, as 
reported in literature.32 
2.3.1 Synthesis and characterisation 
The bis-substituted ligand framework was achieved using a series of protection and 
alkylation steps (Scheme 2.2). Firstly, selective trans-protection of cyclen was achieved 
under pH control using benzyl chloroformate, to afford compound 15, which was N-
alkylated in the 4- and 10- positions using tert-butyl bromoacetate, to give the tetra-
substituted macrocycle 16. The benzyl protecting groups were removed under high-
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pressure hydrogenation over a Pd(OH)2/C catalyst, to afford the desired bis-substituted 
ligand framework 17, as reported in the literature.33! 
!
Scheme 2.2 General procedure for the synthesis of the bis-substituted ligand framework, 17. 
 
Di-alkylation of the two free amine sites on 17 was undertaken, Scheme 2.3, using 2.5 
equivalents of the previously synthesised mesylate precursor, 5. The desired tetra-
alkylated ligand, 18, was separated from the tri-substituted ligand by silica gel column 
chromatography, albeit in modest yield. The ligand 18 was then deprotected using 6 M 
HCl to generate the acid salt of the deprotected ligand. Trifluoroacetic acid, used 
previously, is the obvious choice for the removal of tert-butyl protecting groups. 
However, concentrated HCl was favoured for the treatment of 18, since previous 
unpublished work showed that chloride salts are better tolerated in vivo. Complexation 
of the resulting ligand was achieved with the appropriate hydrated lanthanide(III) 
chloride, in an aqueous solution maintained at pH 5.5. Preparative reverse-phase HPLC 
purification yielded the desired series of complex, [Ln.L2(H2O)]+, where Ln = Eu to Yb 
(19-26). !
!
 
Scheme 2.3 General procedures for the synthesis of the C2-symmetric parent 1H PARASHIFT probes, 
[Ln.L2(H2O)]+, 19-26. !
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The purity of complexes 19-26 was assessed by analytical reverse-phase HPLC. For this 
series of complexes, the retention times ranged between 3.6 and 4.8 min. These 
markedly shorter retention times, compared to the [Ln.L1(H2O)] series (ca. 8.3 to 8.9 
min), reflect an enhancement in the hydrophilicity due to the now cationic nature of the 
complexes. Again, the identity of the desired complexes was confirmed by high-
resolution mass spectrometry, with each complex displaying a characteristic isotope 
pattern in agreement with the simulated isotope pattern. 
 
The q value for the [Ln.L2(H2O)]+ series was estimated by measuring the radiative 
lifetimes of the Tb(III) and Eu(III) emissive excited states in H2O and D2O (Table 2.3) 
and by determining the relaxivity of the Gd(III) complex using equation 3. Both 
calculations indicated that the complexes in the [Ln.L2(H2O)]+ series possess one 
bound water molecule (r1p = 5.8±0.02 mM-1 s-1). 
 
Table 2.3 Experimentally determined radiative rate constants, k, and derived values of q (±20%) for 
[Eu.L2(H2O)]+ and [Tb.L2(H2O)]+ (295 K, pH 7.0). 
 
[Ln.L2(H2O)]+ !!!!/ ms-1 !!!!/ ms-1 q 
Eu 1.59 0.34 1.2 
Tb 0.55 0.35 0.7 
 
2.3.2 1H NMR studies: shift and relaxation behaviour 
The chemical shift behaviour of the tert-butyl reporter group on each complex was 
analysed by 1H NMR spectroscopy (Figure 2.12). Although the shifts appear 
comparable to those previously observed for the [Ln.L1(H2O)] series, closer inspection 
reveals that they are not quite as large. For example, the Tm(III) and Er(III) tert-butyl 
resonances occur 4 ppm closer to the water signal, at +6.2 ppm and +3.4 ppm, 
respectively. In three of the complexes, the resonance still possesses the required shift 
outside of the diamagnetic range, with the Dy(III) complex once again displaying the 
largest shift. Nevertheless, this resonance is also shifted closer to the water signal at -
17.9 ppm, but still in an area of zero background signal in vivo.  
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Figure 2.12 Superimposed 1H NMR spectra of C2-symmetric parent complexes, [Ln.L2(H2O)]+, 
highlighting the shift in the tert-butyl reporter resonance for Ln = Tm, Ho, Tb and Dy (D2O, 9.4 T, 295 
K), with respect to the corresponding Bleaney coefficients (CJ). The solvent water peak and Er spectrum 
are omitted for clarity (Er tert-butyl is at +3.4 ppm). 
 
In each case, one major isomer was observed which accounted for >90% of the 
observed signal intensity; an improvement on the [Ln.L1(H2O)] series (ca. >80%). 
Recent literature has demonstrated that a structurally similar Yb(III) complex bearing 
two pyridine carboxylate units exists as a TSAP in the solid-state, with slightly 
distorted C2 symmetry.32 Such information is consistent with the hypothesis that the 
isomers of [Dy.L2(H2O)]+ are SAP and [Tm.L2(H2O)]+ are TSAP, owing to the change 
in ligand framework conformation as it accommodates the smaller lanthanide(III) ion, 
as the series is traversed. 
 
The chemical shift magnitude of the tert-butyl group was assessed in complexes 21-25 
in terms of the Bleaney coefficients (Figure 2.13). Once again, the shifts showed a 
reasonable agreement with the relative ordering predicted by the Bleaney coefficients 
but failed to fit to a linear trend, with the Tb(III) and Ho(III) complexes displaying 
unexpectedly similar shifts. 
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Figure 2.13 Relationship between the magnitude of the paramagnetic shift, |δpara|, of the tert-butyl 
reporter resonance for [Ln.L2(H2O)]+ and the Bleaney coefficients for each lanthanide(III) ion. N.B. All 
signs are positive for clarity, the |δpara| is estimated by assuming the diamagnetic complex has a shift of 
1.5 ppm and the line shown is a line of best-fit to the data. 
 
Analysis of the ∆! = 1 manifold in the Eu(III) emission spectrum of [Eu.L2(H2O)]+ 
gave a !!! value equal to -360 cm-1 (Figure 2.14), suggesting that the crystal field 
splitting is smaller for the [Ln.L2(H2O)]+ series, compared with the [Ln.L1(H2O)] 
series (ca. -500 cm-1). This is somewhat consistent with the decrease in the tert-butyl 
shift magnitude for the [Ln.L2(H2O)]+ series, relative to the [Ln.L1(H2O)] series. 
 !!!= - 360±40 cm-1 
 
 
Figure 2.14 Emission spectrum of [Eu.L2(H2O)]+ (D2O, 295 K, λexc= 270 nm), analysis of the ∆! = 1 
manifold at 590-595 nm allows the crystal field splitting parameter, !!!, to be estimated. 
 
The relaxation behaviour was analysed by measuring the relaxation rates of the major 
tert-butyl resonances of [Ln.L2(H2O)]+ at 6 different field strengths (Table 2.4). From 
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the previous series, only [Dy.L1(H2O)] possessed the required R1 values, of the order of 
100 to 200 s-1 at 7 T. However, the value was around the lower limit of the desired 
range and so further R1 enhancements were sought. It is evident from this data that two 
complexes from the [Ln.L2(H2O)]+ series exhibit enhanced R1 values that lie in the 
middle of the desired range. The Dy(III) and Tb(III) complexes both show a 60% 
increase compared with their predecessors, with remarkable improvements also 
apparent in their respective R1/R2 ratios. The values achieved for Dy(III) and Tm(III), 
0.78 and 0.79 respectively, are the highest reported values for these type of systems, 
with the previous highest values reported for the isomers of [Tm.DOTMA]- (R1/R2 = 
0.75 for the major Me resonance; 0.72 for the minor Me resonance).1 This marked 
increase in the R1/R2 ratio is indicative of an increase in the structural rigidity of the 
complex. When there are two coordinated pyridyl functionalities, cooperative 
carboxylate arm rotation is minimised, hence chemical exchange broadening is 
suppressed. Such an inference also explains the relative increase in the isomeric ratio. 
 
Table 2.4 Experimental longitudinal relaxation rate data for the major tert-butyl resonance of 
[Ln.L2(H2O)]+ at different magnetic field strengths (D2O, 295 Ka). 
 
Ln R1/ Hz (± error)  R1/R2b 
(9.4 T) 
 1.0 T 4.7 T 9.4 T 11.7 T 14.1 T 16.4 T  
Tb 84 (5) 103 (1) 151 (2) 169 (1) 188 (1) 207 (2) 0.79 
Dy 89 (3) 119 (1) 174 (1) 203 (1) 230 (1) 256 (1) 0.78 
Ho 30 (2) 56 (1) 102 (2) 138 (2) 156 (1) 177 (4) 0.66 
Er 7 (1) 19 (1) 41 (5) 53 (7) 71 (9) 81 (21) 0.40 
Tm 10 (1) 21 (1) 40 (1) 51 (1) 59 (1) 68 (1) 0.46 
Yb 4.0 (0.5) 4.7 (0.2) 7.1 (0.1) 8.3 (0.2) 9.6 (0.3) 10.5 (0.2) 0.22 
 
(a) Temperature was monitored accurately, calibrating against an ethylene glycol shift thermometer; (b) 
R2 values were estimated as (π × ω1/2), for a Lorentzian line fit. 
 
Global fitting of the R1 data for the [Ln.L2(H2O)]+ complex series (Figure 2.15), as 
before, allowed the average distance between the lanthanide(III) ion and the tert-butyl 
reporter group to be estimated as 6.57±0.05 Å (Table 2.5). 
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Table 2.5 Calculated values for r (Å) obtained through fitting of experimental R1 values at 6 different 
magnetic fieldsa for [Ln.L2(H2O)]+ using a fixed µeffb
 
(BM) (D2O, 295 K). 
 
[Ln.L2(H2O)]+ µeff/ BM r/ Å 
Tb 9.8 6.38±0.02 
Dy 10.3 6.36±0.01 
Ho 10.4 6.78±0.02 
Er 9.4 n.d. 
Tm 7.6 6.50±0.02 
Yb 4.3 6.28±0.03 
 Average 6.57±0.05 
 
(a) The fields are 1.0 T, 4.7 T, 9.4 T, 11.7 T, 14.1, 16.4 T; (b) µeff was fixed to literature values.27 The 
data set for Er did not converge to a well-defined minimum. 
 
 
 
Figure 2.15 1H NMR relaxation rates, R1/ s-1, for the tert-butyl resonance on [Ln.L2(H2O)]+ as a function 
of magnetic field, showing the fits (lines) to the experimental data points (circles) (295 K, D2O). Er was 
omitted as reliable fitting did not occur. 
 
Both [Dy.L1(H2O)] and [Dy.L2(H2O)]+ present very good spectral properties satisfying 
the key requirements outlined for the design of 1H PARASHIFT probes in Section 2.1. 
Whilst [Dy.L1(H2O)], possesses the most shifted tert-butyl chemical shift, at -20.1 ppm, 
its R1 is at the lower limit of the required 100 to 200 s-1 range at 7 T. The development 
of the C2-symmetric complex, [Dy.L2(H2O)]+, showed a 60% increase in R1, which 
offsets the slight reduction in the tert-butyl chemical shift at -17.9 ppm. Sufficient 
signal intensity gains were achieved by doubling the number of nuclei contributing to 
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the reporter signal and chemical exchange broadening was reduced by increasing the 
structural rigidity of the complex so that the R1/R2 ratio is amongst the highest reported. 
Such qualities make [Dy.L2(H2O)]+ and its congeners an attractive candidate for 
phantom and in vivo MRS studies. 
2.3.3 1H MRS phantom imaging studies 
Preliminary phantom imaging studies were carried out at 7 T, using a 2 mM solution of 
[Dy.L2(H2O)]+ in a cut-down 5 mm NMR tube, by Prof. Andrew Blamire at the 
Newcastle Magnetic Resonance Centre. The NMR tube was placed at 90° to the 
magnetic field in the bore of a 30 mm birdcage coil, typically used for standard MRI 
experiments on small mice (≤25 g). Due to its favourable shift and relaxation 
characteristics, it was proposed that the tert-butyl resonance on [Dy.L2(H2O)]+ could be 
observed easily against the background noise. In Section 2.1, it was rationalised that a 
shift < -34 ppm or > +44 ppm is essential, at a 7 T magnetic field, if practicable imaging 
pulse sequences are to be used to minimise interference from the water signal. In theory, 
since the tert-butyl resonance on [Dy.L2(H2O)]+ occurs at -17.9 ppm, a pulse bandwidth 
of 10 kHz, centred at the tert-butyl resonant frequency can be used to selectively excite 
the tert-butyl resonance.1 The effect of changing the bandwidth on the 1H MRS image 
of the tert-butyl resonance on [Dy.L2(H2O)]+ is shown in Figure 2.16, where full 
eradication of the water signal is only demonstrated for 10 kHz. Such a result is 
expected, when it is considered that the water and tert-butyl signals are only 6.7 kHz 
apart at 7 T. 
 
 
 
Figure 2.16 Single slice gradient echo 2D scan (axial orientation, 2 mM complex, H2O) displaying 
images for the water signal (top) and the tert-butyl resonance of [Dy.L2(H2O)]+ (bottom). (a-e) Variable 
bandwidths are indicated for each scan. 
 
Whilst this reduced bandwidth method demonstrates the theory, in practice, lower 
bandwidths result in longer acquisition times. In this case, a 5 mm 2D slice was 
analysed but it is predicted that problems will arise when applying these sweep widths 
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to a larger object, i.e. a mouse. Before the use of larger bandwidths can be considered, a 
system needs to be contrived where the tert-butyl displays a larger paramagnetic shift. 
2.3.4 1H MRS in vivo imaging studies  
Proof-of-principle in vivo 1H MRS imaging studies were performed by Prof. Andrew 
Blamire and Dr. Ian Wilson, at the Newcastle Magnetic Resonance Centre, using 
[Dy.L2(H2O)]+. Solutions of 0.12 mmol kg-1 of [Dy.L2(H2O)]+ were administered to 
three separate SCID male mice (25 g), bearing HCT-116 tumours (i.e. human colorectal 
carcinoma xenografts). Intravenous administration of [Dy.L2(H2O)]+ via the tail vein 
was 10-14 days post-inoculation to ensure the tumours were about 10 mm in diameter. 
During the experiment the mice were anaesthetised with oxygen/1-2% isofluorane. 
 
 
 
 
Figure 2.17 Top left: spectroscopic imaging grid overlaid onto a representative slice of a structural scan. 
Top centre: localised signal from the tert-butyl signal of [Dy.L2(H2O)]+ from each corresponding voxel 
of the grid 80 min after administration (0.12 mmol/kg complex, 7 T, TR = 104 ms, TE = 1.2 ms, SW = 5 
kHz, 64 mm FOV, 8 × 8 matrix, 3 min 34 sec, maximum SNR = 25). Top right: Structural scans and 
colour overlay of spectral peak integrals. Bottom: 3D gradient echo 1H MR scan in a different mouse 
(0.03 mmol/kg complex, 7 T, TR = 10 ms, TE = 4.39 ms, SW = 5 kHz, 5 min 28 sec, maximum SNR = 
20). 
 
Strong signals were initially exhibited, but the tert-butyl peak was substantially broader 
than expected in vivo with a linewidth around 200 Hz.1 Localised spectra from across 
the mice were obtained using a 5 kHz bandwidth, centred upon the -17.9 ppm resonant 
frequency of interest, to avoid interference from the water protons. An image 
representation of the distribution of [Dy.L2(H2O)]+ was created by peak integration for 
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each spatial location and overlaid onto the structural scans (Figure 2.17). In the latter 
mice, strong localisation of the complex in the muscular tissue was evident, with later 
accumulation in the bladder. In each case, images were obtained within a relatively 
short amount of time (<6 min) and the complex was tolerated well. 
 
Despite extremely encouraging preliminary results, the retention of the cationic 
complex in muscle tissue remains a concern. However, the high sensitivity associated 
with these complexes has allowed for the acquisition of sufficient signal intensity in a 
living animal, in under 6 min due to the advantage of having a zero-background signal 
at the reporter resonant frequency. 
2.4 Increasing the Shift: The Phosphinate Parent System 
Previous imaging protocols with [Dy.L2(H2O)]+ saw the benefit of using a reduced 
bandwidth, where the water peak is excluded and the tert-butyl peak is imaged 
selectively. However, in order to increase the bandwidth and reduce imaging acquisition 
times, a tert-butyl shift of < -34 ppm or > +44 ppm is essential at 7 T. Consequently, the 
tri-phosphinate system, [Ln.L3] (Figure 2.0), has been designed in accord with 
literature, whereby substitution of carboxylate for phosphinate arms resulted in large 
chemical shift enhancements.8,34 It is predicted that shifts of up to -40 ppm can be 
achieved for the Dy(III) analogue, and >+40 ppm for Tm(III). 
2.4.1 Synthesis and characterisation 
The generally accepted methodology for the synthesis of a tri-phosphinate ligand, is 
shown in Scheme 2.4.8,35,36 First, alkylation of 1,4,7-tris-tert-butoxycarbonyl-1,4,7,10-
tetraazacyclododecane (tri-BOC) is carried out with the pyridyl arm of interest, where 
LG is the leaving group and X is representative of the reporter group. Subsequent 
removal of the tert-butyloxycarbonyl (BOC) protecting groups, with TFA, affords the 
mono-substituted cyclen compound. Finally, a one-pot synthetic step involving the co-
condensation of the secondary amine groups with paraformaldehyde and diethyl 
methylphosphonite, yields the desired tri-phosphinate ligand, following an Arbusov-
type rearrangement. 
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Scheme 2.4 General procedure for the classical synthesis of a tri-phosphinate ligand, where LG = a 
leaving group i.e. Br or OMs, and X = the reporter group i.e. CF3 or tBu. 
 
While this synthetic route is widely accepted, the yields for the final step can be rarther 
low (ca. 30-50%). Therefore, it was proposed that in order to produce higher overall 
yields, a batch of the tri-phosphinate 12-N4 macrocycle should be made, which can be 
alkylated with the pyridyl moiety in the penultimate step, preceding deprotection and 
complexation. This was the case in the syntheses of the [Ln.L1(H2O)] and 
[Ln.L2(H2O)]+ series, where batches of the tri-carboxylate macrocycle, 1, and the bis-
carboxylate macrocycle, 17, were used respectively. This alternative pathway is 
advantageous because the poorest yielding step is early in the synthetic path, and occurs 
with a compound that is easily derived from common starting materials. In addition, 
such an idea allows for alkylation of the free amine site with a variety of different 
substituents and presents a more efficient synthetic route, rather than repeating Scheme 
2.4 for each different complex. 
 
The synthetic route for the formation of the tri-phosphinate 12-N4 macrocycle, 31, is 
described in Scheme 2.5 and employs familiar protecting group chemistry. To begin, the 
protection of three cyclen amine sites was achieved using 3.1 equivalents of benzyl 
chloroformate and triethylamine, to afford the carbamate 27. The remaining amine site 
was alkylated, using di-tert-butyl dicarbonate, to give the tetra-substituted macrocycle 
28. Removal of the benzyl protecting groups under high-pressure hydrogenation, with a 
Pd(OH)2/C catalyst, yielded the mono-BOC protected cyclen compound 29. The tri-
phosphinate mono-BOC compound, 30, was formed by the one-pot co-condensation of 
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29 with paraformaldehyde and diethyl methylphosphonite. Alumina gel column 
chromatography was employed for the purification, since previous work showed poor 
separation of the crude material using silica.  
 
!
 
Scheme 2.5 General procedure for the synthesis of the tris-phosphinate ligand framework, 31. 
 
The resulting 31P NMR spectrum showed that 30 existed as a mixture of stereoisomers 
in solution, differing in configuration at each phosphorus stereocentre (Figure 2.18). 
Finally, the BOC group was removed using trifluoroacetic acid, to give the desired tri-
phosphinate ligand framework, 31, after aqueous basic work up. 
 
 
 
Figure 2.18 31P NMR spectrum of 30, highlighting the presence of stereoisomers (CDCl3, 295 K, 16.4 T). 
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The remaining secondary amine position on 31 was alkylated with the mesylate, 5 
(Scheme 2.6). Once again, alumina gel column chromatography was used to purify the 
crude mixture, allowing isolation of the tetra-substituted ligand, 32. The phosphinate 
esters were cleaved under acidic conditions to give the acid salt of the free ligand, and 
metal complexation was carried out in aqueous solution at pH 5.5, using the appropriate 
hydrated lanthanide(III) chloride. Preparative reverse-phase HPLC purification yielded 
the desired series of complex, [Ln.L3], where Ln = Eu to Yb (33-40). 
 
!
 
Scheme 2.6 General procedures for the synthesis of the PMe3 parent 1H PARASHIFT probes, [Ln.L3], 
33-40. 
 
As for the previous series, the purity of complexes 33-40 was evaluated by analytical 
reverse-phase HPLC (Figure 2.19 shows [Er.L3]). The observed retention times ranged 
between 8.6 and 10.2 min and so are comparable to the [Ln.L1(H2O)] series (ca. 8.3 to 
8.9 min). Such an observation is consistent with the neutral nature and the structural 
similarity of the complexes in each series. Again, the identity of the desired complexes 
was confirmed by high-resolution mass spectrometry, with each complex displaying the 
expected characteristic isotope pattern. 
 
!
 
Figure 2.19 Observed analytical reverse-phase HPLC UV chromatogram of [Er.L3] (λ= 268 nm, 10-
100% MeOH+0.1% formic acid in H2O+0.1% formic acid over 10 min, tR=10.2 min). 
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The hydration state, q, for the [Ln.L3] series was estimated by measuring both the 
radiative lifetimes of the Tb(III) and Eu(III) emissive excited states in H2O and D2O 
(Table 2.6) and by determining the relaxivity of the Gd(III) complex using equation 3. 
In this case, both calculations suggested that the complexes in the [Ln.L3] series do not 
possess a bound water molecule, i.e. they are q = 0 with a coordination number of 8 (r1p 
= 1.5±0.04 mM-1 s-1). Such an inference is plausible when the steric bulk of the PMe 
chelating arms are considered, and is consistent with the behaviour of related tri-
phosphinate pyridyl-based systems.8 
 
Table 2.6 Experimentally determined radiative rate constants, k, and derived values of q (±20%) for 
[Eu.L3] and [Tb.L3] (295 K, pH 7.0). 
 
[Ln.L3] !!!!/ ms-1 !!!!/ ms-1 q 
Eu 0.57 0.48 0 
Tb 0.32 0.28 0 !
2.4.2 1H NMR studies: shift behaviour 
The chemical shift behaviour of the tert-butyl reporter group on each complex was 
analysed by 1H NMR spectroscopy (Figure 2.20). A large increase in shift for the 
[Ln.L3] series is clearly evident, with all six tert-butyl resonances now possessing the 
required shifts, far from the diamagnetic range. For this system, the Tb(III) and Tm(III) 
tert-butyl resonances show the largest improvements on their tri-carboxylate analogues 
(60 ppm) and are the most shifted species with opposite senses, at -77.3 ppm and +67.2 
ppm, respectively. The Dy(III) tert-butyl was predicted to be the most shifted from its 
predecessors, and resonates an additional 50 ppm away from the corresponding C3 
parent complex at -75.1 ppm. Consider lastly the cases of Ho(III) and Er(III), each can 
now be considered as attractive candidates for this work, given their shift enhancements 
of 30 ppm with respect to their tri-carboxylate analogues (-31.9 ppm and +38.3 ppm, 
respectively). 
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Figure 2.20 Superimposed 1H NMR spectra of PMe3 parent complexes, [Ln.L3], highlighting the shift in 
the tert-butyl reporter resonance for Ln = Tm, Er, Yb, Ho, Tb and Dy (D2O, 9.4 T, 295 K), with respect 
to the corresponding Bleaney coefficients (CJ). The solvent water peak is omitted for clarity and * 
represents residual formate from HPLC purification and neutralisation. 
 
For the phosphinate complexes, the number of species in solution can be complicated 
due to the differing configurations at each phosphorus centre, a phenomenon 
demonstrated earlier for the diamagnetic molecule 30 (Figure 2.18). However, it has 
been established that mono-amide tri-phosphinate 12-N4-based lanthanide(III) 
complexes give rise to two favourable low energy isomers where the chirality at each 
phosphorus stereocentre is consistent e.g. RRR or SSS.37,38 For the pyridyl systems 
reported here, additional thermodynamically stable configurations are not possible due 
to the locked configuration of the bound pyridine. As a result, each complex in the 
[Ln.L3] series exists as one major isomer in solution, accounting for approximately 
85% of the observed signal intensity. This observation marks a slight improvement on 
the [Ln.L1(H2O)] series (ca. >80%) whilst remaining comparable to the [Ln.L2(H2O)]+ 
series ( >90%). 
 
The magnitude of the paramagnetic shift of the tert-butyl group for complexes 35-40 
did not correlate well to the Bleaney coefficients (Figure 2.21). However, as 
demonstrated before, the shifts do not fit to a linear trend, with the Er(III), Tm(III) and 
Tb(III) complexes showing the largest deviations.  
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Figure 2.21 Relationship between the magnitude of the paramagnetic shift, |δpara|, of the tert-butyl 
reporter resonance for [Ln.L3] and the Bleaney coefficients for each lanthanide(III) ion. N.B. All signs 
are positive for clarity, the |δpara| is estimated by assuming the diamagnetic complex has a shift of 1.5 
ppm and the line shown is a line of best-fit to the data. 
 
Analysis of the ∆! = 1 manifold in the Eu(III) emission spectrum of [Eu.L3] gave the 
crystal field splitting parameter, !!!, to be -590 cm-1 (Figure 2.22). An increase in the 
crystal field splitting for the [Ln.L3] complex series is consistent with the fact that the 
tert-butyl shift magnitude has increased relative to the [Ln.L1(H2O)] and 
[Ln.L2(H2O)]+ series. 
 !!!= - 590±40 cm-1 
 
 
Figure 2.22 Emission spectrum of [Eu.L3] (D2O, 295 K, λexc= 270 nm), analysis of the ∆! = 1 manifold 
at 590-595 nm allows the crystal field splitting parameter, !!!, to be estimated. 
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The sharp well defined 1H NMR spectrum of [Yb.L3] was fully assigned (Figure 2.23), 
with the aid of relaxation rate data and by comparison with structurally equivalent 
systems. 
 
 
Figure 2.23 Annotated 1H NMR spectrum of [Yb.L3] (D2O, 9.4 T, 295 K). The unassigned resonances 
are due to the minor isomer. 
2.4.3 1H NMR studies: relaxation behaviour 
The relaxation behaviour of the major tert-butyl resonances of the [Ln.L3] series was 
assessed at 6 different fields (Table 2.7). A decrease in the observed relaxation rates 
was observed for all the complexes in the [Ln.L3] series, except in the case of Er(III), 
which showed the highest longitudinal relaxation rate across all the fields measured, 
with a 70% enhancement relative to the tri-carboxylate system. Remarkable also, is the 
high longitudinal relaxation rate of the Er(III) complex at low field whereas the other 
complexes show a steeper field dependence. To add to this, only the Er(III) complex 
possesses the required R1 value of the order of 100 to 200 s-1 at 7 T, with the Dy(III) and 
Tb(III) complexes each showing a marked decrease in their respective relaxation rates, 
relative to the tri-carboxylate system. The calculated R1/R2 ratios across the series are 
comparable to those previously observed.1,8,39 The relatively bulky phosphinate 
substituents enhance the structural rigidity of the complex by hindering cooperative arm 
rotation. Global fitting of the experimental R1 data sets for the [Ln.L3] complex series, 
allowed the average distance between the lanthanide(III) ion and the tert-butyl reporter 
group to be estimated with an average r of 6.61±0.07 Å. 
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Table 2.7 Longitudinal relaxation rate (R1) data for the major tert-butyl resonance of [Ln.L3] at different 
magnetic field strengths (D2O, 295 Ka). 
 
Ln R1/ Hz (± error) R1/R2b 
(9.4 T) 
 1.0 T 4.7 T 9.4 T 11.7 T 14.1 T 16.4 T  
Tb 35 (2) 53 (2) 81 (2) 91 (1) 102 (1) 113 (1) 0.71 
Dy 40 (2) 59 (1) 96 (1) 114 (1) 132 (1) 150 (1) 0.59 
Ho 35 (1) 61 (2) 100 (1) 127 (1) 147 (1) 166 (1) 0.57 
Er 77 (2) 88 (2) 120 (2) 135 (1) 152 (1) 169 (1) 0.71 
Tm 18 (2) 55 (1) 97 (1) 115 (1) 129 (1) 142 (1) 0.50 
Yb 11.1 (0.1) 10.7 (0.1) 11.4 (0.7) 11.6 (0.6) 12.0 (0.1) 12.4 (0.3) 0.39 
 
(a) Temperature was monitored accurately, calibrating against an ethylene glycol shift thermometer; (b) 
R2 values were estimated as (πω1/2), for a Lorentzian line fit. 
 
Such unprecedented relaxation behaviour has been reported for a related tri-phosphinate 
Er(III) complex with q = 0 and a coordination number of 8 (Figure 2.24), suggesting 
that these tri-phosphinate 12-N4-based systems show unique behaviour in their Er(III) 
complexes.25,28 In contrast, relaxation analyses of the 9 coordinate tri- and bis-
carboxylate systems (q = 1) showed that only the Dy(III) and/or Tb(III) complexes 
possess the required R1 values of the order of 100 to 200 s-1 at 7 T, with the highest 
relaxation rates observed with the Dy(III) C2-symmetric parent system. Therefore, it is 
clear that Er(III) tri-phosphinate complexes, and Dy(III) and/or Tb(III) tri- and bis-
carboxylate complexes appear to be the best candidates for use as PARASHIFT probes, 
in the field range 1.5 to 7.0 T, based on the critical balance between the shift and 
relaxation behaviour, presented in Section 2.1. 
 
 
 
Figure 2.24 Structure of a related tri-phosphinate Er(III) complex, showing analogous relaxation rate 
behaviour to [Er.L3]. 
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Overall, the [Ln.L3] series demonstrates the desired enhancements in shift behaviour, 
with shifts of >60 ppm from the water signal achieved in the (Tb(III), Dy(III) and 
Tm(III) complexes. Such a shift magnitude allows larger bandwidths of 20 kHz to be 
used in imaging, so that shorter repetition rates and faster data acquisition can occur. 
The previously overlooked later lanthanide(III) ions, Er(III) and Ho(III) show 
interesting shift behaviour in this system, with tert-butyl groups resonating 30 ppm 
away from the water signal but remain just inside the desired goal posts of < -34 ppm or 
> +44 ppm and so are less suitable for imaging with a 20 kHz bandwidth.  
 
The relaxation behaviour presents a few surprises, however. Firstly, both [Dy.L3] and 
[Tb.L3] display lower relaxation rates than the tri-carboxylate systems across all the 
fields measured. Conversely, increases in relaxation rates were observed for Ho(III), 
Tm(III), Yb(III) and in particular Er(III), which shows a 70% increase across all fields 
and was the only candidate from the [Ln.L3] series with the required relaxation rates of 
100 to 200 s-1 at 7 T. It is clear that there are stark differences between the shift and 
relaxation behaviour of the [Ln.L1(H2O)] and [Ln.L3] systems and a more detailed 
analysis of this behaviour was carried out. 
2.5 Comparing the [Ln.L1(H2O)] and [Ln.L3] Parent Complexes 
2.5.1 Shift Behaviour 
Comparison of the tert-butyl shift behaviour in the two series of complexes (i.e. tri-
carboxylate vs. tri-phosphinate) reveals an increase of over 50 ppm for the tri-
phosphinate complexes of Tb(III), Dy(III) and Tm(III) and 30 ppm for Er (III) and Ho 
(III) (Table 2.8). Such large shift differences cannot simply be attributed to a change in 
the ligand crystal field, as defined by !!! (-590 vs. -500 cm-1), or to any significant 
structural change in these relatively rigid systems.  
 
 
 
 
 
 
 
 
 
Chapter Two: Parent 1H PARASHIFT Probes !
! 75 
Table 2.8 1H NMR tert-butyl shift data for the [Ln.L1(H2O)] and [Ln.L3] complex series’ (D2O, 295 K, 
9.4 T). 
 
Lanthanide(III) δH/ ppm 
[Ln.L1(H2O)] [Ln.L3] 
Tb -11.1 -76.6 
Dy -20.1 -75.1 
Ho -7.2 -31.9 
Er +7.0 +38.3 
Tm +10.5 +67.2 
Yb +6.3 +18.1 
 
One of the assumptions of Bleaney’s theory concerns the treatment of the f electron 
distribution, detailed on page 15 in Section 1.2.1.1. It is assumed that the unpaired f 
electrons can be treated as a point dipole on the nucleus, but this argument neglects to 
represent the overall spatial distribution of the 4f electron cloud for these anisotropic 
lanthanide(III) complexes. Recently, Kuprov put forward a new distributed model that 
better represents the f electron density probability functions. However, this is yet to find 
wide-scale application since it requires a description of the electron probability 
density.40 However, a more intuitive approach has been adopted by Rinehart and Long, 
who simulated the shape variation of the quadrupole moments of the 4f electron cloud 
using the angular dependence of the 4f orbitals.41 The variation in the 4f electron density 
cloud is evident from oblate (where ml is highest) for Tb(III), Dy(III) and Ho(III), to 
prolate for Er(III), Tm(III) and Yb(III) (where ml is lowest) (Figure 2.25). Such a 
variation across the later lanthanide(III) ions correlates with the differing sense of shift 
incorporated in the Bleaney coefficients, CJ. Note the curious case of Er(III) and 
Pm(III), which appear almost isotropic in this model, potentially explaining the 
observation of small paramagnetic shifts in many Er(III) complexes. 
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Figure 2.25 Representations of the shape of the 4f orbitals from the highest magnitude ml (most oblate on 
the left) to the lowest magnitude ml (most prolate on the right) (bottom) and the quadrupole 
approximations of the 4f electron cloud for the lanthanide(III) ions (top), based on the total angular 
momentum, J, the Stevens coefficient and the 4f orbital radii.41 
 
Bleaney additionally assumed that the principal axis of magnetisation, defined by the 
energetically favoured direction of the spontaneous magnetisations, is the same for each 
lanthanide(III) ion in a complex series. The generalisation that the position of this 
principal (or easy) axis does not change as the lanthanide(III) ion varies across an 
isostructural series of complexes is not valid, as demonstrated by Sessoli et al.42 Their 
work shows the change in the position of the principal axis of magnetisation in the C4 
symmetric [Ln.DOTA(H2O)]- series, as the later lanthanide(III) ions are traversed 
(Figure 2.26). In the case of Dy(III), it moves by 90° according to whether or not there 
is an axially bound water molecule.43 Such a finding is of particular interest when 
considering the q = 0 and q = 1 complexes discussed here. The axis rotates by 90° from 
Tb(III) to Yb(III) such that for the oblate ions, it is perpendicular to the C4 axis, and as 
the ions become more prolate, alignment with the C4 axis occurs. Again, the most 
intriguing case is Er(III), which shows a significant discrepancy between experimental 
data and calculated simulations. 
 
 
 
Figure 2.26 The variation in the experimental (pink) and calculated (blue) easy axis of magnetisation 
across the [Ln.DOTA(H2O)]- series (2 K), shown perpendicular (top) and parallel (bottom) to the C4 
symmetry axis.42 
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Overall, these findings indicate that the lanthanide(III) ions possess different 4f electron 
distributions depending on the coordination ligand field. Hence, the oblate ions are most 
likely to show the largest anisotropy when the ligand electron density is mainly above 
and below the xy plane in a ‘sandwich’ type interaction, and ligands with predominantly 
equatorial distributed ligand electron density are most likely to show the largest 
anisotropy for the prolate ions, so as to minimise the repulsive charge between the 
ligand and the f electron cloud.41,44 As a result, the magnetic moments for the 
lanthanide(III) ions may vary as a function of their coordination environment, especially 
in complexes where the ligand field splitting is significantly larger than !!!. This 
aspect will be analysed in more detail in Section 2.5.2.  
 
Another key issue relates to the anisotropy of the individual mJ states. The separation 
between the mJ states is a function of ligand geometry and symmetry, and the 
Boltzmann population depends on their energy separation with respect to !!!. Consider 
Tb(III) with a ‘sandwich’ type ligand: the mJ = ±6 state has oblate electron density, 
whereas the remaining mJ = 0, ±1, ±2, ±3, ±4 and ±5 states are predominantly prolate in 
form. Such behaviour leads to a large separation between the ground ±6 state and the 
higher lying mJ states, and so determines the relative population and overall magnetic 
anisotropy, at a given temperature. In order to further investigate the paramagnetic 
NMR shift of the [Ln.L1(H2O)] and [Ln.L3] systems, analysis of the magnetic 
anisotropy must consider the population-weighted contribution of the ground and lowest 
excited mJ states of the lanthanide(III) ion. One possible means of probing these 
complex issues is to look at the emission profile of relevant [Ln.L1(H2O)] and [Ln.L3] 
complexes by optical spectroscopy, in order to interrogate the electronic ground state 
manifold. 
 
2.5.1.1 Emission Spectra Studies 
Lanthanide(III) ion optical emission behaviour can be very sensitive to single ligand 
variations and can offer information towards elucidating the differing contributions 
from the mJ states of the electronic ground state to the size and magnitude of the 
magnetic anisotropy.45,46 The complexes of Dy(III) and Tb(III) have been investigated 
here. In each case, the energy gap between the emissive state and the highest lying 
electronic energy level of the ground state manifold correspond to emission in the 
visible region of the spectrum. The usefulness of investigating the Eu(III) spectrum, 
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particularly the energy gap in the ∆! = 1 manifold, has been illustrated previously for 
all three systems.  
 
The pyridyl group in [Ln.L1(H2O)] and [Ln.L3] acts as an antenna to aid sensitisation 
of lanthanide(III) luminescence. Following excitation of the pyridine π to π* transition 
at 270 nm, intramolecular energy transfer populates the lowest manifold of the excited 
state of the lanthanide(III) ion (4F9/2 for Dy(III), 5D4 for Tb(III)). For Dy(III), the 
emissive excited state is relatively long-lived, with lifetimes of the order of 10 µs. 
Emission spectra of [Dy.L1(H2O)] and [Dy.L3] were recorded at 295 K in D2O. As the 
temperature was decreased from 295 to 80 K, a MeOH/EtOH (1:4) frozen glass 
containing each complex was examined. In each case, the main observed transitions 
occur to the 6H15/2 and 6H13/2 multiplets of the ground state manifold, centred at 480 and 
580 nm respectively (Figure 2.27). 
 
           295 K          80 K 
  ! !
  
 
Figure 2.27 (Left) Solution emission spectra for [Dy.L1(H2O)] (dash) and [Dy.L3] (solid) (D2O, 295 K, 
λexc = 270 nm). (Right) [Dy.L1(H2O)] (dash) and [Dy.L3] (solid) in a frozen EtOH/MeOH glass (4:1) (80 
K, λexc = 270 nm). (Bottom) Expansion of the 6H15/2 manifolds of [Dy.L1(H2O)] and [Dy.L3]. 
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Significant differences were observed between the tri-carboxylate and tri-phosphinate 
systems at 295 K. The appearance of additional strong transitions in the 6H15/2 and 6H13/2 
manifolds for the tri-phosphinate system, were observed at lower energy. At first, it was 
thought to be associated with an increase in the crystal field, previously demonstrated 
by 1H NMR shift and Eu(III) spectral analyses. However, comparative analysis of the 
spectral profile at 80 K (where !!! = 56 cm-1) and 295 K (where !!! = 204 cm-1) 
strongly suggested that the additional observed bands for [Dy.L3] at 460, 469, 494, 
582.5 and 589 nm are ‘hot bands’ (Table 2.9). These typically occur at higher energy, 
however, as they are associated with transitions from a higher energy component of the 
4F9/2 excited state manifold. Recent Dy(III) emission spectral analyses of 8 or 9 
coordinate complexes have shown that the lowest two levels of the 4F9/2 manifold are 
separated by about 40 to 60 cm-1.43,47,48 In the case of [Dy.L1(H2O)], variable 
temperature emission did not resolve the hot bands so well. 
 
Table 2.9 Energies of transitions observed for [Dy.L1(H2O)]  and [Dy.L3] in solution (D2O, 295 K).a,b 
 
 4F9/2 -
6
H15/2 energy gap/ cm
–1
 
4
F9/2 -
6
H13/2 energy gap/ cm
–1
 
[Dy.L1(H2O)] 20,555 17,180 
 20,611 17,345 
 20,812 17,390 
 20,899 17,482 
 21,008 17,575 (w) 
 21,097  
[Dy.L3] 20,242 (s) 16,978 (s) 
 20,408 17,167 (s) 
 20,620 17,331 
 20,768 17,422 
 20,920 17,559 
 20,986  
 21,368 (w)  
 21,739 (w)  
 
(a) Bands in bold were absent or of much reduced intensity in a MeOH/EtOH (1:4) frozen glass at 80 K;  
(b) w = weak, s = strong. 
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Similarly, following excitation at 270 nm, the emission spectra of [Tb.L1(H2O)] and 
[Tb.L3] were recorded in D2O at 295 K, and in a MeOH/EtOH (1:4) frozen glass at 80 
K (Figure 2.28). The lifetimes of the Tb(III) emissive states are much longer-lived, 
falling into the ms range (!!!! = 2.5 for [Tb.L1(H2O)] and 3.6 ms for [Tb.L3]). In the 
Tb(III) complexes, no evidence of hot bands was found. 
 
           295 K            80 K 
  ! !
  
 
Figure 2.28 (Left) Partial solution emission spectra for [Tb.L1(H2O)] (dash) and [Tb.L3] (solid) (D2O, 
295K, λexc 270 nm). (Right) [Tb.L1(H2O)] (dash) and [Tb.L3] (solid) in a frozen EtOH/MeOH glass (4:1) 
(80 K, λexc = 270 nm). (Bottom) Expansion of the 7F6 manifolds of [Tb.L1(H2O)] and [Tb.L3]. 
 
The information gained from the emission studies sheds some light on the nature of the 
relative energies of the ground state multiplets for the Dy(III) and Tb(III) complexes of 
L1 and L3. However, the scarcity of literature regarding Dy(III) emission and the 
relation to the anisotropy of the magnetic susceptibility, lends itself to further studies. A 
handful of investigations into the emissive properties of Er(III) and Tm(III) complexes 
have been reported, which could be useful here, however the former requires powerful 
1064 nm laser excitation,49 and the latter complexes typically give rise to very weak 
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emission, attributed to quenching of the Tm(III) excited state by C-H oscillators.50 
Nevertheless, acquiring a library of emission spectra is useful, and offers a comparative 
analysis; the examples detailed here do not indicate stark differences in the ligand field.  
 
2.5.2 Comparative Analysis of Relaxation Behaviour 
Consider last, the longitudinal relaxation rate behaviour of the tert-butyl reporter group 
in each series of complexes. The dependence of R1 on (µeff)4 in the Curie term (the 
second term) dominates at high field, especially for lanthanide(III) ions possessing large 
values of µeff. 
 !! = ! !!" !!!! ! !!!!!""!!! ! !!!!!!!! !!!!!!! + ! !!!!!!!! !! !!!!! + !!! ! !!!! ! !!! !!""!!!" !!! ! !!!!!! !! !!!  (6) 
 
 
For systems which follow the assumptions of this point dipole model, the relaxation 
rates should follow the sequence of the µeff values at high field strengths, i.e. [Dy(III), 
Ho(III)] > Tb(III) > Er(III) > Tm(III) > Yb(III). The experimental data showed that for 
the 8 coordinate [Ln.L3] series, the Er(III) complex relaxed significantly faster than the 
Dy(III), Ho(III) and Tb(III) analogues (Figure 2.29), whereas in the 9 coordinate 
[Ln.L1(H2O)] series, the longitudinal relaxation rates followed the order Dy(III) > 
[Tb(III), Ho(III)] > Er(III) > Tm(III) > Yb(III). Most surprising, is that [Er.L3] has a 
longitudinal relaxation rate up to 90% higher than the analogous Dy(III) complex at 1.0 
T, and [Tm.L3] displays a faster relaxation rate than the corresponding Tb(III) complex 
between 4.7 and 16.4 T. Field dependent behaviour like this, is unprecedented, and 
suggests that the assumptions of the BRW model that is used here are not valid, or that 
values for the magnetic moments of the complexed or bound lanthanide(III) ions differ 
significantly from their free-ion values.  
 
In BRW theory, the dipolar interaction between the lanthanide(III) ion and the nucleus 
of interest is considered a point dipole interaction, therefore treating the magnetic 
susceptibility of the lanthanide(III) ion as a scalar parameter, lacking directionality. In 
addition, the anisotropy of the static ligand field of a lanthanide(III) complex can 
certainly affect the degree of anisotropy found in the magnetic susceptibility tensor, 
neither of which is accounted for in equation 6. In the past, the anisotropy of the 
magnetic susceptibility tensor has been unequivocally considered, leading to the 
modification of equation 6 to account for the directionality.51,52 For such approaches to 
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be relevant, information concerning the magnetic susceptibility is required, but with this 
information difficult to obtain, this adaptation is uncited in terms of application.  
 
!
 
Figure 2.29 1H NMR relaxation rates, R1/ s-1, for the tert-butyl resonance on [Ln.L3] as a function of 
magnetic field, showing the fits (lines) to the experimental data points (circles) (295 K, D2O). 
 
The latter deduction prompted investigations into the magnetic susceptibility of the 
lanthanide(III) ions in the [Ln.L1(H2O)] and [Ln.L3] complex series. Dr. Nicola Rogers 
at Durham University applied the same iterative minimisation fitting method that was 
used to estimate the distance between the tert-butyl reporter group and the 
lanthanide(III) ion, holding r at 6.6 Å and τr at 260 ps, allowing variation of µeff and T1e. 
 
Table 2.10 Estimated best fit values of µeff for the [Ln.L1(H2O)] and [Ln.L3] complex series’ (D2O, 295 
K, r = 6.6 Å and τr = 260 ps) and free-ion values from the literature27. 
 
Lanthanide(III) µeff/ BM 
Free27 [Ln.L1(H2O)] [Ln.L3] 
Tb 9.8 9.68(02) 8.81(03) 
Dy 10.3 10.22(02) 9.47(02) 
Ho 10.4 9.82(02) 9.77(02) 
Er 9.4 8.95(01) 9.70(02) 
Tm 7.6 8.12(03) 9.51(01) 
Yb 4.3 4.44(08) 4.57(09) 
 
The magnetic moments for the [Ln.L3] series follow the unfamiliar sequence Ho(III) > 
Er(III) > Tm(III) > Dy(III) > Tb(III) (Table 2.10). The largest difference vs. the free-ion 
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value is observed for Tm(III), showing a 24% enhancement. In fact, all the 
lanthanide(III) ions showed up to 11% variations relative to the free-ion values, except 
Yb(III) which was within 5%. Notably, the magnetic moments for the [Ln.L1(H2O)] 
series follow the a more plausible order predicted by the free-ion values: Dy(III) > 
Ho(III) > Tb(III) > Er(III) > Tm(III). Therefore, it can be surmised that the fast 
relaxation rates of the Tm(III) and Er(III) tri-phosphinate complexes can be attributed, 
in part, to the discrepancies between the magnetic susceptibilities of the lanthanide(III) 
ions and the directional dependence on their magnetic susceptibility anisotropy, within 
each system. 
 
Examples of lanthanide(III) complexes with large crystal fields are seldom studied in 
detail, but Hölsä has reported a significant magnetic moment variation using SQUID 
magnetometry, where the room temperature magnetic moments of the LnOBr series (!!! 
-1200 for Tb to -1350 for Yb) are systematically lower than the free-ion values.53  
 
At low field (1.0 T), the order of the measured relaxation rates echoes the sequence of 
the T1e values, in line with the disappearance of the Curie relaxation contribution 
(equation 6). Even though values for T1e typically fall between 0.1 and 1 ps, the size and 
order of T1e can vary dramatically, since it is thought to be determined by the transient 
ligand field and the nature of the lanthanide(III) ion. Therefore, important information 
can also be gained by investigating the electronic relaxation times, T1e, of the 
lanthanide(III) ions in the [Ln.L1(H2O)] and [Ln.L3] complexes. 
 
Table 2.11 Estimated best fit values of T1e for the [Ln.L1(H2O)] and [Ln.L3] complex series’ (D2O, 295 
K, r = 6.6 Å and τr = 260 ps). 
 
Lanthanide(III) T1e/ ps 
[Ln.L1(H2O)] [Ln.L3] 
Tb 0.59(02) 0.49(02) 
Dy 0.49(02) 0.45(02) 
Ho 0.22(02) 0.37(02) 
Er 0.17(01) 0.85(01) 
Tm 0.29(02) 0.30(01) 
Yb 0.29(03) 0.53(02) 
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For Dy(III), Tb(III) and Tm(III), the differences between the [Ln.L1(H2O)] and [Ln.L3] 
series are negligible (≤0.05 ps), whereas dramatic increases are observed for Er(III) 
(+0.63 ps) and Ho(III) (+0.23 ps) (Table 2.11). As equation 6 suggests, the order of the 
measured relaxation rates is primarly determined by T1e at low field, hence the 
remarkably fast relaxation rate of the Er(III) tri-phosphinate complex, in particular, can 
be rationalised.  
 
The diminishing impact of the Curie relaxation term can be demonstrated by variable 
temperature 1H NMR studies at different field strengths. The resonant frequency of 
every nucleus on a paramagnetic lanthanide(III) complex has a T-2 dependence in the 
Curie term of equation 5. As expected, the study at high field (11.7 T) revealed the 
expected dependence of the longitudinal relaxation rate with 1/T2 for [Dy.L3] (Figure 
2.31). In contrast, no significant variation was observed at low field (1.0 T), in accord 
with the absence of a significant Curie contribution at this field, where the dipolar term 
dominates. 
 
 
 
Figure 2.31 1H NMR relaxation rates, R1, for the tert-butyl resonance on [Dy.L3] as a function of 1/T2, at 
11.7 T (blue) and 1.0 T (red) (D2O). 
 
Application of BRW theory here suggests that for both series of complexes, the order of 
the magnetic moments and the estimated electronic relaxation times were anomalous, 
explaining the unusually fast relaxation properties of [Er.L3] and [Tm.L3] compared to 
[Dy.L3] and [Ho.L3]. Clearly, the anisotropy of the magnetic susceptibility tensor in the 
8 coordinate tri-phosphinate systems, which lack an axial donor, needs to be considered, 
prompting independent variable temperature electron paramagnetic resonance (EPR) 
and superconducting quantum interference device (SQUID) magnetometry studies.  
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2.5.2.1 EPR Studies  
EPR spectroscopy provides direct evidence of the low-energy electronic and magnetic 
structure of paramagnetic species. Lanthanide(III) ions possess first order orbital 
angular momentum and strong spin-orbit coupling, resulting in total angular momentum 
states (i.e. J = L + S). Therefore, the interaction between a lanthanide(III) ion’s 
magnetic moment and its environment is very strong such that the spin-lattice 
relaxation, T1e, is very fast. This contrasts classical ‘spin-only’ compounds with 
orbitally non-degenerate ground states (Cu(II), Gd(III), etc.), where orbitally degenerate 
states are only mixed in via high-energy perturbations, resulting in a weaker spin-lattice 
interaction and therefore slower T1e times. Owing to their fast electronic relaxation 
times, T1e, lanthanide(III) ions have very weak and broad EPR spectra, such that 
acquisition must occur at below 10 K in order to observe a signal. At these temperatures !!! is equal to 5 – 7 cm-1, meaning that only the very lowest energy states possess any 
thermodynamic population. Coupled with the microwave energy in EPR being on the 
order of a few cm-1 at the most, this results in only these lowest states being 
interrogated.  
 
In these low-symmetry lanthanide(III) systems, the lowest state(s) will either be a 
Kramers’ doublet, pseudo-doublet (near double degeneracy) or singlet, whose 
characteristics are entirely determined by the environment. The EPR selection rule is 
ΔmJ = ±1 (just like ΔmS = ±1), so that there must be states within the microwave 
quantum of energy with mJ compositions providing this ±1 difference. For Kramers’ 
ions, the ground doublet must therefore be pure mJ = ±½ or a mixed doublet; the latter is 
much more likely in systems of low symmetry. For non-Kramers’ ions, there must be a 
pseudo-doublet ground state with some component of ΔmJ = ±1 in order to observe a 
spectrum. 
 
EPR spectra were measured by Dr. Nicholas Chilton at the EPSRC EPR National 
Facility at the University of Manchester on desalted samples of the tri-carboxylate, 
[Ln.L1(H2O)], and tri-phosphinate, [Ln.L3], complexes of Tb(III), Dy(III), Er(III) and 
Tm(III) at 5 K. The data was collected at Q-band (~34 GHz), both on solid-state and 
frozen glass (80% water, 20% glycerol, ~ 1 mM) samples. The complexes of Tb(III) 
and Er(III) were EPR active, whilst the complexes of Dy(III) and Tm(III) were EPR 
silent. The frozen glass spectra possess a large signal at ~ 12000 G due to impurities in 
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the glass capillaries and the smaller signal in all spectra at a similar field is due to an 
impurity in the cavity. 
 
The EPR spectra were similar in the solid and frozen glass for both [Tb.L1(H2O)] and 
[Tb.L3] (Figure 2.32). The absorption-like feature at low field can most likely be 
attributed to the large gz component of a strongly axial pseudo-doublet (Tb(III) is non-
Kramers’). The stabilisation of an axial pseudo-doublet can be rationalised on 
electrostatic grounds,54 where two trans- anionic pendant arms form a stronger axial 
potential than the single anionic pendant arm trans to the pyridine arm. The 
perpendicular components of the pseudo-doublet (i.e. gx and gy) are not observed 
because the sample is weak and the signals are too broad. In solution, the spectra gain 
slightly more structure due to the hyperfine splitting with the I = 3/2 nuclear spin of the 
isotope, 159Tb (100%).  
 
           [Tb.L1(H2O)]            [Tb.L3] 
  
 
Figure 2.32 Q-band EPR spectra of [Tb.L1(H2O)] (left) and [Tb.L3] (right), recorded in the solid-state 
and in a frozen glass (80% water, 20% glycerol) at 5 K. The large signal at 12000 G is attributed to an 
impurity in the glass capillary and the small signal at the same field is due to a cavity impurity. 
 
The spectra for [Er.L3] appear to be very similar in both the solid and frozen states, 
displaying two resonances from the ground Kramers’ doublet (Figure 2.33, right). The 
low-field feature is attributed to a high gz value, however the feature at 7000 – 8000 G 
is yet to be assigned to either a purely axial gx = gy signal or only one of these 
components. In the latter case, the remaining feature may occur at higher field and/or be 
much broader and is possibly not observed. Such behaviour could relate to the bigger 
T1e value found for Er(III) in the tri-phosphinate complex, in Section 2.5.2. The EPR 
spectrum for [Er.L1(H2O)] in the solid-state is very striking, clearly showing three 
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transitions corresponding to gx, gy and gz (Figure 2.33, left). When recorded as a frozen 
glass, the spectral profile changes dramatically, apparently indicating that the high field 
resonances have collapsed down and the gz feature has moved up in field. Such a 
marked change between the solid and frozen state spectra implies a significant change 
in the molecule, resulting in a much more isotropic ground Kramers’ doublet, and can 
be tentatively rationalised by a change in hydration of the complex. In the frozen glass, 
the sample almost certainly exists as the hydrated species [Er.L1(H2O)]. However, it is 
possible that the complex might not possess bound water in the solid-state, giving rise 
to stark differences in the EPR spectra of the two samples. An inference such as this is 
consistent with the spectra obtained for the q = 0 [Er.L3] complex, where there is no 
observed difference between the solid and frozen states. In contrast, both Tb(III) 
complexes showed similar solid and frozen state EPR spectra, accounted for by their 
rather hygroscopic and ‘sticky’ nature in the solid-state. 
 
                  [Er.L1(H2O)]            [Er.L3] 
  
 
Figure 2.33 Q-band EPR spectra of [Er.L1(H2O)] (left) and [Er.L3] (right), recorded in the solid-state 
and in a frozen glass (80% water, 20% glycerol) at 5 K. The large signal at 12000 G is attributed to an 
impurity in the glass capillary and the small signal at the same field is due to a cavity impurity. 
 
In these systems, the difference between Er(III) and Dy(III) is remarkable. Both are 
Kramers’ ions but the Er(III) analogues have gorgeous spectra whilst the Dy(III) 
analogues are EPR silent. This behaviour occurs because, in the same environment, the 
ground states must have very different mJ compositions, owing to the different nature of 
the pure mJ states between the two ions. In fact, such an observation makes sense: in the 
same axial potential (as evidenced for Tb(III)), Dy(III) has a nearly-pure large |mJ| state 
and Er(III) has a very mixed state.  
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The non-Kramers’ ion Tm(III) appears to have a singlet ground state (see later, Section 
2.5.2.2) and an EPR spectrum was not observed. In the case of Tb(III), the pseudo-
doublet ground state stabilised by the axial potential must possess some ΔmJ = ±1 
character components. Thus, information about the mixing in Tb(III) compared to 
Dy(III) can be gleaned, which most likely relates to the low symmetry perturbations 
affecting the non-Kramers’ Tb(III) compared to the Kramers’ Dy(III) and reflects the 
latter’s tendency to display Single Molecule Magnetic (SMM) behaviour.55 
 
2.5.2.2 Magnetic Susceptibility Studies  
Magnetic susceptibility measurements were collected by Dr. Nicholas Chilton at the 
University of Manchester on the tri-carboxylate, [Ln.L1(H2O)], and tri-phosphinate, 
[Ln.L3], complexes of Tb(III), Dy(III), Er(III) and Tm(III) at 0.5 T. 
 
The magnetisation profiles for the Tb(III), Dy(III) (shown in Figure 2.34, left) and 
Er(III) samples are consistent with well isolated and anisotropic ground-state doublets 
(pseudo-doublet in the case of the Tb(III)). The data for both Tm(III) samples exhibit 
overlapping magnetisation isotherms at 2 and 4 K (Figure 2.34, right), indicating an 
isolated singlet state that has some degree of magnetic character. This singlet state is not 
a traditional singlet state; instead it is highly anisotropic with a magnetic field 
dependence (hence non-zero magnetisation). This behaviour explains the lack of an 
EPR signal for the Tm(III) complexes in Section 2.5.2.1, since there is no state within 
the microwave energy (~ 1 cm-1 at Q-band). 
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    [Dy.L3]!  [Tm.L3]!
  
 
Figure 2.34 The magnetisation of selected [Ln.L1(H2O)] and [Ln.L3] complexes as a function of 
magnetic field strength, measured at 2 and 4 K. (Top, left) [Dy.L1(H2O)], (top, right) [Tm.L1(H2O)], 
(bottom, left) [Dy.L3]; (bottom, right) [Tm.L3]. 
 
In general, the magnetic susceptibility, χT, decreases as a function of decreasing 
temperature for all four samples, owing to the depopulation of the crystal field states 
(Figure 2.35). Such a profile gives an indication of the splitting of the lowest spin-orbit 
manifold but cannot provide unequivocal evidence on the energy or mJ composition of 
the states, in the absence of further more-detailed investigations. 
 
 
 
Figure 2.35 The magnetic susceptibility, χT, of the [Ln.L1(H2O)] complexes as a function of 
temperature, where Ln = Tb (green), Dy (blue), Er (purple) and Tm (pink), measured in a 0.5 T field. 
 
However, the experimental magnetic susceptibility values were systematically lower 
than the theoretical values (Table 2.12). Such errors can be attributed to the small 
amount of sample analysed (< 10 mg) and the presence of diamagnetic impurities (up to 
~ 30% sodium formate from HPLC purification), resulting in a small paramagnetic 
signal comparable to the diamagnetic contribution. A situation such as this means that 
the diamagnetic impurities cannot accurately be corrected for, and as a result, the 
0 
1 
2 
3 
4 
5 
0 2 4 6 8 
M
ag
ne
tis
at
io
n/
 B
.M
. 
Field/ T 
2 K 
4K 
0 
1 
2 
3 
4 
0 2 4 6 8 
M
ag
ne
tis
at
io
n/
 B
.M
. 
Field/ T 
2 K 
4 K 
0 
2 
4 
6 
8 
10 
12 
14 
0 50 100 150 200 250 300 
χT
/ c
m
3 
K
 m
ol
-1
 
T/ K 
Chapter Two: Parent 1H PARASHIFT Probes !
! 90 
measurements are not entirely representative of the complexes studied here. The 
situation was exacerbated by the hygroscopic nature of the samples, such that variable 
water amounts were present long after [Ln(III)] had been calculated on each sample by 
ICP-MS and BMS methods. However, a general trend has been established where the 
Dy(III) and Tb(III) tri-carboxylate room temperature average magnetic moments are 
greater than the analogous tri-phosphinate complexes, and the Er(III) and Tm(III) tri-
phosphinate values are greater than the analogous tri-carboxylate complexes, echoing 
the behaviour observed whilst interrogating µeff and T1e in Section 2.5.2. For example, 
the values of the magnetic moments suggested for [Dy.L1(H2O)] and [Dy.L3] from this 
analysis, of 10 and 9.5 BM respectively, echo the trends observed earlier in the 1H 
NMR data. Clearly, in the future, the samples must be sealed, after the thorough 
removal of the diamagnetic impurities has been carried out and/or corrected for, before 
reliable data can be obtained. 
 
Table 2.12 Theoretical and experimental χT values for the [Ln.L1(H2O)] complexes. 
 
Lanthanide(III) 
ion 
Ground state 
term 
g Theoretical 
χT value 
Experimental 
χT value 
Tb 7F6 3/2 11.82 5.75 
Dy 6H15/2 4/3 14.17 12.50 
Er 4I15/2 6/5 11.48 7.59 
Tm 3H6 7/6 7.15 5.86 
2.6 Conclusions 
The feasibility of using lanthanide(III) based paramagnetic, i.e. PARASHIFT, probes 
for 1H MRS studies, in which a reporter resonance is highly shifted from the 
diamagnetic region, has been of interest over the last two decades, as shown by the 
examples highlighted in Section 1.3. However, whilst some promising in vivo studies 
have been reported, limitations regarding signal intensity are continually cited and as a 
result, high doses and long acquisition times are used. Such limitations pose significant 
drawbacks to this inherently more sensitive imaging technique, which takes advantage 
of imaging where there is a zero-background signal in vivo, and has left progress in the 
field somewhat behind that of heteronuclear (i.e. 19F) imaging. 
The work detailed here goes some way to bridging that gap, focusing on the design, 
synthesis and application of a novel class of 1H PARASHIFT probes, with the criteria 
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outlined at the end of Chapter 1 of fundamental significance. Three parent systems have 
been derived, in which a reporting tert-butyl resonance is incorporated about 6.5 Å from 
a lanthanide(III) ion in a kinetically stable macrocyclic complex (Figure 2.36). At such 
a distance, the tert-butyl reporter is shifted to a 1H NMR window that is well removed 
from the diamagnetic range, allowing its selective observation. Additionally, prudent 
selection of the lanthanide(III) ion, in accord with magnetic field strength, leads to R1 
values of the order of 100 to 200 s-1, permitting faster data acquisition per unit time in 
spectroscopy and imaging protocols; a concept not fully optimised in the literature 
examples. Furthermore, by selecting a tert-butyl group, the number of magnetically 
equivalent nuclei comprising the reporter resonance is maximised.  
 
!
 
Figure 2.36 The 1H PARASHIFT probes detailed in this Chapter: the model system, [Ln.L1(H2O)] (left); 
the C2-symmetric system, [Ln.L2(H2O)]+ (middle) and the phosphinate system, [Ln.L3] (right). 
 
The Dy(III) complex proved to be the most attractive candidate from the proof-of-
principle tri-carboxylate series, [Ln.L1(H2O)] (Figure 2.36), possessing a tert-butyl 
chemical shift of -20.1 ppm, with an R1 value of about 100 Hz at 7 T. However, the 
R1/R2 ratio was moderate (0.6 at 9.4 T) and so further enhancements were sought, in 
order to achieve an R1/R2 ratio close to unity and further enhance the sensitivity in MRS 
protocols.  
 
An enhancement in signal intensity was observed for the C2-symmetric bis-carboxylate 
series, [Ln.L2(H2O)]+ (Figure 2.36), bearing two equivalent tert-butyl reporter groups. 
The case of Dy(III) once again presented the most attractive candidate for in vivo 
studies, displaying a 60% increase in the R1 value (150 Hz at 7 T) and a significant 
increase in the R1/R2 ratio (0.8 at 9.4 T). This enhanced sensitivity permitted strong 1H 
MRS images to be obtained following the injection of solutions of [Dy.L2(H2O)]+ into 
live mice, showing strong localisation of the complex in the muscular tissue, followed 
by clearance to the bladder. In each study, the signal for the tert-butyl reporter was 
acquired, without water interference, within a few minutes (<6 min), at a well-tolerated 
dose (0.12 mmol kg-1) that is of the same order as commercially administered Gd(III)-
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based contrast agents. However, in order to further reduce acquisition times, a spectral 
bandwidth of more than 20 kHz was desired, requiring shifts of over 10 kHz from the 
water and fat signals in vivo.  
 
Remarkable tert-butyl chemical shifts of up to ±70 ppm were achieved for the tri-
phosphinate series, [Ln.L3] (Figure 2.36), exhibiting shift enhancements of up to 60 
ppm compared to the tri-carboxylate series, in the cases of Tb(III) and Tm(III). Analysis 
of the relaxation rate behaviour presented a few surprises, however. Only the Er(III) 
complex showed the required R1 value at 7 T, and the Tm(III) complex possessed an 
80% increase in R1 relative to its tri-carboxylate analogue. Meanwhile, both the Tb(III) 
and Dy(III) complexes displayed systematically lower R1 values in comparison to their 
tri-carboxylate equivalents. 
 
Such unprecedented behaviour prompted further investigations into the comparative 
shift and relaxation behaviour of the [Ln.L1(H2O)] and [Ln.L3] series, where the scope 
and limitations of current theories that address magnetic susceptibility and its 
anisotropy in lanthanide(III) complexes were assessed using optical spectroscopy, EPR 
spectroscopy and SQUID magnetometry. One of the approximations that does not hold 
up in many lanthanide(III) systems is whether J is a good quantum number in the Landé 
and Van Vleck approximations, most generally used to treat paramagnetism, and the 
assumption that J-mixing does not occur. With the ‘goodness’ of J far from certain, the 
Bleaney coefficients, CJ, in Bleaney’s theory that are derived from J, and µeff in 
paramagnetic relaxation theory that is derived from the Landé factor, are rendered 
inadequate. Whilst these two theories underpin the analysis of paramagnetic induced 
shifts and paramagnetic relaxation, respectively, clearly a challenge is presented to build 
a better approach towards predicting the behaviour of lanthanide(III) complexes such as 
those reported herein, through modern computational methods. 
 
With promising results presented thus far, the basic framework from which future 
PARASHIFT probes can be derived has been established. The next step for this work is 
to address the idea of responsiveness, where the relative chemical shift of the reporter 
resonance is indicative of a stimulus in the local environment of the probe. 
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Chapter Three: Development of pH Responsive 
1H PARASHIFT Probes 
3.1 Introduction 
As introduced in Chapter 1, 1H magnetic resonance spectroscopic imaging studies are 
limited due to the strong water and fat signals in vivo. Following the recent successes in 
19F MRI, novel 1H paramagnetic lanthanide(III)-based probes were developed, and 
described in Chapter 2. In such systems, judicious placement of a tert-butyl reporter 
group within 6 to 7 Å of a paramagnetic lanthanide(III) centre has two benefits for MRS 
imaging protocols. First of all, the chemical shift of the reporter group is enhanced via 
the pseudocontact shift mechanism (see Section 1.2.1.1, page 15), leading to observed 
shifts >60 ppm away from the water signal. Such a shift magnitude is necessary, if 
bandwidths around 20 kHz are to be used in imaging sequences (i.e. δH < -34 ppm or > 
+44 ppm). Secondly, the relaxation behaviour of the tert-butyl reporter nuclei has been 
optimised so that the longitudinal relaxation rate, R1, is in the 100 to 200 s-1 range at 7 
T, and chemical exchange broadening processes are limited such that R1/R2 is close to 
unity; permitting fast data acquisition. Such success opens up many possibilities for new 
imaging experiments to be developed, and with this in mind the next step is to adapt the 
systems in Chapter 2 to incorporate responsiveness towards a biologically relevant 
marker. The responsiveness of a probe is defined as its ability to measure fluctuations in 
the concentration of a biologically relevant species, such as H+ (pH) or Ca2+ (pMn+), by 
means of an interpretable experimental read-out.  
 
Of course, the concept of responsive probe behaviour has been demonstrated before, in 
the field of MRI. In Section 1.1.1, the excellence of using the contrast of an MR image 
to detect even subtle changes in anatomy and function was described. However, the 
reliability of making diagnoses from the image contrast information alone is poor.1 For 
example, in the diagnosis of breast cancer, MRI is far superior to X-radiography in its 
ability to detect tumours, but it cannot readily distinguish between malignant and 
cancerous tissue, lending itself to misdiagnoses and needless false-positive results.2 
Also, changes that are detectable by MRI are often only present in the mid- to late-
stages of disease development, and detection of these, in some cases, can be too late.1 In 
an effort to overcome these limitations and recognising the possibility of probing 
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physiological environments non-invasively, a vast amount of work has gone into the 
development of responsive Gd(III)-based MRI contrast agents, where relaxivity changes 
as a function of an environmental factor in the area in which they localise. Since the 
relaxivity is concentration dependent (see equation 3 in Section 2.2.2), and therefore 
complicated to quantify in vivo, the majority of the literature reports in vitro examples, 
with very few being translated to in vivo studies.3 
 
When deciding how to make a system responsive, the parameter under investigation 
merits careful selection. Perhaps the most straightforward and understood parameter is 
that of pH; a particular interest in biological systems, where fluctuations can be 
associated with various pathologies such as stroke, infection and renal failure. A 
technique with which pH changes can be monitored is highly sought after in cancer 
diagnosis in particular, with malignant tissue often found to be more acidic due to 
reduced bicarbonate levels, poor perfusion rates or increased lactic acid secretion.4,5 
 
Early techniques for measuring pH included the use of microelectrodes, however due to 
their destructive and invasive nature, alternative methods have been sought.6 Before the 
advent of 19F NMR, 31P MRS studies became the obvious choice due to its 100 % 
abundance, I = ½, large chemical shift range and the prevalent nature of 31P in many 
biological metabolites at mM levels; these are detailed in Section 1.1.2. However, the 
limited sensitivity associated with 31P MRS permitted only one example to be applied in 
vivo, presenting measurements from large tissue volumes only and non-discrete pH 
values for isolated spatial locations.7  
 
In light of these limitations, the use of paramagnetic lanthanide(III)-based probes has 
been investigated, where changes in pH can be signalled by a change in the relative 
chemical shift of the probe’s reporter resonance. As a result of the close proximity (4.5-
7.5 Å) of the reporter nuclei to a lanthanide(III) centre, the chemical shift non-
equivalence is magnified such that small structural and/or conformational changes 
afforded by the protonation/deprotonation events result in amplified chemical shift 
differences between the acid and base forms. This experimental read-out is 
concentration independent, negating the major problem of calibration that is hindering 
the translation of responsive Gd(III) contrast agents to in vivo protocols.  
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It was briefly discussed in Section 1.1.2, how 19F MRI has been a focus of interest over 
the last 30 years, and in particular the more recent development of fluorinated 
paramagnetic lanthanide(III) probes.8–14 Research in Durham over the last decade has 
led to the development of novel fluorinated paramagnetic lanthanide(III) complexes 
with interesting pH responsive 19F chemical shift behaviour. The first example describes 
a fluorinated Ho(III) complex, where pH sensitivity arises due to the on-off ligation of a 
sulphonamide moiety, as shown in Figure 3.0.9 The 19F chemical shift separation 
between the two forms is 40 ppm but chemical exchange between the acid and base 
forms is slow on the NMR timescale, such that the relative ratios of the two peaks vary 
with pH. The pKa of this ratiometric process was found to differ in 0.1 M NaCl solution 
(5.71) and mouse serum or urine (6.92), due to the presence of competitive hydrogen 
carbonate binding that shifts the equilibrium in favour of the acid form in the latter.  
 
 
 
 
 
Figure 3.0 (Top) Schematic representation of the pH sensitive mode of operation of the sulphonamide 
moiety on the complex. (Bottom) The pH dependence of the 19F chemical shift for the Ho(III) 
sulphonamide complex in water, mouse urine and mouse plasma.9  
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In the second example, a fluorinated Ho(III) complex with a different pH sensitive 
coordinated moiety was described, displaying pH sensitivity through the 
protonation/deprotonation behaviour of an amide nitrogen (Figure 3.1).9,10 The most 
promising results were achieved for the ortho-cyano bearing system. Unlike the 
previous example, this system exhibited fast exchange between the acid and base forms 
on the NMR timescale, so that a time-averaged signal was observed, varying in shift as 
a function of pH, with a pKa of 7.1 (Figure 3.1). Due to the restricted rotation about the 
aryl C-N bond, this system exists as two major isomers in solution. Such an occurrence 
is of benefit ratiometrically, provided that each isomer exhibits large chemical shift non-
equivalence and a different pH-dependent chemical shift. As a result, a ratiometric 
approach was used to calculate the pH, by measuring the shift separation between the 
two isomers (~ΔδF = 14 ppm).  
 
 
 
 
 
Figure 3.1 (Top) Schematic representation of the protonation/deprotonation behaviour of the amide 
nitrogen on the complex. (Bottom) The variation in the 19F chemical shift for the two isomers of the 
Ho(III) ortho-cyano amide complex.10 
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In both examples, the ratiometric approach alleviates the requirement for calibrating the 
chemical shift: in the second case the pH was measured using the pH dependent 
chemical shift separation, and in the previous example it relies upon measuring the pH 
dependent ratio of two signals. Ideally, the number of isomeric species in solution 
should be minimised so that one signal dominates, and is a key consideration when 
designing future systems. Also, it is far easier to monitor a shift difference than a 
relative ratio change in MRS imaging protocols, and so fast exchange on the NMR 
timescale is favoured. Nevertheless, the works detailed above do possess favourable 
characteristics, such as pKa values around 7, and functionality in the physiological range 
(pH 5.5-7.5). !!
However, the use of 19F MRI is far from trivial in commercially available 1H operating 
systems, thus leading to the development of 1H paramagnetic lanthanide(III) 
(PARASHIFT) probes, such as those described in this thesis. Amongst the 1H 
PARASHIFT probes highlighted in Section 1.3, the Yb(III) and Tm(III) complexes of 
DOTP were shown to possess pH sensitive chemical shifts (pages 27 and 29-30).15,16 
However, neither of these studies appreciated properly the need for a 1H reporter group 
with a high equivalent spin density, the importance of lanthanide(III) ion selection, or 
the benefits of paramagnetic longitudinal relaxation enhancement in terms of increasing 
sensitivity in MRS imaging experiments.  
 
In an effort to address these issues, more recent work in Durham has seen the 
development of a pH responsive 1H PARASHIFT probe, in close relation to the systems 
outlined within Chapter 2. The complex possesses a tert-butyl reporter group, situated 6 
to 7 Å away from a paramagnetic lanthanide(III) centre (Figure 3.2).17 Additionally, 
Dy(III) has been selected in order to achieve the desired enhancements in R1 (140±8 s-1 
at 4.7 T, 185±10 s-1 at 9.4 T). The pH sensitive mode of operation relies on the 
previously observed concept of the reversible ligation of a trans- sulphonamide moiety. 
At high pH, the sulphonamide moiety is deprotonated and binds to the lanthanide(III) 
centre through the nitrogen atom, further stabilised by additional ligation through the 
sulphur oxygen atom. At pH 8, the tert-butyl reporter group resonates at -58.9 ppm 
(Figure 3.2).18 As the pH lowers, protonation occurs so that sulphonamide coordination 
can no longer occur and a solvent water molecule binds instead to complete the 
coordination sphere, a theory confirmed by measuring the radiative lifetimes of the 
corresponding Tb(III) complex in D2O and H2O. At pH 4, the tert-butyl reporter 
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resonance cannot be observed. Such an observation is thought to arise due to the 
severity of the line-broadening associated with an increased rate of chemical exchange 
when the sulphonamide functionality is unbound. As a result, in order for pH changes to 
be measured, an internal standard is required so that relative signal intensity changes 
can be compared, thereby offering little improvement on the first fluorinated Ho(III) 
complex. 
 
 
 
Figure 3.2 (Left) Schematic representation of the pH functionality of the sulphonamide moiety on the 
complex. (Right) 1H NMR spectra for the Dy(III) complex at high and low pH values, indicating the ‘loss 
of signal’ at low pH (D2O, 9.4 T, 298 K).18 
 
The above analysis of current pH responsive PARASHIFT probes validates the need for 
the research outlined in the remainder of this Chapter and indicates that ideal probe 
characteristics include: 
• An acid dissociation constant, pKa, of the sensing functionality around pH 6.5 to 
7. 
• An operating window in the physiological range (pH 5.5-7.5). 
• Sensitivity such that small pH changes translate to observable changes in the 
chemical shift. 
• The existence of one predominant isomer in solution. 
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• Fast chemical exchange on the NMR timescale, so that a time-averaged signal 
is observed.  
• Protonation/deprotonation events that are not associated with severe line-
broadening. 
 
The design of the novel pH responsive 1H PARASHIFT probes detailed herein are 
generalised in Figure 3.3. The design features are in keeping with the complexes 
described in Chapter 2, since the criteria governing their design still applies to this 
work. Minimal modifications were sought in order to retain as many of the favourable 
MR properties as possible. The most notable change arises through the incorporation of 
an acid/base sensitive functionality in the 4-position of the tert-butylpyridyl moiety. It is 
suggested that, due to its close proximity, any change occurring upon the protonation 
and/or deprotonation of this functional group will have an effect on the tert-butyl 
chemical shift. This effect is of course amplified, due to the close proximity (6.5 Å) of 
the tert-butyl reporter to the lanthanide(III) ion, that a relatively large shift change was 
foreseen. Additionally, it was thought that because the change is occurring locally on 
the pyridyl moiety, line-broadening would be minimised, thereby eliminating problems 
associated with several of the previous examples. 
 
!
 
Figure 3.3 The key design features of suggested pH responsive 1H PARASHIFT probes, where X = C or 
PMe, Y = an acid/base functionality; and n = the number of water molecules (typically 1 when X = C, and 
0 when X = PMe). 
3.2 First Generation System: A Dimethylamine Substituent 
The first system to be designed incorporated a dimethylamine substituent in the 4-
position of the tert-butylpyridyl moiety, [Ln.L4(H2O)] (Figure 3.4). It is envisaged that 
steric inhibition of resonance, created by the ortho- tert-butyl group, might suppress 
lone pair conjugation into the pyridine ring. In the absence of the tert-butyl group, a 
para-dimethylamine substituent is strongly conjugated, so that protonation at the 
nitrogen is inhibited and the pKa <3.19 Despite the favourable shift enhancements 
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achieved with phosphinate pendent arms, carboxylate pendent arms were selected for 
relative ease of synthesis. !
!
 
Figure 3.4 The design of the dimethylamine-bearing 1H PARASHIFT probe, [Ln.L4(H2O)]. 
 
3.2.1 Complex synthesis and characterisation 
The N-oxide, 3, was prepared as described previously.17 The desired ring substitution 
was effected by nitration, using a concentrated mixture of H2SO4 and HNO3, to give the 
para-nitro N-oxide, 41 (Scheme 3.0).  The reaction was monitored by thin-layer 
chromotography and mass spectrometric analysis. Reduction of the nitro- group under 
low-pressure hydrogenation conditions afforded the amino product, 42. However, 
attempted alkylation with methyl iodide, under both harsh basic and typical SN2 
conditions, did not lead to the desired dimethylamine product. Indeed, only a trace 
amount of mono-alkylated product was observed by mass spectrometry, suggesting the 
nitrogen lone pair was still conjugated efficiently, lowering the amine nucleophilicity. 
 
 
 
Scheme 3.0 General procedures for the synthesis of the mesylate 45. 
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A similar process was subsequently attempted, opting instead to rearrange the N-oxide 
species prior to reduction and alkylation (Scheme 3.0). Accordingly, in the presence of 
trifluoroacetic anhydride, an intramolecular rearrangement transformed 41, to the 
trifluoroacetate ester intermediate, as characterised by 19F and 1H NMR spectroscopy. 
The ester was hydrolysed in a 1:1 mixture of ethanol and water to reveal the desired 
alcohol, 43. Nonetheless, following nitro- group reduction, alkylation of the amine 
species, 44, failed to occur again. Such limitations again suggested that the 
nucleophilicity of the amine is dramatically decreased due to conjugation of the lone 
pair density into the pyridine ring. 
 
Finally, a reaction pathway involving displacement of the reactive nitro- group on the 
complex was considered. In this route, the amine species, 44, was reacted with methane 
sulphonyl chloride to gain the mesylate, 45, in a near quantitative yield. The mesylate, 
45, was used without delay to achieve N-alkylation of the previously synthesised tri-
carboxylate 12-N4-based macrocycle, 1 (Scheme 3.1). Purification of the fully alkylated 
ligand, 46, was achieved using silica gel column chromatography. After the tert-butyl 
ester protecting groups had been removed using trifluoroacetic acid, complexation with 
Dy(III)Cl3.6H2O in aqueous solution, at pH 5.5, gave the intermediate complex, 47. The 
complex 47 was characterised by 1H NMR spectroscopy and high-resolution mass 
spectrometry. 
 
 
 
Scheme 3.1 General procedures for the synthesis of [Ln.L4(H2O)]. 
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In order to transform the para-nitro derivative into the desired dimethylamino- 
compound, a substitution reaction was performed using a solution of dimethylamine in 
ethanol. This reaction was inspired by previous work in the group, which demonstrated 
the reactivity of a related 4-nitro-pyridyl 12-N4-based paramagnetic lanthanide(III) 
complex towards nucleophilic displacement.20 It is thought that the enhanced reactivity 
in the 4-position is brought about by charge transfer to the lanthanide(III) centre, which 
acts as an ‘electron sink’ and increases the electrophilicity of the para-pyridyl carbon. 
Following purification of the crude mixture by reverse-phase preparative HPLC (tR = 
5.8 min), [Dy.L4(H2O)] was successfully isolated.  
 
However, the molecular masses of 47 and [Dy.L4(H2O)] only differ by 2 mass units, so 
characterisation by mass spectrometry was uncertain. Other conventional methods such 
as TLC and reverse-phase analytical HPLC provided ambiguous information, seemingly 
showing the same retention behaviour as 47. In the end, UV absorption spectroscopy 
and IR spectroscopy were used to confirm the desired identity of [Dy.L4(H2O)]. UV 
absorption spectral measurements were undertaken for both 47 and [Dy.L4(H2O)] 
(Figure 3.5). The values of λmax differ slightly: for 47, λmax is 278 nm, whereas for 
[Dy.L4(H2O)] λmax occurs at 270 nm. Since the observed profile corresponds to the π to 
π* transition of the pyridine ring, it was concluded that the substituents were different. 
This conclusion was also consistent with the absence of the N-O stretching bands at 
1540 and 1360 cm-1 in the IR spectrum for [Dy.L4(H2O)]. 
 
 
 
Figure 3.5 Overlaid absorption spectra for 47 (line) and [Dy.L4(H2O)] (dash) (H2O, 295 K, pH 6). 
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3.2.2 1H NMR studies: shift and relaxation behaviour 
The shift behaviour of the tert-butyl reporter groups in complexes 47 and [Dy.L4(H2O)] 
was analysed using 1H NMR spectroscopy (Figure 3.6). In each case, the tert-butyl 
group was shifted a further 10 ppm compared to the related tri- and bis-carboxylate 
complexes, [Dy.L1(H2O)] and [Dy.L2(H2O)]+ (reported in Chapter 2), and resonated at 
-28.1 ppm and -28.4 respectively. 
 
The 1H NMR spectrum of [Dy.L4(H2O)] revealed additional well-shifted resonances at 
-8.1 and -19.3 ppm, corresponding to the methyl groups on the nitrogen atom (Figure 
3.6). Integration confirmed this assignment and an investigation into their relaxation 
rates supported this hypothesis. Interestingly, the diastereotopic methyl groups resonate 
more than 10 ppm apart due to amplification of the chemical shift non-equivalence 
induced by the paramagnetic Dy(III) ion. Depending on the geometry adopted by 
[Dy.L4(H2O)], it can be imagined that each methyl group will be orientated differently, 
assuming that they do not adopt a conformation purely in the plane of the pyridine ring, 
as drawn. One methyl group will be arranged so that it is closer to the Dy(III) ion, 
displaying a greater shift and experiencing a greater enhancement in R1 (162±3 s-1 at 9.4 
T), as defined by the pseudocontact shift21 and SBM22–24 equations, respectively, with 
the other showing contrasting behaviour (a slower R1 value of 57±2 s-1 at 9.4 T). 
 
 
 
Figure 3.6 Stacked 1H NMR spectra of [Dy.L4(H2O)] (top) and complex 47 (bottom), highlighting the 
major tert-butyl and methyl resonances (D2O, pH 6, 295 K, 9.4 T).  
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The relaxation behaviour of the tert-butyl resonances was examined at 6 different field 
strengths for both 47 (Y = NO2) and [Dy.L4(H2O)] (Y = N(CH3)2). Rate data are shown 
in comparison to [Dy.L1(H2O)] (Y = H), Table 3.0. An increase in R1 was observed for 
the para-substituted complexes, relative to the unsubstituted tri-carboxylate complex. 
When Y = NO2, the para-substituent is strongly electron withdrawing, whereas an 
N(CH3)2 normally presents strong electron donating character vide supra. Despite this, 
such a difference appears to have little effect on the observed R1 values. As a result of 
selecting Dy(III), the R1 values are of the required 100 to 200 s-1 order at 7 T and the 
R1/R2 ratios are comparable to those previously achieved.17 
 
Table 3.0 Experimental longitudinal relaxation rate data for the major tert-butyl resonance of 47 (Y = 
NO2) and [Dy.L4(H2O)] (Y = N(CH3)2) at different magnetic field strengths (D2O, 295 Ka); 
[Dy.L1(H2O)] (Y = H) is shown for comparison. 
 
Y substituent  R1/ s-1 (± error)  R1/R2b 
(9.4 T) 
 1.0 T 4.7 T 9.4 T 11.7 T 14.1 T 16.4 T  
H 55 (2) 73 (1) 124 (1) 149 (1) 170 (1) 210 (2) 0.56 
NO2 59 (3) 88 (2) 149 (1) 175 (1) 199 (1) 224 (1) 0.46 
N(CH3)2 52 (4) 83 (1) 144 (2) 168 (1) 198 (1) 223 (1) 0.60 
 
(a) Temperature was monitored accurately, calibrating against an ethylene glycol shift thermometer; (b) 
R2 values were estimated as (π × ω1/2), for a Lorentzian line fit. !
Assuming classical BRW theory, iterative minimisation methods were carried out by 
Dr. Nicola Rogers to estimate values for µeff, T1e and τR by holding the distance between 
Dy(III) and the tert-butyl group, r, at 6.6 Å (Table 3.1). Earlier fitting simulations found 
that this average distance agreed well with the distance estimated using DFT 
calculations, that were, in turn, based on a closely related X-ray crystal structure.25 
 
Table 3.1 Estimated best fit values of µeff, T1e and τR for 47 (Y = NO2) and [Dy.L4(H2O)] (Y = N(CH3)2) 
(D2O, 295 K and r = 6.6 Å). [Dy.L1(H2O)] (Y = H) is shown for comparison. 
 
Y substituent µeff/ BM T1e/ ps τR/ ps 
H 10.32 (2) 0.52 (2) 196 (3) 
NO2 10.57 (3) 0.52 (3) 285 (3) 
N(CH3)2 10.55 (4) 0.47 (3) 267 (4) 
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For each complex, the values for µeff fell within ±5% of the literature value of 10.4 
BM.26 Estimated values for T1e converged uniformly to 0.46 (±0.06) ps, corroborating 
the similarity of the observed R1 values at 1.0 T for each of the three complexes, and in 
accord with the vanishing Curie term at low field. A small increase in τR for the para-
substituted systems is consistent with the complex occupying a slightly larger molecular 
volume. 
 
3.2.3 pH Responsive chemical shift behaviour 
An investigation was carried out to examine the pH dependence of the chemical shift of 
the tert-butyl resonance. A pH titration was performed with a sample of [Dy.L4(H2O)] 
in D2O. The pH was raised using NaOD and lowered using DCl. Each time, the pH 
within the NMR tube was accurately measured using a pH meter, which was pre-
calibrated using standard buffer solutions. The operating temperature of the NMR 
spectrometer was recorded accurately, calibrating against a standard ethylene glycol 
shift thermometer, to ensure that shift was down to pH variations only (recall the 
sensitive T-2 dependence, page 13). The 1H NMR spectrum was acquired at different pD 
values, ranging from 2.2 to 9.9, where pD = pH + 0.41 (Figure 3.7). 
 
 
 
Figure 3.7 Stacked 1H NMR spectra showing the behaviour of the methyl groups and the tert-butyl 
resonance on [Dy.L4(H2O)] as a function of pD, where pD = pH + 0.41 (D2O, 295 K, 9.4 T). 
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There was no observable shift in the tert-butyl resonance of [Dy.L4(H2O)] over the 5-10 
pD range. However, upon lowering the pD to 3.9, substantial shifts in the methyl 
resonances became apparent; shifting further still as the pD was lowered to 2.2. By 
plotting the change in the chemical shifts of the three resonances as a function of pH, it 
is evident that about the pKa, shifts of around 5 ppm/pH unit are observed (Figure 3.8). 
Such shifts suggest that protonation is occurring, albeit at a much lower pH value than 
had been surmised if steric inhibition of lone pair conjugation was operative. During the 
synthetic route (Scheme 3.0), it became clear that it was difficult to alkylate the pyridyl-
amine group citing its poor nucleophilicity due to lone pair conjugation. This 
phenomenon must also be occurring here, amplified by the presence of the ‘electron 
sink’ that is the coordinated Dy(III) ion. Another suggested explanation cites the steric 
hindrance associated with the bulky tert-butyl group, leading to less effective solvation 
of the protonated amine. The apparent broadening of the observed resonance is ascribed 
to the dynamic exchange processes associated with nitogen protonation. Such behaviour 
is not desirable, Section 3.1, as it can result in signal intensity loss in MRS imaging 
protocols.  
 
 
 
Figure 3.8 Plot showing the change in chemical shifts, δH, for NMe1 (blue), NMe2 (red) and the tert-butyl 
resonance (green) in [Dy.L4(H2O)] as a function of pD, where pD = pH + 0.41 (D2O, 295 K, 9.4 T). 
 
Nonetheless, some positive features were established in this work. Firstly, chemical 
exchange was fast on the NMR timescale, manifesting in a time-averaged signal, which 
shifted as a function of pH. Secondly, the para-substituted complex [Dy.L4(H2O)] 
clearly existed as one dominant isomer in solution, identifiable by the major tert-butyl 
reporter resonance. Finally, a sensitivity of 5 ppm/pH unit was estimated that is of 
comparable size to the published [Yb.DOTP]5- example.15 Sadly, however, the pH shift 
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sensitivity manifested itself within the methyl signals rather than the tert-butyl, which is 
of paramount importance for the sensitivity of these probes. Notwithstanding the 
favourable relaxation rate characteristics at 7 T, it is clear that the pKa associated with 
this para-substituent is unsuitable. 
3.3 First Generation System: An Acetamide Substituent 
The next system to be considered had an acetamide substituent in the 4-position of the 
tert-butylpyridyl moiety, [Ln.L5(H2O)] (Figure 3.9). An acetamide substituent has a 
pKa around 15.27 It was therefore reasoned that [Ln.L5(H2O)] could possess a more 
desirable pKa value. In the para-substituted complex, it was envisaged that the 
conjugate base, arising from deprotonation would be stabilised through delocalisation of 
the negative charge into the coordinated pyridyl moiety. A related effect has been 
observed in structurally related 4-amide derivative of quinoline containing ligands.28 
 
 
 
Figure 3.9 The design of the acetamide-bearing 1H PARASHIFT probe, [Ln.L5(H2O)]. 
 
3.3.1 Complex synthesis and characterisation 
The synthesis of the acetamide pyridyl precursor, 52, began with the previously 
synthesised amino-alcohol compound, 44 (Scheme 3.2).  
 
 
Scheme 3.2 General procedure for the synthesis of the mesylate 52. 
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In the presence of acetic anhydride, it was hypothesised that acetylation would occur on 
both the amine and alcohol groups. However, due to the poor organic solubility of 44, 
mildly basic conditions were employed, in a water-dioxane mixed solvent. Under these 
conditions, selective acetylation of the alcohol occured, with the formation of 
compound 49 confirmed by heteronuclear multiple-bond correlation spectroscopy, 
HMBC (Figure 3.10).  
 
 
 
Figure 3.10 HMBC spectra showing the correlation between the acetyl CH3 and the aryl CH2 (top) and 
the lack of correlation between the pyridyl C4 and the acetyl CH3 (bottom) to prove the identity of 49. 
Excess acetic anhydride is crossed out. 
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Such poor amine reactivity should have been anticipated, however, following the poor 
nucleophility of the amino- species, 42 and 44. An organic base and solvent allowed the 
amine on 49 to be successfully acetylated in the subsequent step, however. The acetate 
ester on 50 was cleaved selectively in good yield, using sodium ethoxide in ethanol, to 
give the desired alcohol 51, monitored by TLC and 1H NMR spectroscopy. Afterwards, 
reaction with methane sulfonyl chloride, in the presence of triethylamine, afforded the 
mesylate 52. 
 
Immediate use of the mesylate 52 in an alkylation reaction with the previously 
synthesised tri-carboxylate 12-N4-based macrocycle, 1, yielded the tetra-substituted 
ligand, 53, following purification by silica gel column chromatography (Scheme 3.3). 
Quantitative removal of the tert-butyl esters using trifluoroacetic acid followed by 
complexation in aqueous solution, with Dy(III) chloride, gave the desired complex, 
which was purified by reverse-phase preparative HPLC (tR = 5.7 min). 
 
 
 
Scheme 3.3 General procedure for the synthesis of the acetamide complex, [Dy.L5(H2O)]. 
 
3.3.2 1H NMR studies: shift and relaxation behaviour 
Analysis by 1H NMR spectroscopy revealed the shift of the major tert-butyl resonance 
at -23.3 ppm for [Dy.L5(H2O)] (Figure 3.11), with the acetamido- methyl resonating at 
-7.7 ppm, in the major isomer. Not surprisingly, such a shift magnitude is comparable 
to that previously displayed within this work for structurally related tri-carboxylate 
based systems, but remains significantly less than that observed for the tri-phosphinate 
analogues (ca. -75 ppm for Dy(III)). 
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Figure 3.11 1H NMR spectrum of [Dy.L5(H2O)], highlighting the major tert-butyl and methyl 
resonances (D2O, pD 7, 295 K, 9.4 T).  
 
Examination of the relaxation behaviour of the major tert-butyl resonance on 
[Dy.L5(H2O)] revealed a similar R1 value to the aforementioned para-substituted 
complexes (Table 3.2). Typically, as can be predicted for a Dy(III) tri-carboxylate based 
12-N4 complex, [Dy.L5(H2O)] exhibits an R1 value in the desired 100 to 200 s-1 range at 
7 T and an R1/R2 ratio that is comparable to those reported.17 
 
Table 3.2 Experimental longitudinal relaxation rate data for the major tert-butyl resonance of 
[Dy.L5(H2O)] (Y = NHCOCH3) at different magnetic field strengths (D2O, 295 Ka). [Dy.L1(H2O)] (Y = 
H), 47 (Y = NO2) and [Dy.L4(H2O)] (Y = N(CH3)2) are shown for comparison. 
 
Y substituent  R1/ s-1 (± error)  R1/R2b 
(9.4 T) 
 1.0 T 4.7 T 9.4 T 11.7 T 14.1 T 16.4 T  
H 55 (2) 73 (1) 124 (1) 149 (1) 170 (1) 210 (2) 0.56 
NO2 59 (3) 88 (2) 149 (1) 175 (1) 199 (1) 224 (1) 0.46 
N(CH3)2 52 (4) 83 (1) 144 (2) 168 (1) 198 (1) 223 (1) 0.60 
NHCOCH3 53 (5) 85 (1) 152 (2) 180 (1) 210 (1) 241 (1) 0.61 
 
(a) Temperature was monitored accurately, calibrating against an ethylene glycol shift thermometer; (b) 
R2 values were estimated as (π × ω1/2), for a Lorentzian line fit. 
 !!
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3.3.3 pH Responsive chemical shift behaviour 
A 1H NMR spectroscopy pH titration was carried out with [Dy.L5(H2O)], over the pD 
range 2.5 to 11.5. The chemical shift of the major tert-butyl and methyl resonances was 
recorded at 8 different pD values, along with values for the transverse relaxation rates, 
R2, which were estimated from the individual linewidths (at half-height), using a π × 
ω1/2 relationship in a Lorentzian fit (Figure 3.12). 
 
  
 
Figure 3.12 Variations of the shift of the major tert-butyl resonance (left, red), the major methyl 
resonance (right, blue), and the corresponding changes in R2 (both, green) as a function of pD (D2O, 295 
K, 9.4 T). 
 
A negligible shift in the tert-butyl resonance was observed over the pD range shown, 
with minimal fluctuations also apparent in R2. There appears to be a small, reversible 
shift change over the pH range 5-9, where R2 also increases reversibly. Such behaviour 
is mirrored by the shift of the methyl resonance and suggests that the pKa of the 
acetamide substituent could be around 6.5. Whilst this pKa is highly desirable, a larger 
shift change is required for use in MRS imaging protocols, since the total shift change 
of 0.4 ppm is equal to 120 Hz at 7 T, and may therefore be difficult to calibrate 
accurately. 
 
Given the minimal structural modifications in the 4-position of the tert-butyl pyridyl 
moiety, both [Dy.L4(H2O)] and [Dy.L5(H2O)] showed similar shift and relaxation 
properties to the parent tri- and bis-carboxylate complexes ([Dy.L1(H2O)] and 
[Dy.L2(H2O)]+), detailed in Chapter 2. However, the desired pH sensitivity of the tert-
butyl signal was not achieved through introduction of a dimethylamine or acetamide 
substituent. In the former case, the pKa was much too low (< 3), with only the methyl 
groups shifting as a function of pH (5 ppm/pH unit). In the latter example, the pKa was 
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optimised, but the tert-butyl resonance did not shift with sufficient magnitude, as a 
function of pH. Such shift behaviour could be attributed to the magnitude of the shift in 
these carboxylate complexes; the overall shift is markedly lower than for the related tri-
phosphinate system, [Dy.L3] (ca. δH tBu = -75 ppm). If Bleaney’s theory for the 
pseudocontact shift of a paramagnetic lanthanide(III) based system is considered, page 
13, it might be surmised that in order to achieve a larger shift magnitude with respect to 
pH, the overall shift of the resonance must be greater. As a result, the second generation 
system detailed in the remainder of this Chapter will focus on enhancing the shift. 
3.4 Second Generation System: A Phosphonate Substituent 
The design of [Ln.L6] incorporates a phosphonate group in the 4-position of the tert-
butylpyridyl moiety (Figure 3.13). The early work on 31P MRS, detailed in Section 
1.1.2, inspired the selection of this substituent. In each case, the 31P NMR signal shifted 
as a function of pH, with a pKa around 7.29–31 In order to increase the shift magnitude of 
the tert-butyl reporter group, phosphinate arms have been incorporated. At 
physiological pH, it is expected to exist as the anionic species shown, such that the 
observable pKa corresponds to the formation of a dianionic species. 
 
!
 
Figure 3.13 The design of the phosphonate-bearing 1H PARASHIFT probe, [Ln.L6]. 
 
3.4.1 Complex synthesis and characterisation 
A synthetic approach was devised to place the phosphonate group in the desired 4-
position, based on a method by Redmore, whereby substitution of a phosphonate group 
occurred in the sterically hindered 4-position of a positively charged N-pyridinium 
salt.32 In this work, a bulky triphenylcarbenium ion was used to block the 2- and 6-
positions, facilitating selective substitution in the 4-position, albeit in a poor yield 
(28%). Interestingly, in this procedure the phosphite was sodiated in situ to enhance its 
nucleophilicity. Based on this precedent, alkylation of the oxygen on the previously 
synthesised N-oxide, 3, was achieved using dimethylsulfate to give the N-pyridinium 
N N
NN
P
O
O
P
O
O
P
O
O
NLn
P
O
O
OH
Chapter Three: Development of pH Responsive 1H PARASHIFT Probes !
! 115 
ion, 55 (Scheme 3.4). Reaction between 55 and sodiated-diethylphosphite in neat 
diethylphosphite gave the pyridyl-phosphonate species, 56, observable by low-
resolution mass spectrometry, which was then isolated using silica gel column 
chromatography, albeit in poor yield. 
 
 
 
Scheme 3.4 General procedure for the synthesis of the phosphonate labeled tert-butylpyridyl moiety, 56. 
 
Characterisation of 56 by HRMS showed the correct mass for the desired pyridyl-
phosphonate species (calcd for [C14H25NO3P]+ 286.1572, found 286.1574) but the 
resulting 1H NMR spectrum showed an unexpected splitting pattern in the two aromatic 
protons (Figure 3.14). The most shifted proton is split into a triplet (with J = 8 Hz) and 
the least shifted proton exists as a doublet of doublets (with J = 3 and 8 Hz). 
 
 
 
Figure 3.14 1H NMR spectrum of the pyridyl-phosphonate 56, showing expansion of the aromatic 
protons (CDCl3, 295 K, 16.4 T). 
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Two constitutional isomers can be proposed as products of the reaction, following 
substitution at either the 2- or 4-positions (Figure 3.15). However, it can be argued that 
substitution in the 2-position on 55 should be disfavoured due to the steric hindrance 
offered by the neighbouring tert-butyl and methoxy substituents. In contrast, 
nucleophilic substitution in the 4-position appears to be less hindered.  
 
 
 
Figure 3.15 Schematic representation of the two possible isomers of the phosphonate labeled tert-
butylpyridyl moiety, 56. 
 
Out of the two-dimensional 1H NMR techniques available, Nuclear Overhauser Effect 
spectroscopy (NOESY) was selected since it offered the most appropriate information 
for the characterisation of 56. In an NOE spectrum, the cross-peaks are representative of 
spatially close nuclei, rather than those that are through bond-coupled. As a result, the 
desired 4- substituted product would show 2 NOE cross-peaks, illustrating the spatial 
proximity between H3 and the methyl group, and H6 and the tert-butyl group (Figure 
3.16). In the case of the undesired 2- substituted product, 4 NOE cross-peaks would be 
seen and is the case upon expansion of the NOE spectrum in Figure 3.16. It is highly 
probable that the desired isomer was also formed in the reaction, but was not isolated. 
The appearance of a triplet in the 1H NMR spectrum, corresponding to H4, can be 
attributed to the similarity of the 3JHH and 4JHP coupling constants (8 Hz), which 
effectively masks a doublet of doublets.  
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Figure 3.16 1H NMR 2D NOE spectrum of the pyridyl-phosphonate species, confirming the identity of 
56 as the 2- substituted product by the revealed 4 red cross-peaks (CDCl3, 295 K, 16.4 T). 
 
Subsequently, a different synthetic route was proposed, utilising palladium-catalysed 
cross coupling procedures (Scheme 3.5). First, the removal of the N-oxide on the 
previously synthesised nitro-derivative, 41, was effected using phosphorus tribromide, 
to give 57, after purification on silica gel. Introduction of a bromine atom in the 4-
position was furnished in neat acetyl bromide to afford 58. The coupling between 58 
and diethylphosphite was then attempted using two different palladium catalysts. In 
neither case was reaction to the desired 4- substituted product observed. A possible 
explanation could be that oxidative addition of the carbon-bromine bond is sterically 
hindered due to the proximal tert-butyl group. 
 
 
 
Scheme 3.5 General procedure for the proposed introduction of the phosphonate group by palladium-
catalysed cross coupling methods. 
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In an effort to further weaken the carbon-halogen bond and encourage cross coupling to 
occur, a route was undertaken, using iodine in the 4-position (Scheme 3.6). 
Diazotisation of the aromatic amine 42 was achieved using nitrous acid, which was 
generated in situ using sodium nitrate and fluoroboric acid. Preparation of the halide 
was completed using potassium iodide, giving 59 in moderate yield, following 
purification by silica gel column chromotography. A [3,3]-sigmatropic rearrangement 
occurred in acetic anhydride to afford the acetate ester, 60. However, as before, the 
coupling between 60 and diethylphosphite yielded no product in the presence of the 
palladium catalysts used previously. 
 
 
 
Scheme 3.6 General revised procedure for the proposed introduction of the phosphonate group by 
palladium-catalysed cross coupling reactions. 
 
A palladium catalysed Arbusov reaction has been reported between triethyl phosphite 
and a variety of aryl iodides.33,34 Upon heating Pd(dba)2 and triethyl phosphite to 120 
°C, Pd{P(OEt)3}4 formed in situ and facilitated the formation of the desired 4-
phosphonate species, 61, which was isolated on silica gel in a reasonable yield (Scheme 
3.7). 
 
 
 
Scheme 3.7 General procedure for the synthesis of the mesylate 63. 
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The aromatic protons, H6 and H3, resonated as doublets in the 1H NMR spectrum, with 
coupling constants of 8 (4JHP) and 16 Hz (3JHP), respectively. Treatment of 61 with 
freshly prepared sodium ethoxide, effected acetate ester cleavage to give 62. Mesylation 
of 62 under standard conditions afforded the mesylate, 63, in excellent yield. 
 
Alkylation of the previously synthesised tri-phosphinate 12-N4-based macrocycle, 31, 
was undertaken with freshly prepared mesylate, 63 (Scheme 3.8). Reaction completion 
was monitored by TLC, after which purification using alumina gel column 
chromatography yielded the tetra-substituted ligand, 64. The removal of both the 
phosphinate and phosphonate esters using 6 M hydrochloric acid was monitored by 
LRMS and 1H NMR spectroscopy. Following complexation with the appropriate 
hydrated lanthanide(III) chloride, and isolation by reverse-phase preparative HPLC, the 
[Ln.L6] series of complexes was prepared, with Ln = Eu, Gd, Tb, Dy, Er and Tm (65-
70). 
 
 
 
Scheme 3.8 General procedures for the synthesis of the phosphonate-bearing 1H PARASHIFT probes, 
[Ln.L6], 65-70. !
The identity and purity of each complex were established by high-resolution mass 
spectrometry and analytical reverse-phase HPLC (tR ranged between 6.8 and 7.3 min). 
The metal hydration number, q, was assessed at pH 7 by measuring the radiative 
lifetime of the Eu(III) and Tb(III) excited state, k, in both D2O and H2O, as described in 
Section 2.2.2. In the case of [Tb.L6], values of 0.31 and 0.26 ms-1 were recorded 
experimentally for !!!!  and !!!!  respectively, giving a q value of 0. The 
experimentally determined values for [Eu.L6] were 1.32 and 0.82 ms-1 with a q value of 
0.3.  
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It is expected that such tri-phosphinate complexes will not possess a bound water 
molecule, due to the steric bulk associated with the PMe chelating arms, and is 
consistent with each of the [Ln.L3] systems discussed in Section 2.4.1 and related tri-
phosphinate based systems.11 The relaxivity, r1p, of 2.0±0.05 mM-1 s-1, obtained for 
[Gd.L6] is consistent with the absense of an inner-sphere water molecule, corresponding 
well to the value obtained with [Gd.L3] (r1p = 1.5±0.04 mM-1 s-1). The small increase 
for the para-substituted system is also consistent with an increase in the rotational 
correlation time, τR. 
 
3.4.2 1H NMR studies: shift and relaxation behaviour 
The chemical shifts ascribed to the tert-butyl reporter resonance of the [Ln.L6] 
complexes were greater than anticipated, as shown (Figure 3.17) for the Tm(III), 
Er(III), Dy(III) and Tb(III) analogues. Increases of 5 ppm were observed for each 
lanthanide(III) ion relative to the unsubstituted tri-phosphinate [Ln.L3] systems, 
detailed in Section 2.4, and are therefore the most shifted examples of this class. The 
Tb(III) analogue has the most shifted resonance, despite a Bleaney coefficient lower 
than Dy(III) (-86 vs. -100 respectively). In the Er(III) complex, the tert-butyl group 
resonated at +42.5 ppm, and the major isomer contributed to ≥83% of the total signal in 
each case. 
 
 
Figure 3.17 Stacked 1H NMR spectra of the [Ln.L6] complexes, highlighting the shift (in ppm) of the 
tert-butyl reporter resonance for Ln = Tm, Er, Tb and Dy (D2O, 9.4 T, 295 K, pD 7.4). 
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In each case, longitudinal relaxation rate data for the major tert-butyl resonances in the 
[Ln.L6] series were measured at 6 magnetic fields and showed an increase relative to 
the unsubstituted tri-phosphinate [Ln.L3] complexes (Table 3.3). As anticipated from 
previous investigations,13,25 the Er(III) analogue displayed the highest R1 across all the 
fields. In fact, the previously established R1 trend where Er(III) > Tm(III) > Dy(III) > 
Tb(III) is exhibited for this series of complexes also, further exemplifying the earlier 
finding that Er(III) and Tm(III) tri-phosphinate-based complexes show markedly higher 
relaxation rates than their Dy(III) and Tb(III) equivalents. Furthermore, in this para-
substituted system, all four of the complexes that were assessed possess the required R1 
values in the 100 to 200 s-1 range at 7 T.  
 
Table 3.3 Longitudinal relaxation rate data for the major tert-butyl resonance of [Ln.L6] at different 
magnetic field strengths (D2O, pD 7.4, 295 Ka). 
 
Ln R1/ Hz (± error) R1/R2b 
(9.4 T) 
 1.0 T 4.7 T 9.4 T 11.7 T 14.1 T 16.4 T  
Tb 42 (3) 73 (1) 122 (2) 134 (1) 150 (1) 164 (1) --- 
Dy 54 (5) 88 (3) 156 (1) 179 (1) 195 (1) 218 (1) 0.50c 
Er 92 (10) 117 (7) 173 (3) 198 (3) 214 (7) 239 (8) --- 
Tm 25 (4) 99 (5) 139 (1) 160 (1) 179 (1) 190 (1) --- 
 
(a) Temperature was monitored accurately, calibrating against an ethylene glycol shift thermometer; (b) 
R2 values were estimated as (πω1/2), for a Lorentzian line fit; (c) measured at pH = 9, at pH 7.1 (i.e. the 
pKa, at 295 K) T2* increases by a factor of 3, see Section 3.4.3 for more information. 
 
The degree of deviation of the R1 values from these of the parent, unsubstituted complex 
was more pronounced with increasing field strength, such that in the case of Dy(III), a 
45% R1 improvement is evident at 16.4 T (for Y = H, R1 = 150 s-1 at 16.4 T). Such 
increases in R1 at high field are associated with increases in the Curie contribution to 
relaxation, and the dominance of the (µeff)4 term. Estimated values of µeff, obtained by 
iterative minimisation methods, demonstrated disparities between [Dy.L3] and [Dy.L6]. 
In the former case, the µeff value of 9.47 deviated by more than -5% from the free ion 
value of 10.4, whereas in the latter, the µeff value of 10.65 fell within the classical 
range.26 Values for τR were also estimated for [Dy.L3] and [Dy.L6], displaying a 38% 
increase upon inclusion of an anionic para-substituent (for Y = H, τR = 249 ps; for Y = 
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PO3H, τR = 345 ps). The increase in relaxivity that was conveyed in Section 3.4.1 
reflects such behaviour and is consistent with the larger apparent molecular volume 
occupied by the more strongly hydrated anionic [Dy.L6] complex. 
   
Strikingly high R1 values at clinically relevant field strengths (1.0 to 7.0 T), coupled 
with a favourable chemical shift, make [Er.L6] an attractive candidate for MRS imaging 
protocols. In this particular system, the case of Tm(III) can also now be considered of 
interest, given that it fulfills the required enhancements in R1 at 7 T.  
 
The achievement of the required R1 values for the Er(III), Tm(III), Dy(III) and Tb(III) 
para-substituted [Ln.L6] complexes provided encouragement for MRS applications, 
given that the previously detailed series presented only one attractive candidate for any 
further investigation. This new series of complexes, through optimisation of both shift 
and relaxation characteristics, presents the opportunity for using more than one probe in 
MRS imaging protocols. Investigations into the pH responsive tert-butyl chemical shift 
behaviour were clearly warranted, to assess the utility of these systems as pH probes. 
 
3.4.3 Responsive chemical shift behaviour of [Dy.L6] 
An initial 1H NMR study of [Dy.L6] in D2O showed reversible pH dependent tert-butyl 
chemical shift behaviour, over the 4.4 to 9.4 pD range. At high pD, the signal resonated 
at -77.2 ppm, and as the pD decreased the signal shifted to -79.1 ppm (Figure 3.18). 
This culminated in a total shift change, ΔδH tBu, of 1.9 ppm between the protonated and 
deprotonated forms shown in Figure 3.19, corresponding to 570 Hz at 7 T. Such a shift 
magnitude is 2.5% of the overall observed shift and might explain why the shift 
difference is greater for this tri-phosphinate system compared to the tri-carboxylate 
acetamide system, [Dy.L5(H2O)]. Here, the total change is also 2% of the overall shift 
but the markedly smaller shift (δH tBu = 23.3 ppm) results in a smaller total change of 
0.4 ppm. The shift increase can be linked to the change in solvation around the tert-
butyl group as the neighbouring phosphonate group becomes more negatively charged, 
i.e. at the pKa where it changes from mono-anionic to di-anionic.  
 
By plotting the change in the tert-butyl chemical shift as a function of pD and fitting 
the resulting curve, the pKa of this process was measured to be 7.11±0.05. With the 
physiological pH window being the range within which it functions, and high 
sensitivity around the pKa, the complex, [Dy.L6] was the subject of further studies. 
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Figure 3.18 The shift in the major tert-butyl resonance of [Dy.L6] as a function of pD (D2O, 11.7 T, 295 
K) and the corresponding pH equilibrium. 
 
The effect on the transverse relaxation rates, R2, also needs to be noted, since the criteria 
detailed in Section 3.1 clearly set out the need to minimise chemical exchange 
broadening. It is evident (Figure 3.18), that the most broad spectral peak occurs around 
pD 7.1, when the tert-butyl chemical shift is at -78.3 ppm. By estimating the full-width 
half-height of the spectral peak at the two limiting pD values, 4.4 and 9.4, T2* was found 
to increase by a factor of 3 about the pKa. However, such behaviour is not thought to 
have major sensitivity implications when applied to MRS imaging protocols. 
 
Further investigations with [Dy.L6] were undertaken in order to establish the pH 
responsive chemical shift behaviour in aqueous solutions. As a result, studies were 
carried out in a 0.1 M NaCl solution in H2O and a 50:50 mixture of murine plasma and 
H2O, as a control as in vivo work was now envisaged. The shifts differed slightly 
depending on the medium, with the data recorded in D2O being shifted to slightly lower 
frequency (Figure 3.19). When locking an NMR instrument to a standard reference 
solution, a deuterated solvent is typically used. For the experiments run in H2O, the D2O 
lock was present inside an insertable lock tube. In the case of the experiment ran in neat 
D2O, the slight upfield shifting of the resonances can be ascribed to the paramagnetic 
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induced shift effects exerted by the dissolved Dy(III) complex. Nonetheless, the overall 
profile was similar for the three data sets. The fitted curve for the murine plasma H2O 
mix data revealed a sharp region around the pKa. This is slightly misleading but can be 
rationalised in part by the buffering that occurs in the aqueous plasma medium and 
explains why there are no experimental data points between 6.5 and 7.0. The reduction 
in the pKa at an ionic strength of >0.05 accords with simple Debye-Hückel theory. 
 
 
 
Figure 3.19 The shift in the major tert-butyl resonance of [Dy.L6] as a function of pH or pD in a 0.1 M 
NaCl solution in H2O (black), D2O (red) and a 50:50 mixture of murine plasma and H2O (blue) (11.7 T, 
295 K). 
 
The temperature variation of chemical shifts for paramagnetic lanthanide(III) complexes 
was demonstrated in Section 1.3, with several of the 1H PARASHIFT probes reported, 
offering scope for use in temperature sensing applications. Recalling, the T-2 
dependence for the pseudocontact shift of nuclei within paramagnetic lanthanide(III) 
complexes (equation 1):  
 
 (1) 
 
Variations in temperature must be accounted for with in vivo protocols. Accordingly, 
the temperature sensitivity of the tert-butyl chemical shift on [Dy.L6] was analysed 
from 290 to 315 K. Two solutions of [Dy.L6] in D2O, at pD values either side of the 
pKa, and a solution of [Dy.L6] in a 50:50 murine plasma: H2O mix at pH 7.1 were 
prepared. The chemical shift of the tert-butyl resonance was recorded at 6 temperatures, 
with each temperature checked by using an ethylene glycol shift thermometer. Each 
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data set displayed a linear dependence with respect to T (R2 = 1.00 for the lines of best-
fit shown in Figure 3.20), shifting 0.41±0.10 ppm/K-1 in D2O and 0.43±0.10 ppm/K-1 in 
murine plasma: H2O. 
 
 
 
Figure 3.20 Variation in the chemical shift of the major tert-butyl resonance of [Dy.L6] as a function of 
T: pD 6.9 (blue triangles), gradient = 0.414, R2 = 0.998; pD 7.9 (blue squares), gradient = 0.414, R2 = 
0.998; and in a 50:50 murine plasma: H2O mix at pH 7.1 (red triangles), gradient = 0.431, R2 = 0.999 
(11.7 T). 
 
The collection of such data for [Dy.L6] allows a 3D volumetric plot to be constructed, 
depicting the tert-butyl chemical shift behaviour in terms of pH and temperature 
(Figure 3.21). Ideally, prior to in vivo work, the majority of this plot should be filled in 
order to ascertain the responsive behaviour of the tert-butyl signal in more detail. 
Thorough work such as this has been demonstrated by Hyder et al., who built up 
volumetric plots for the pH and temperature sensitivity for four 1H resonances of 
[Tm.DOTP]5-.16 Rather than run consecutive pH titrations at the remaining 5 
temperatures, it was decided that more telling information could be gained from 
phantom imaging studies in a 7 T MRI machine. This work will be discussed in Section 
3.4.5. Such methodology also allows the feasibility of the chemical shift read-out 
protocol to be tested and refined prior to in vivo studies. 
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Figure 3.21 3D volumetric plot showing the dependence of the major tert-butyl chemical shift of [Dy.L6] 
on the T and pD (D2O, 11.7 T). 
 
The effect of temperature on the longitudinal relaxation rate, R1, of the tert-butyl 
resonance of [Dy.L6] was also assessed, given the T-2 dependence in the Curie term of 
the following equation: 
 !! = ! !!" !!!! ! !!!!!""!!! ! !!!!!!!! !!!!!!! + ! !!!!!!!! !! !!!!! + !!! ! !!!! ! !!! !!""!!!" !!! ! !!!!!! !! !!!  (2) 
 
 
The variations in the R1 of the tert-butyl chemical shift on [Dy.L6] were measured for 
the three solutions described above, at 6 temperatures in the 290 to 315 K range. The 
linearity between R1 and T-2 is evident in Figure 3.22, where R2 = 0.98 for the lines of 
best-fit shown. The data in murine plasma: H2O displays a slightly steeper gradient 
compared to the solutions in D2O, but is less linear. These slight perturbations in R1 
could be accredited to interactions with plasma proteins; but this is not too much of a 
concern for in vivo applications, since the perturbation is negligible. 
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Figure 3.22 Variation in the longitudinal relaxation rate, R1, of the major tert-butyl resonance of [Dy.L6] 
as a function of T-2: pD 6.9 (blue triangles), gradient = 252, R2 = 0.984; pD 7.9 (blue squares), gradient = 
252, R2 = 0.980; and in a 50:50 murine plasma: H2O mix at pH 7.1 (red triangles), y = 314, R2 = 0.977 
(11.7 T). 
 
3.4.4 Responsive chemical shift behaviour of [Tb.L6], [Er.L6] and 
[Tm.L6] 
Due to the favourable shift and relaxation characteristics that were established in 
Section 3.4.2, the chemical shift behaviour of the [Tb.L6], [Er.L6] and [Tm.L6] 
complexes were assessed in D2O. The tert-butyl resonance on each complex exhibited 
pH responsive chemical shift behaviour, as shown in Figure 3.23. The total shift change 
between the acid and base forms of each complex differed slightly. For example, 
[Er.L6] showed a total shift change of 0.7 ppm, which is half the 1.4 ppm difference 
found for [Tb.L6]. The overall shift magnitude of the tert-butyl resonance of [Er.L6] is 
half of that for [Tb.L6], at least in part explaining the observed trend. Since there is no 
obvious trend with lanthanide(III) ion size or geometry, the pKa values are proposed to 
be the same, within the experimental error of ±0.05.   
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Figure 3.23 The shift in the major tert-butyl resonance of [Ln.L6] (Ln = Tb, Dy, Er and Tm) as a function of pD (D2O, 11.7 T, 295 K). 
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The linearity of the temperature dependence of the tert-butyl resonance for each 
complex also scaled with the magnitude of the overall tert-butyl chemical shift. As 
shown in Table 3.4, the largest temperature coefficient is evident for the most shifted 
[Tb.L6] species, and the smallest for the least shifted species, [Er.L6]. 
 
Table 3.4 Comparison of the total shift and temperature sensitivities for the major tert-butyl resonance of 
the [Ln.L6] complexes (all D2O, ~pD 7.4, 11.7 T). 
 
[Ln.L6] δH tBu/ ppm ΔT/ ppm K-1 
Tb -83.1 0.52 
Dy -78.3 0.41 
Tm +74.6 0.44 
Er +42.5 0.24 
 
Prior to the commencement of 1H MRS imaging studies, a control experiment to 
monitor the change in relaxivity as a function of pH was undertaken with a solution of 
[Gd.L6] (0.5 mM, H2O). Over the measured pH range of 4 to 9, no significant change 
was observed in the relaxivity. This is an expected result, given that the coordination 
number of the metal is not being affected during the deprotonation/protonation process.!!
3.4.5 1H MRS phantom imaging studies with [Tm.L6] and [Dy.L6] 
Following the in vitro analyses of the complexes described in Sections 3.4.3 and 3.4.4, 
and the shift and relaxation successes in Sections 3.4.2, Dr. Dara O’Hogain carried out 
phantom imaging studies at the Newcastle Magnetic Resonance Centre at 300 MHz (7 
T). These were undertaken first to assess the feasibility of imaging at such remote 
spectral frequencies, and second to ascertain whether the shift changes can be observed 
by imaging methods.  
 
Five equimolar solutions of [Tm.L6] were prepared in buffered aqueous solution (0.1 M 
MOPS), at a range of pH values, inside cut-down 5 mm NMR tubes. The five NMR 
tubes were placed within a Teflon spacer, as shown in Figure 3.25 (left), with an NMR 
tube containing deionised water only, occupying the central position. Use of the 1H 
MRI inactive Teflon spacer ensured that there would be no image interference. 
Subsequently, the experimental array was placed inside the bore of a 30 mm birdcage 
coil, typically used for murine imaging. First, an image corresponding to the H2O 
protons was obtained by imaging at the H2O offset (Figure 3.25, middle) and second, by 
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setting the offset to the resonant frequency of [Tm.L6] at pH 7 (Figure 3.25, right). As a 
result of using a well-removed offset, an image corresponding to the tert-butyl reporter 
resonance was acquired, separately from the endogenous water signal.  
 
 
 
Figure 3.25 (Left) Illustration of experimental array, in a Teflon holder, using 5 equimolar solutions of 
buffered [Tm.L6] at different pH values shown and with de-ionised H2O in the centre (0.1 M MOPS, 1.2 
mM, H2O). (Middle) Phantom image at the H2O offset (-641.4 Hz, intensity scale 0-4000 a.u.). (Right) 
Phantom image at the [Tm.L6] tert-butyl offset (19103 Hz, intensity scale 0-0.1 a.u.), both: TR = 23.6 
ms; TE= 1.2 ms; nt = 4 (H2O), 80 (tert-butyl); SW = 6000 Hz; spectral points 128; spectral width 128; 
Matrix 16 x 16; FOV 40 x 40; slice thickness 8 mm; T = 303 K).  
 
The feasibility of spectral analysis from the CSI data was demonstrated for the five 
phantoms of [Tm.L6], with Figure 3.26 showing the frequency of the tert-butyl signal 
observed in each tube. With a total shift of 144 Hz at 7 T (0.48 ppm) between pH 6.2 
and 8.1, the data obtained was in good agreement with the results from the in vitro 
studies. 
 
 
Figure 3.26 Spectral analysis from CSI image of [Tm.L6], showing the frequency detected for each ROI 
peak for: pH 6.2 (purple), 3037 Hz; 6.6 (yellow); 7.1 (blue); 7.5 (green); and 8.1 (red), 2893 Hz. Total 
shift = 144 Hz, 0.48 ppm, offset frequency = -27432 Hz, TR = 23.5, TE = 1.2, nt = 30, slice thickness = 8 
mm, 128 spectral points, 6010 spectral width, T = 310 K. 
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The temperature of the five solutions of [Tm.L6] was varied using an externally 
controlled heated airflow around the Teflon spacer array and was monitored by 
positioning a thermometer in the middle of the array. The PARASHIFT images were 
acquired 5 min after setting the temperature so as to minimise any chemical shift 
fluctuations. The plot in Figure 3.27 shows the temperature dependent tert-butyl 
chemical shift behaviour of the five solutions. Such linear dependencies are in 
agreement with the data obtained on a spectral NMR instrument (11.7 T) for [Tm.L6], 
and pH 7, reporting tert-butyl chemical shift temperature dependencies of 0.44±0.02 
ppm/K.  
 
!
 
Figure 3.27 Variation in the chemical shift of the major tert-butyl resonance of five different pH 
solutions of [Tm.L6] as a function of T (7 T): pH 6.2 (orange), gradient = 0.44; pH 6.6 (blue), gradient = 
0.46; pH 7 in vitro (black), gradient = 0.44; pH 7.1 (purple), gradient = 0.44; pH 7.5 (green), gradient = 
0.46; and pH 8.1 (red), gradient = 0.46. All lines of best-fit have R2 = 0.998. 
 
Next, two fresh solutions of [Tm.L6] were prepared in MOPS buffered water, at the 
extreme pH values of 6.1 and 8.1, so that the shift difference was optimised. A CSI 
image was acquired of the two phantoms at the tert-butyl offset. This image was then 
processed using the spectral data, gaiting signal intensity at the offset 20227 Hz for pH 
6.1 (Figure 3.28, left) and 20383 Hz for pH 8.1 (Figure 3.28, right). As a result, the 
applicability of selectively imaging two differently shifted tert-butyl resonant 
frequencies has been demonstrated (Figure 3.28). Clearly, a difference of 144 Hz (ca. 
0.48 ppm) is not a problem for CSI protocols, and offers much promise for in vivo 
studies. 
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Figure 3.28 CSI image of [Tm.L6] phantoms at offset frequency = 20383 Hz, TR = 19.8, TE = 12.4, nt= 
40, slice thickness = 10 mm. At pH 6.1 (left), pixel intensity showing intensity at a frequency offset of 
20227 Hz, and at pH 8.1 (right), pixel intensity showing signal intensity at frequency offset of 20383 Hz. 
(Images use thresholding to reduce noise). 
 
Analogous phantom imaging experiments were repeated with a spacer unit comprising 
four equimolar solutions of [Dy.L6] and de-ionised water (Figure 3.29, left). As before, 
the benefits of using a well-shifted tert-butyl reporter signal enabled the acquisition of 
an image corresponding to the tert-butyl signal intensity only, independent of the 
solvent water. 
 
 
 
Figure 3.29 (Left) Illustration of experimental array, in a Teflon holder, using 4 equimolar solutions of 
buffered [Dy.L6] at different pH values shown and with de-ionised H2O in the centre (MOPS, 1.2 mM, 
H2O). (Middle) Phantom image at the H2O offset (-2839 Hz, intensity scale 0-4000 a.u.). (Right) Phantom 
image at the [Dy.L6] tert-butyl offset (-27432 Hz, intensity scale 0-0.1 a.u.), both: TR = 17.2 ms; TE= 0.7 
ms; nt = 4 (H2O), 30 (tert-butyl); SW = 6000 Hz; spectral points 128; spectral width 8013; Matrix 16 x 
16; FOV 40 x 40; slice thickness 60 mm; T = 296 K). 
 
The feasibility of spectral analysis from the CSI data was demonstrated for each 
phantom of [Dy.L6], with Figure 3.30 showing the frequency of the tert-butyl signal 
observed in each tube. With a total shift of 318 Hz at 7 T (1.06 ppm) between pH 6.2 
and 7.5, the data obtained was in good agreement with the results from the in vitro 
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studies, where the total pH dependent shift for [Dy.L6] is greater than the total shift for 
[Tm.L6] (1.06 ppm vs. 0.48 ppm here). The difference in the size of the shift change 
here is somewhat surprising, but is very useful as it distinguishes each from the 
concomitant temperature dependent behaviour. 
 
!!
 
Figure 3.30 Spectral analysis from the CSI image of [Dy.L6], showing the frequency detected for each 
ROI peak for: pH 6.2 (red), 3543 Hz; 6.6 (green), 3644; 7.1 (blue), 3773 Hz; and 7.5 (yellow), 3861. 
Total shift = 318 Hz, 1.06 ppm; offset frequency = -27432 Hz, TR = 17.2, TE = 0.7, nt = 30, slice 
thickness = 60 mm, 128 spectral points, 8013 spectral width, T = 296 K. 
 
3.4.6 1H MRS in vivo imaging studies with [Gd.L6] and [Dy.L6] 
In order to establish the biodistribution and clearance profile of the [Ln.L6] complexes, 
preliminary in vivo imaging studies focused on using [Gd.L6] so that it could be viewed 
by standard dynamic contrast enhanced 1H MRI protocols. Solutions containing 5 mM 
[Gd.L6] were prepared in saline, and administered to separate anaesthetised mice by 
intravenous injection via the tail vein. The dose administered was calculated to be 0.04 
mmol/kg, for a 25 g mouse. 
 
The presence of contrast in the kidney and skeletal muscle first, and the bladder later, 
arising from [Gd.L6], was observed (Figure 3.31). Such a result indicates that the 
addition of an anionic para-substituent facilitates slightly slower clearance, affording 
biodistribution in tissue, and supports well the observation made for an increasing τR. A 
slower rate of clearance, favouring the biliary route, has been recently reported for a 
structurally related para-substituted anionic lanthanide(III) complex.35 It also marks a 
slight improvement on the outcome of the imaging experiment with the di-carboxylate 
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parent complex, [Gd.L2(H2O)], which was found to clear more rapidly via the kidneys. 
However, with the SNR increasing in the bladder 30 min after injection, the clearance 
rate of [Gd.L6] is still faster than is ideally required for this work, and so further 
complex retention is sought. 
 
 
Figure 3.31 A plot of the normalised SNR from the gradient echo multi slice scan of [Gd.L6] in the 
bladder (red), kidney (green) and skeletal muscle (purple) as a function of time after injection for mouse 
1. Data was acquired as a gradient echo multi-slice scan, without gaiting, and with the following 
parameters; TR = 175.54 ms; TE = 4.89 ms; FOV 32 x 32; Matrix 128x128; 18 slices. The total 
acquisition time = 22.5 s. The mouse was injected with 200 µL of 5 mM [Gd.L6] (i.e. a 0.04 mmol/kg 
dose) at time 0 min. 
 
An analogous biodistribution study was undertaken with a 12.5 mM solution of 
[Dy.L6], injecting a dose of 0.1 mmol/kg. The 1H PARASHIFT scans acquired at the 
tert-butyl offset of [Dy.L6] are shown as two slices through the mouse in Figure 3.32 
(top), in which the first slice includes the kidneys, and the second slice includes the 
bladder. Signal intensity corresponding to the tert-butyl reporter resonance of [Dy.L6] 
can be seen 4 min after injection, in each kidney, and in the bladder, 10 min after 
injection. The relative concentration of the tert-butyl signal as a function of time after 
injection shows rapid clearance through the kidneys, with later accumulation in the 
bladder (Figure 3.32, bottom). 
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Figure 3.32 (Top) The corresponding 1H PARASHIFT scans of two slices through the mouse, injected 
with 200 µL of 10 mM [Dy.L6] at time 0 min, at the time intervals shown. Slice 1 includes the kidneys, 
and slice 2 includes the bladder. Furthest right are the standard structural scans (TR = 7.69 ms; TE = 0.73 
ms; FOV 32 x 32; Matrix 16x16; 8 mm slices; sweepwidth 20 kHz; duration 63 s. The total acquisition 
time = 22.5 s). (Bottom) A plot of the relative concentration of [Dy.L6] in the bladder (red) and kidney 
(green) as a function of time after injection of a 200 µL of 10 mM [Dy.L6] at time 0 min.  
 
Overall, the pH dependence of the tert-butyl chemical shift of the [Ln.L6] complexes 
has allowed chemical shift differences of 144 Hz to be observed in MRS protocols, with 
high sensitivity and confidence. However, despite such behaviour, it is clear that the 
retention of the [Ln.L6] complexes is a concern if in vivo pH mapping is to be realised. 
Of course, the clearance rates of these complexes are species-dependent, and will be 
slower and differ in the relative proportion of renal/biliary clearance routes for mice vs. 
rats/rabbits/humans. 
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0 min 4 min 10 min 20 min 
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3.5 Conclusions 
The utility of pH responsive PARASHIFT probes has been described in Section 1.3 (1H) 
and Section 3.1 (19F). However, the former cases did not satisfy the requirements for 
increasing sensitivity in MRS imaging experiments, whilst the latter cases used the less 
readily observed 19F reporter nucleus. Such drawbacks led to the development of closely 
related 1H PARASHIFT systems, but extreme line-broadening associated with the pH 
dependent reversible ligation of a sulphonamide moiety led to significant signal 
intensity losses, and rendered it unsuitable for in vivo applications.  
 
The work described allowed such limitations to be alleviated by fulfilling a new set of 
criteria (pages 100-101). As a result, three systems have been derived, in which 
minimal structural modifications on the parent systems from Chapter 2 have occurred in 
the 4- position of the pyridyl moiety (i.e. para- to the coordinated nitrogen atom), such 
that changes to the favourable shift and relaxation characteristics are minimised. 
 
 
 
Figure 3.33 The pH responsive 1H PARASHIFT probes detailed in this Chapter: the dimethylamine 
system, [Dy.L4(H2O)] (left); the acetamide system, [Dy.L5(H2O)] (middle) and the phosphonate system, 
[Ln.L6] (right). 
 
The dimethylamine substituted complex, [Dy.L4(H2O)] (Figure 3.33), possessed one 
major tert-butyl resonance at -28.4 ppm, showing a 10 ppm enhancement when 
compared to the unsubstituted tri-carboxylate analogue, [Dy.L1(H2O)] (δH = -20.1 
ppm). Upon para- substitution, R1 increases of up to 16% are achieved across all 
measured field strengths. However, there was no observable shift in the tert-butyl 
reporter resonance over the 5-10 pH range. Significant shift dependencies of 5 ppm/pH 
unit were observed for the diastereotopic methyl groups, at -8.1 and -19.3 ppm, but 
indicated that the pKa (<3) of the dimethylamine substituent was too low for 
physiological purposes. 
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As expected, the acetamide substituted complex, [Dy.L5(H2O)] (Figure 3.33), gave rise 
to one major tert-butyl signal at -23.3 ppm, and exhibited the required R1 enhancements 
in the 100 to 200 s-1 range at 7 T. However, whilst the pKa was found to be desirable at 
6.5, the total tert-butyl chemical shift change of 0.4 ppm was deemed to be too difficult 
to calibrate accurately in MRS imaging protocols. 
 
Tert-butyl chemical shifts up to ±80 ppm were achieved for a phosphonate substituted 
system, [Ln.L6], marking improvements of 5 ppm when compared to the unsubstituted 
tri-phosphinate predecessors, [Ln.L3]. As has been established for related tri-
phosphinate systems, the Er(III) complex showed the highest R1 across all the fields, 
with particularly attractive enhancements at clinical field strengths.  
 
The tert-butyl resonance on [Dy.L6] exhibited the largest total chemical shift change 
between the acid and base forms (1.9 ppm), and a highly desirable pKa between 6.7 and 
7.1 according to the ionic strength of the medium. Coupled with the enhanced 
sensitivity of imaging in a well-removed spectral window, such pH responsive chemical 
shift behaviour permitted the visualisation of the tert-butyl signal in both in vitro and in 
vivo MRS imaging protocols within a matter of minutes, at a well-tolerated dose, that is 
the size of clinically accepted contrast agents. However, [Dy.L6] appeared to clear 
rapidly and accumulate in the bladder, mimicking the behaviour observed for 
[Dy.L2(H2O)]+. 
 
Clearly, a method needs to be devised to enhance the retention of the complex in vivo so 
that the tert-butyl reporter signal can be observed for a longer period of time in MRS 
imaging procedures, whilst still satisfying the shift and relaxation criteria at the heart of 
this work. The final Chapter of results and discussion will focus on the concept of 
substantially increasing the size of the probe, by conjugation of several probes to one 
polymeric vector. !  
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Chapter Four: A Strategy to Enhance Complex 
Retention In Vivo 
4.1 Introduction 
As discussed in Chapter 1, one of the major problems plaguing any NMR spectroscopy 
based technique is the inherently low sensitivity. The work discussed in this thesis has 
set out to alleviate these drawbacks through the use of paramagnetic lanthanide(III)-
based complexes, exhibiting sufficient sensitivity gains such that 1H MRS imaging can 
be carried out in vivo, using clinically viable doses with clinically attractive acquisition 
times. Unfortunately, such approaches have led to fast probe clearance and as a result, 
the fast accumulation of the reporter signal in the bladder. With temperature and pH 
maps of the bladder being rather uninteresting, a method using the mouse model 
available needs to be devised to increase the tissue retention of the complex, such that 
increases in the local probe signal density can be observed.  
 
One possible means of achieving this is to increase the size of the probe substantially, 
by covalently linking the lanthanide(III)-based complex to a higher molecular weight 
adduct (Figure 4.0). Originally a method formulated to increase the imaging nuclei 
density per unit concentration, applications with medium to high molecular weight 
conjugates have been shown to possess relatively slower rates of clearance from the 
body.1–3 
 
 
Figure 4.0 Schematic representation of the conjugate principle: where the blue centre represents a high 
molecular weight adduct, Ln-tBu the lanthanide(III)-based complex and the black line a covalent bond.   
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In order to maximise the signal intensity gained through this methodology, it is 
imperative that the magnetic equivalence of the reporter groups is retained, and that 
chemical exchange broadening is limited, giving rise to one major signal in solution. Of 
additional importance are the good biocompatibility characteristics, i.e. the low toxicity 
and good water solubility attained for the PARASHIFT probes detailed in Chapters 2 
and 3. 
 
A biocompatible vector of particular interest is that of glycol chitosan, a linear 
polysaccharide derived from chitin, composed of randomly distributed β-(1,4)-linked D-
glucosamine and N-acetyl-D-glucosamine moieties. Its non-toxicity, biodegradability 
and good tolerance in vivo present crucial characteristics for the applications of this 
work.4 In its commercially available form, the mean molecular weight is approximately 
195 kD, but a significantly reduced molecular weight polymer (~6.5 kD) can be 
obtained through acidic digestion of the commercial material with 4 M HCl at 50 °C 
over a period of 24 h (Scheme 4.0).4–6 This latter compound possesses greatly improved 
water solubility, and owing to the deacetylation under acidic treatment, yields a material 
bearing primary amine groups which are amendable for conjugation. 
 
 
 
Scheme 4.0 Synthesis of the medium molecular weight deacetylated chitosan from the commercially 
available glycol chitosan by acidic digestion.   
 
Previous work has demonstrated the preparation of medium molecular weight 
conjugates by appending paramagnetic lanthanide(III) complexes labeled with a 
trifluoromethyl reporter group, via an amide linkage to the acid digested product 
(Figure 4.1).7 Characterisation by aqueous gel permeation chromatography (GPC) 
revealed average molecular weights of 13.8 kD for Gd(III), 14.6 kD for Dy(III) and 
16.2 kD for Ho(III), consistent with the addition of 8.5, 9.5 and 13 complexes, 
respectively. The more promising characteristics were found for the tri-phosphinate 
Dy(III) complex conjugate (i.e. when X = PMe and n = 0, Figure 4.1), revealing a 19F 
signal with one principal (86%) resonance. The independent rotational motion of the 
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complex with respect to the polymer, meant that the relaxation rates remained largely 
unaffected, with the conjugate product displaying a decrease in R2 (440 s-1 for free 
complex vs. 367 s-1 for the conjugate at 9.4 T) and an increase in the R1/R2 ratio (0.42 
for free vs. 0.50 for conjugate at 9.4 T).  
 
 
 
Figure 4.1 The structure of paramagnetic fluorine labeled glycol chitosan conjugates, where Ln = Gd, Dy 
and Ho, X = C or PMe; and n = the number of water molecules (typically 1 when X = C, and 0 when X = 
PMe). 
 
Scouting experiments were undertaken to assess the biodistribution of the Gd(III) 
complex conjugates in nude mice bearing HT29 colorectal tumour xenografts. Doses of 
the order of 0.017 mmol kg-1 led to an almost immediate contrast enhancement (<1 min) 
in the tumour tissue and bladder by dynamic contrast enhanced 1H MRI (Figure 4.2). 
Over a 10 min acquisition period, rapid and selective uptake of the Gd(III) complex 
conjugate was observed in the tumour (Figure 4.2), owing to an enhanced permeability 
and retention effect characteristic of such medium molecular weight systems.8 
 
 
 
Figure 4.2 (Left) T1-weighted 1H MRI images before and after injection of a 0.017 mmol kg-1 dose of a 
Gd(III) complex conjugate, tumour indicated by an arrow. (Right) Temporal profile of the mean signal 
intensity in the tumour area over a 10 min acquisition window post-Gd(III) administration, where the 
fluctuations are due to respiratory motion.7  
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4.2 Glycol Chitosan Based System 
With this background in mind, a medium molecular weight glycol chitosan conjugate 
has been designed, conjugated through an amide bond to a paramagnetic lanthanide(III) 
complex in which a tert-butyl reporter group is engineered to be about 6.5 Å from the 
lanthanide(III) centre (Figure 4.3). For this work, a tri-phosphinate-based 
lanthanide(III) complex has been selected, following the promising shift characteristics 
achieved in Section 2.4.2 and the aforementioned work of De Luca et al..7 Provided that 
the relaxation behaviour and the magnetic equivalence of the tert-butyl reporter 
resonance are retained in the conjugated species, it is expected that such systems will 
enhance signal retention in vivo in 1H MRS imaging protocols and alleviate some of the 
clearance problems presented by [Dy.L2(H2O)]+ and [Dy.L6] in Chapters 2 and 3, 
respectively. 
 
 
 
Figure 4.3 The design of a medium molecular weight glycol chitosan conjugate, bearing a tert-butyl 
labeled paramagnetic lanthanide(III) complex (left) and the disconnection revealing the target carboxylic 
acid bearing precursor complex, [Ln.L7] (right). 
4.2.1 The precursor complex, [Ln.L7] 
4.2.1.1 Synthesis and characterisation 
The synthesis of the precursor complex is detailed in Scheme 4.1, beginning with the 
previously synthesised nitro- alcohol 43. Previously alluded to synthetic procedures 
have shown the ability to replace a nitro- group in the 4-position of a coordinated 
pyridyl moiety on a paramagnetic lanthanide(III) complex with a sulphur containing 
compound.9 In this case, a displacement reaction occurred with ethyl thioglycolate in 
the presence of sodium hydride, on the diamagnetic substrate 43 to achieve the ester 71, 
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following purification by silica gel column chromatography. Formation of the mesylate 
72 was undertaken using mesyl chloride and triethylamine and proceeded in near 
quantitative yield.     
 
 
 
Scheme 4.1 General synthetic procedures for the synthesis of the carboxylic acid bearing precursor 
complex, [Ln.L7]. 
 
Afterwards, N-alkylation of the previously derived tri-phosphinate macrocycle 31 was 
carried out with 72, in a small volume of dry acetonitrile to accelerate the reaction 
towards the tetra-alkylated ligand 73. Following isolation by alumina gel column 
chromatography, the ethyl esters were removed in 6 M hydrochloric acid. Complexation 
of the corresponding hydrochloride salt of the ligand was achieved by reaction with the 
hydrated chlorides of Gd(III) and Dy(III), in aqueous solution at pH 5.5. Pure 
complexes were derived therefrom by reverse-phase preparative HPLC, with high 
resolution mass spectrometry methods confirming the desired constitution of the 
complexes in good agreement to the experimentally calculated isotope patterns. 
 
For [Gd.L7], the relaxivity, r1p, was found to be 1.86±0.05 mM-1 s-1 (H2O, 60 MHz, 310 
K) and is consistent with the values obtained for the related q = 0 tri-phosphinate 
systems detailed in Chapters 2 and 3. It is expected that a large increase in r1p will 
accompany the corresponding glycol chitosan conjugate, indicative of the slower 
molecular tumbling of the overall complex in solution and an increase in the rotational 
correlation time, τr.8 The literature example described above reports that an r1p value 
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doubles in magnitude for the glycol chitosan conjugate compared with the free 
uncoupled tri-carboxylate complex (4.62 vs. 11.2 mM-1 s-1; H2O, 60 MHz, 310 K).7  
4.2.1.2 1H NMR shift and relaxation behaviour of [Dy.L7] 
The 1H NMR spectrum of [Dy.L7] showed the presence of one major tert-butyl signal in 
solution, indicating the formation of one preferred isomer (85%). The major and minor 
tert-butyl reporter groups resonated at -75.8 and -78.1 ppm, respectively. Such shifts are 
of comparative magnitude to those reported earlier for the unsubstituted tri-phosphinate 
[Dy.L3] complex but slightly less than those found for the para-substituted [Dy.L6] 
complex (ca. 80 ppm). 
 
The relaxation rate analysis of the major isomer of [Dy.L7] crucially revealed the 
achievement of the desired R1 enhancement at clinical field (Table 4.0).  It is evident 
that only the para-substituted tri-phosphinate systems display the required 
enhancements, showing 45% improvements compared to their unsubstituted analogues. 
 
Table 4.0 Experimental longitudinal relaxation rate data for the major tert-butyl resonance of [Dy.L7] (Y 
= SCH2COO-) at different magnetic field strengths (D2O, 295 Ka). [Dy.L3] (Y = H) and [Dy.L6] (Y = 
PO3H-) are shown for comparison. 
 
Y substituent  R1/ s-1 (± error)  R1/R2b 
(9.4 T) 
 1.0 T 4.7 T 9.4 T 11.7 T 14.1 T 16.4 T  
H 40 (2) 59 (1) 96 (1) 114 (1) 132 (1) 150 (2) 0.59 
PO3H- 54 (5) 88 (3) 156 (1) 179 (1) 195 (1) 218 (1) 0.50 
SCH2COO- 53 (6) 87 (3) 158 (2) 179 (1) 201 (1) 215 (1) 0.55 
 
(a) Temperature was monitored accurately, calibrating against an ethylene glycol shift thermometer; (b) 
R2 values were estimated as (π × ω1/2), for a Lorentzian line fit; (c) measured at pH = 9, at pH 7.1 (i.e. the 
pKa, at 295 K) T2* increases by a factor of 3, see Section 3.4.3 for more information. 
 
Analogous work has reported the relaxation rate behaviour of the major isomer of a 
series of para-substituted tri-phosphinate Dy(III) complexes across 6 different field 
strengths (Figure 4.4).10 The degree of deviation of the R1 values from these of the 
parent, unsubstituted complex was more pronounced with increasing field strength, such 
that in the cases of [Dy.L6] (Y= PO3H-) and [Dy.L7] (Y = SCH2COO-), a 45% R1 
improvement is evident at 16.4 T.  
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Figure 4.4 1H NMR relaxation rates, R1/ s-1, for the tert-butyl resonance on [Dy.L3] (Y = H), [Dy.L6] (Y 
= PO3H-) and [Dy.L7] (Y = SCH2COO-) as a function of magnetic field, showing the fits (lines) to the 
experimental data points (circles) (295 K, D2O, in the case of [Dy.L6] pD 7.4). 
 
Such increases in R1 at high field are associated with increases in the Curie contribution 
to relaxation, and the dominance of the (µeff)4 term. Estimated values of µeff, obtained by 
iterative minimisation methods, demonstrated that the value for [Dy.L7] fell within ±5% 
of the classical range (Table 4.1).11 A value for τR was also estimated for [Dy.L7], 
displaying a 38% increase for the inclusion of an anionic para-substituent, observed 
previous. The increases in relaxivity conveyed for both [Dy.L6] and [Dy.L7] reflect such 
behaviour and is consistent with the larger apparent molecular volume occupied by the 
more strongly hydrated anionic complexes. Estimated values for T1e converged 
uniformly to 0.46 (±0.01) ps, corroborating the similarity of the observed R1 values at 
1.0 T for the three complexes, and in accord with the vanishing Curie term.  
 
Table 4.1 Estimated best fit values of µeff, T1e and τR for [Dy.L7] (Y = SCH2COO-) (D2O, 295 K and r = 
6.6 Å). [Dy.L3] (Y = H) and [Dy.L6] (Y = PO3H-) are shown for comparison. 
 
Y substituent µeff/ BM T1e/ ps τR/ ps 
H 9.47 (3) 0.45 (2) 249 (3) 
PO3H- 10.65 (6) 0.46 (4) 345 (3)a 
SCH2COO- 10.69 (7) 0.44 (3) 357 (2)b 
 
(a) For data fitted with a fixed τR = 280 ps, minimisation gave a poorer fit: µeff = 10.56 B.M. and T1e = 
0.51 ps; (b) For data fitted with a fixed τR = 280 ps, minimisation gave a poorer fit: µeff = 10.58 B.M. and 
T1e = 0.50 ps. 
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Variable temperature 1H NMR spectroscopy shift studies were undertaken for the major 
and minor tert-butyl resonances of [Dy.L7]. A shift change of 0.46 ppm/ K-1 was 
observed for both resonances, owing to the T-2 dependence in the Curie term of the 
pseudocontact shift equation (Figure 4.5) and was comparable to the value obtained for 
the anionic para-substituted [Dy.L6] complex reported in Chapter 3 (ca. 0.41 ppm/ K-1). 
 
 
 
 
Figure 4.5 Stacked 1H NMR spectra of the major (*) and minor (§) tert-butyl resonances of [Dy.L7], 
showing a change of 0.46 ppm/ K-1 as a function of temperature (D2O, pD 7.4, 11.7 T). 
4.2.2 The glycol chitosan conjugate complex, [Dy.L7-chitosan] 
4.2.2.1 Synthesis and characterisation  
Before coupling reactions were undertaken with [Ln.L7], the residual sodium formate 
from HPLC purification and neutralisation was removed by passing the complexes 
through a plug of alumina gel, using 20% methanol in dichloromethane as the carrier 
solvent, to ensure both complex elution and salt deposition. Following this procedure, 
the appearance of the complexes changed dramatically from white solids to coloured 
powders; with the disappearance of sodium formate confirmed by 1H NMR 
spectroscopy (Figure 4.6) and inductively coupled plasma mass spectrometry (ICP-
MS). 
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Figure 4.6 Stacked 1H NMR spectra of [Dy.L7] showing the disappearance of sodium formate, before 
(bottom) and after (top) the desalting procedure (D2O, 295 K, pD 7.4, 11.7 T). 
 
The synthesis of the desired glycol chitosan conjugate, [Ln.L7-chitosan], was first 
attempted with [Dy.L7], following literature protocols,7 and is outlined in Scheme 4.2. 
The carboxylic acid functionality on [Dy.L7] was first converted to an active ester, by a 
reaction with o-(benzotriazol-1-yl)-N,N,N’,N’-tetramethyluronium tetrafluoroborate 
(TBTU) and N-methylmorpholine (NMM) in anhydrous DMF. After stirring for 1 h, 
allowing sufficient time for the formation of the active ester species, a concentrated 
aqueous solution of glycol chitosan was added and the resulting mixture was stirred at 
40 °C. However, regular mass spectrometry sample analysis showed little evidence of 
reaction progress, with peaks corresponding to the free complex and the coupling agents 
evident in each sample.  
 
With the real-time monitoring of reaction progress difficult, after 48 h, the coupling 
agents were removed by dialysing the reaction mixture against Purite H2O using 
commercially available MWCO 0.5 - 1 kD dialysis tubing, for a period of 48 h in which 
the bulk water was replaced periodically (i.e. every 3 h except when overnight). The 
material was then transferred into MWCO 2 kDa dialysis tubing for a period of 48 h in 
an effort to exclude the free complex (MW ca. 850 g mol-1), evident from earlier mass 
spectrometry analyses.  
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Scheme 4.2 General synthetic procedures for the attempted synthesis of the glycol chitosan conjugate, 
[Dy.L7-chitosan]. 
 
Following lyophilisation, the material was analysed by 1H NMR, assessing the tert-
butyl shift and relaxation behaviour in particular. The 1H NMR spectrum showed the 
presence of one major tert-butyl signal in solution, indicating possible equivalence of 
each complex in the conjugated adduct (~85%). Once again, major and minor isomers 
were evident, resonating at -75.5 and -78.1 ppm, respectively. However, with the 
reaction material exhibiting a similar isomeric ratio and shift to the free complex, 
reverse-phase analytical HPLC was also used to assess the composition of the reaction 
material. The UV chromatograms for [Dy.L7] and the reaction material looked identical 
within the 240 and 268 nm detector channels, and indicated that either the reaction had 
not proceeded to product or that the product was not visible under such conditions. The 
later inference is not entirely inconceivable, when the poly-disperse nature of the 
material is considered. 
 
Finally, in order to eliminate one of these possibilities a solid sample was submitted for 
aqueous GPC analysis at Smithers Rapra. The resulting GPC molecular weight 
distribution was dominated by a higher molecular weight component with minor lower 
molecular weight components, implying that reaction to the desired glycol conjugate 
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species had not occurred. A couple of limiting factors can be at fault here: first, the 
reaction could be hindered by the proximal steric bulk provided by the tert-butyl group, 
and also, the formation of the active ester species could be reversed back to the 
carboxylic acid by the addition of solvent water. 
4.2.3 The glucosamine conjugate complex, [Dy.L7-glucosamine] 
4.2.3.1 Synthesis and characterisation 
The coupling between [Dy.L7] and glucosamine, the monomer unit of glycol chitosan, 
was tested so that reaction progress could be monitored with more readily available 
analytical techniques such as mass spectrometry and reverse-phase analytical HPLC, 
due to its size (ca. 1000 g mol-1). The first coupling procedure between [Dy.L7] and 
glucosamine, obtained by anion exchange of the commercially available hydrochloride 
salt, utilised the same reaction conditions used previous (Scheme 4.3). Similarly, 
however, reaction progress to the active ester and/ or to the glucosamine conjugate was 
not evident by MS or HPLC. Previous unpublished work has demonstrated the 
feasibility of synthesising and isolating the active ester species,12,13 but subsequent 
reaction attempts under the same conditions did not yield the active ester species for 
[Dy.L7]. 
 
!!
 
Scheme 4.3 General synthetic procedures for the synthesis of the glucosamine conjugate, [Dy.L7-
glucosamine], 76. 
 
Instead, a related approach using HATU and N,N-diisopropyl ethylamine (DIPEA) was 
adopted (Scheme 4.3). The reaction went to completion, with full consumption of the 
free complex confirmed by low-resolution mass spectrometry. The crude mixture was 
precipitated in diethyl ether and triturated with acetonitrile, before being dissolved in 
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H2O and purified by reverse-phase preparative HPLC to yield [Dy.L7-glucosamine], 
76, as a white solid. 
4.2.3.2 1H NMR shift and relaxation behaviour 
The 1H NMR spectrum of [Dy.L7-glucosamine] revealed the presence of an additional 
isomeric species upon comparison to [Dy.L7] (Figure 4.7). This behaviour in solution 
can attributed to the chiral centre in the 2- position (*) of the glucosamine moiety, 
giving rise to diastereoisomeric D-Δ and D-Λ complexes in an approximately 1:1 ratio. 
Clearly, the [Dy.L7-glucosamine] complex is not well suited for 1H MRS imaging, 
since the complex should exist as one major isomer in solution. 
 
 
 
 
Figure 4.7 Stacked 1H NMR spectra of [Dy.L7] (top) and [Dy.L7-glucosamine] (bottom) showing the 
appearance of an additional isomeric species due to chiral centre marked with an * (D2O, 295 K, pD 7.4, 
9.4 T). 
 
Next, assessment of the relaxation rate behaviour indicated that appending a large 
molecule did not affect the favourable R1 of the tert-butyl reporter group, already 
obtained for [Dy.L7] (Table 4.0). At 9.4 T, the R1 of the major tert-butyl group(s) on 
[Dy.L7-glucosamine] were 140 Hz, compared to 158 Hz for the tert-butyl group on 
[Dy.L7]. The R1/R2 ratio also remained largely affected, giving values of ~0.49 and 
0.55, respectively. 
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4.2.4 The glycol chitosan conjugate complex revisited, [Dy.L7-chitosan] 
4.2.4.1 Synthesis and characterisation  
Following the successful reaction between [Dy.L7] and glucosamine under adapted 
literature conditions, an analogous reaction was undertaken with glycol chitosan 
(Scheme 4.4). 
 
 
 
Scheme 4.4 General synthetic procedures for the synthesis of the glycol chitosan conjugate, [Dy.L7-
chitosan], 77. 
 
For the initial characterisation of reaction progress, reverse-phase analytical HPLC was 
preferred. The comparative UV chromatograms (268 nm) for [Dy.L7] and the reaction 
mixture are shown in Figure 4.8. Indication of reaction completion was afforded by the 
trace observation of [Dy.L7] in the top chromatogram at tR = 10.3 min and the marked 
change in retention time. The reaction mixture chromatogram suggests that the 
compound is highly water soluble, eluting almost immediately at tR = 1.7 min, where 
the solvent is predominantly water (10% MeOH+0.1% formic acid in H2O+0.1% formic 
acid) and is consistent with the formation of the highly water soluble glycol chitosan 
conjugate complex, [Dy.L7-chitosan]. 
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Figure 4.8 Observed analytical reverse-phase HPLC UV chromatograms of [Dy.L7-chitosan] (top) and 
[Dy.L7] (bottom) (λ= 268 nm, 10-100% MeOH+0.1% formic acid in H2O+0.1% formic acid over 10 min, 
tR=1.7 and 10.3 min, respectively). 
 
Following the work up of the crude reaction mixture by dialysis, initial 1H NMR studies 
on the lyophilised solid further confirmed that a reaction had occurred to form [Dy.L7-
chitosan]. The complex apparently existed as one major species in solution, evident 
from the observation of one major tert-butyl signal at -75.2 ppm, indicating the 
magnetic equivalence of the complexes in the conjugated adduct (Figure 4.9). 
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Figure 4.9 1H NMR spectrum of [Dy.L7-chitosan] (D2O, 295 K, pD 7.4, 9.4 T). 
 
The mean R1 value of the tert-butyl reporter group in [Dy.L7-chitosan] was measured 
and showed the required enhancement of 100 to 200 s-1 at 7 T (Table 4.1). Upon 
comparison with the values measured for the [Dy.L7] complex, it is evident that the 
relaxation rate behaviour remains largely unaffected for the higher molecular weight 
conjugate species. This was proposed to be the case, due to the fast independent motion 
of the complex with respect to the slow motion of the polymer, in solution.  
 
Table 4.1 Experimental longitudinal relaxation rate data for the major tert-butyl resonance of [Dy.L7] and 
[Dy.L7-chitosan] (D2O, 295 Ka). 
 
Complex  R1/ s-1 (± error)  R1/R2b 
(9.4 T) 
 1.0 T 4.7 T 9.4 T 11.7 T 14.1 T 16.4 T  
[Dy.L7] 53 (6) 87 (3) 158 (2) 179 (1) 201 (1) 215 (1) 0.55 
[Dy.L7-chitosan] n.d.c 88 (1) 148 (2) 175 (1) 197 (1) 221 (1) 0.53 
 
(a) Temperature was monitored accurately, calibrating against an ethylene glycol shift thermometer; (b) 
R2 values were estimated as (π × ω1/2), for a Lorentzian line fit; (c) The signal was too weak/ broad. !
The final characterisation of [Dy.L7-chitosan] by aqueous GPC analysis is ongoing but 
must be carried out before 1H MRS imaging studies can be considered. It is imperative 
that the complex constitution of the conjugate species is ascertained, so that 
concentrations can be calculated for forthcoming in vivo studies.!
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4.4 Conclusions  
A high molecular weight adduct has been investigated as a potential platform for the 
conjugation of multiple tert-butyl labeled lanthanide(III) based complexes as a strategy 
to enhance complex retention in vivo. The selected platform is a modified, reduced 
molecular weight (6.5 kD) form of the naturally derived polymer, glycol chitosan. 
 
The precursor complex, [Ln.L7], was designed and synthesised, bearing a carboxylic 
acid moiety that offered amide linkage potential to the free amines on the chitosan 
polymer. Following unsuccessful reaction attempts using a literature coupling 
procedure,7 a modified method using HATU was tested for the coupling between 
[Dy.L7] and glucosamine, the monomer component of chitosan. The formation and 
isolation of [Dy.L7-glucosamine] gave rise to two diasteroisomeric pairs of complex 
isomers, evidenced by the appearance of a second set of tert-butyl peaks in the 1H NMR 
spectrum. As a result of [Dy.L7-glucosamine] not forming one predominant isomer in 
solution, it was not considered for further investigations.  
 
The peptide-coupling reagent, HATU, was subsequently used in the successful coupling 
between the reduced weight chitosan compound and [Dy.L7] to afford the desired 
[Dy.L7-chitosan] species, characterised by both reverse-phase analytical HPLC and 1H 
NMR spectroscopy. The 1H NMR shift and relaxation analyses of [Dy.L7-chitosan] 
satisfied the criteria for 1H MRS imaging purposes with a shift at -75.2 ppm for its tert-
butyl reporter signal, comprising ~80% of the signal and a favourable R1 at 7 T of ~120 
s-1. Provided that GPC anaylsis confirms that the identity of [Dy.L7-chitosan], 
forthcoming in vivo studies are expected to show a slower rate of clearance from the 
body, with non-specific distribution throughout the tumour and the tissue.1–3 Due to the 
advantages of imaging in a spectral region with zero background signal in vivo in 1H 
PARASHIFT protocols, it is expected that the tert-butyl reporter group will be imaged 
selectively using a clinically accepted dose and within a matter of minutes, analogous to 
the previous examples detailed in this work. The advantage of tert-butyl signal retention 
in vivo is so additional anatomical areas can be analysed (i.e. not the bladder) in a 
greater time window for imaging, in which the compound is still expected to clear and 
accumulate in the bladder so as not to incur any toxicity effects, thereby affording 
improvements on the previously detailed systems. 
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Chapter Five: Conclusions and Future Work 
5.1 General Conclusions 
From the outset, the aim of this project has been to design, synthesise and evaluate a 
novel class of 1H PARASHIFT probes that can be used for in vivo 1H magnetic 
resonance imaging and spectroscopy studies. 1H MRS promises to be a powerful 
imaging technique, offering non-invasive information without the need to know local 
probe concentrations, as long as the intense background signal arising from the water 
and fat signals in vivo is negated. 
 
Through the inclusion of a tert-butyl reporter group, within 6 to 7 Å of a lanthanide(III) 
ion, on a kinetically stable macrocylic complex based on 1,4,7,10-
tetraazacyclododecane-1,4,7,10-triacetic acid (DO3A) or 1,4,7,10-
tetraazacyclododecane-4,10-diacetic acid (DO2A) (Figure 5.0), chemical shifts up to 80 
ppm away from the water signal have been achieved. By moving the goal posts for 1H 
MRS imaging to a spectral region with zero-background signal in vivo, the sensitivity 
associated with the technique is increased significantly. At this distance, concomitant 
enhancements in the longitudinal relaxation rate, R1, of the tert-butyl reporter offer 
further sensitivity gains when the lanthanide(III) ion is selected judiciously, by allowing 
faster data acquisition, provided that the R1/R2 ratio is close to unity. 
 
 
 
Figure 5.0 The general design of the 1H PARASHIFT probes detailed within this thesis: where X = C 
(tri-carboxylate) or PMe (tri-phosphinate), Y = H, NO2, N(CH3)2, NHCOCH3, PO3H- or SCH2COO-, and 
n = the number of coordinated water molecules (typically n = 1 when X = C or n = 0 when X = PMe). 
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Three series of 1H PARASHIFT complexes, [Ln.L1(H2O)], [Ln.L2(H2O)]+ and 
[Ln.L3], were derived and synthesised in Chapter 2. The [Dy.L2(H2O)]+ complex 
showed a good balance between shift and relaxation enhancement. Such enhanced 
sensitivity permitted rapid detection of [Dy.L2(H2O)]+ in live mice using 1H MRS, 
within a few minutes, following the tail vein injection of a 0.1 mmol kg-1 dose. 
However, the largest tert-butyl chemical shifts were observed for the Tb(III), Dy(III) 
and Tm(III) complexes of the tri-phosphinate [Ln.L3] series, resonating at up to ±70 
ppm, thus favouring the use of larger imaging bandwidths (e.g. 20 kHz) in 1H MRS 
protocols with a concomitant reduction in acquisition times.  
 
The favourable design features established in the parent systems were carried through to 
Chapter 3, where minimal structural modifications afforded three series of pH 
responsive 1H PARASHIFT probes, [Ln.L4(H2O)], [Ln.L5(H2O)] and [Ln.L6]. By far 
the most promising pH dependent tert-butyl chemical shift behaviour was exhibited by 
the complexes in the [Ln.L6] series, with pKa values around 7, functionality in the 
physiological range and a total shift change of 1.9 ppm between the acid and base forms 
(for Dy(III)). Once again, the enhanced sensitivity allowed the detection of [Dy.L6] and 
[Tm.L6] in phantom 1H MRS imaging protocols, where the feasibility of pH chemical 
shift imaging was realised. In preliminary in vivo studies, the signal was obtained within 
a matter of minutes, following the tail vein injection of a 0.1 mmol/kg dose of [Dy.L6]. 
 
Following the rapid in vivo clearance of both [Dy.L2(H2O)]+ and [Dy.L6], Chapter 4 
described a strategy for enhancing the retention of the complexes, and hence the tert-
butyl signal, in vivo, through the conjugation of multiple 1H PARASHIFT probes to a 
large polymeric vector. Two conjugated species were formed following the design and 
synthesis of a precursor complex, [Ln.L7], by appending a carboxylic acid functionality 
in an amide linkage with glucosamine and glycol chitosan to form [Dy.L7-
glucosamine] and [Dy.L7-chitosan], respectively. The [Dy.L7-glucosamine] complex 
was isolated as two major diastereoisomeric species with separate tert-butyl chemical 
shifts in the 1H NMR spectrum, hence rendering it inappropriate for application here. 
Conversely, the [Dy.L7-chitosan] complex possessed the required shifted tert-butyl and 
relaxation characteristics, with tert-butyl resonance equivalence observed by the 
appearance of one major 1H NMR signal in solution. Whilst preliminary in vivo studies 
are yet to be carried out, [Dy.L7-chitosan] is expected to show the desired slower rate 
of clearance from the body. 
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Surprisingly large R1 enhancements were observed in the cases of the Er(III) and 
Tm(III) tri-phosphinate complexes, leading to the conclusion that Er(III) tri-phosphinate 
complexes, and Dy(III) and/or Tb(III) tri- and bis-carboxylate complexes appear to be 
the best candidates for use as 1H PARASHIFT probes, in the field range 1.5 to 7.0 T, 
based on the critical balance defined between shift and relaxation enhancement. Such 
unprecedented behaviour challenges the theories with which the paramagnetic shift and 
relaxation of these lanthanide(III) based complexes are currently modeled. However, 
whilst the limitations and inadequacies of the current theories have been alluded to and, 
in part, evaluated here, more work is required to pave a way towards formulating a 
better model for predicting their behaviour and with it, developing a toolkit for the 
design of future 1H PARASHIFT probes. 
5.2 Short-term Future Work 
5.2.1 EPR and SQUID Analysis of [Ln.L1(H2O)] and [Ln.L3] 
At the end of Chapter 2 (Sections 2.5.2.1 and 2.5.2.2), preliminary EPR spectroscopy 
and SQUID magnetometry results were reported in a comparative study between the tri-
carboxylate, [Ln.L1(H2O)], and the tri-phosphinate parent systems, [Ln.L3]. EPR 
spectroscopy on solid and frozen samples at 5 K probed the very lowest mJ states, since 
they are the only ones populated in the Boltzmann distribution. The general results were 
promising, highlighting that there are significant differences in the mJ composition of 
the ground states of the lanthanide(III) ions in these complexes. The SQUID 
magnetometry studies revealed a significant variation from the predicted magnetic 
moments. However, despite these promising general trends, a more in-depth EPR 
spectroscopy and SQUID magnetometry treatment is required on larger quantities of 
sample, where water and other impurities are rigorously excluded, before reliable data is 
obtained. 
5.2.2 Co-injection In Vivo Studies with [Dy.L6] and [Tm.L6]!
In Chapter 3 (Section 3.4), the pH responsive tert-butyl chemical shift behaviour of the 
1H PARASHIFT probes, [Ln.L6], were evaluated in vitro. Phantom and preliminary in 
vivo 1H MRS studies with [Dy.L6] and [Tm.L6] demonstrated the feasibility of a non-
invasive pH CSI approach. However, future work should seek to consider the possibility 
of co-injecting [Dy.L6] and [Tm.L6], where the difference between the tert-butyl 
chemical shifts can be monitored as a function of pH and temperature. The tert-butyl 
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groups on [Dy.L6] and [Tm.L6] exhibit different temperature and pH dependencies, as 
demonstrated from the in vitro analysis. With temperature and pH unknown entities in 
vivo, due to the similar distribution profiles of [Dy.L6] and [Tm.L6], a potential means 
of internal calibration is afforded since the local conditions will be the same for each 
complex. In vitro calibration studies can be carried out using the existing data in this 
thesis. The tert-butyl groups of [Dy.L6] and [Tm.L6] resonate 150 ppm apart but can be 
imaged in 1H MRS imaging protocols, utilising the sequences demonstrated in this 
work. However, for the method to work, the two spectral windows will need to be 
viewed alternately and sequentially throughout the duration of the imaging experiment, 
in order to exclude the background signals. The advantages of using the [Tb.L6] and 
[Er.L6] complexes should also be considered, since they exhibit the most remarkable 
shift and relaxation characteristics, respectively. 
5.3 Long-term Future Work 
5.3.1 Another Strategy for Enhancing Complex Retention In Vivo!
The strategy devised in Chapter 4, for enhancing complex retention in vivo, focused on 
appending multiple tert-butyl labeled paramagnetic lanthanide(III) complexes to a 
medium to high molecular weight vector. Whilst characterisation by GPC analysis and 
in vivo studies are ongoing with [Dy.L7-chitosan], future work could also focus on the 
design and synthesis of a lower molecular weight analogue, with the 9N3-based 
framework suggested in Figure 5.1. Advantages over a poly-disperse chitosan system 
include the relatively straightforward, in-house, characterisation of the conjugate, and 
the ease with which the number of attached complexes can be quantified. Provided that 
the magnetic equivalence of the tert-butyl groups is retained, and the shift and 
relaxation characteristics satisfy the 1H PARASHIFT probe criteria, it is believed that 
this system will clear slower from the body, compared with the complexes detailed here. 
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Figure 5.1 Proposed structure of a triazacyclononane, 9N3, based conjugate species using [Ln.L7]. 
5.3.2 Creating a p[Mn+] Responsive 1H PARASHIFT Probe 
The final future direction for this work should be in the design, synthesis and evaluation 
of a 1H PARASHIFT probe capable of sensing changes in metal ion concentration, 
p[Mn+]. In a p[Mn+] responsive system, the binding of a metal should induce a chemical 
shift change in the tert-butyl reporter group. As a result, and in accord with the 
favourable design features of the pH responsive system, [Ln.L6], a general structure has 
been proposed in Figure 5.2. It is hypothesised that by functionalising the 3- and 4- 
positions of the pyridyl moiety, in close proximity to the tert-butyl reporter group, with 
chelating arms that display a high affinity for a particular metal ion, in the concentration 
range at which it is present in vivo, the desired shift changes will be observed upon 
metal binding. 
 
 
 
Figure 5.2 Possible design features of a p[Mn+] responsive 1H PARASHIFT probe, building on the 
successes of the work in this thesis. 
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5.4 Final Thoughts 
The birth of human MRI in 1977 is regarded unequivocally and universally as one of 
the most importance developments in modern day medicine. Despite its worldwide 
adoption, the technique is extremely limited to only the observation of the water signal 
in living systems, with the non-invasive detection of relevant small metabolites 
impossible in a background of 55 M water, and as a complication of the inherent 
sensitivity issues with any NMR spectroscopy based technique. Nevertheless, it is 
evident from the work in this thesis that existing modern clinical instrumentation can be 
used to image the 1H NMR signal of an administered probe selectively. Such 1H 
PARASHIFT probes offer themselves to a novel imaging modality, called 1H 
PARASHIFT MRS, in which data acquisition occurs within minutes with doses of the 
same order as for clinically approved Gd(III) contrast agents, due to enhanced signal 
sensitivity. This approach may only mark the beginning of a field that can be developed 
further towards making ‘smart’ and/ or targeted probes and with it, a new toolkit for 
non-invasively interrogating the in vivo environment.!
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Chapter Six: Experimental 
6.1 Experimental Procedures 
6.1.1 General Procedures 
All solvents used were laboratory grade and anhydrous solvents, when required, were 
freshly distilled over the appropriate drying agent. Water was purified by the 
‘PuriteSTILLplus’ system, with a conductivity of ≤ 0.04 µS cm-1. All reagents used were 
purchased from commercial suppliers and were used without further purification. 
Reactions requiring anhydrous conditions were carried out using Schlenk line 
techniques under argon. Where necessary, solvents were degassed using the freeze-thaw 
cycle method. 
 
Thin layer chromatography was performed on silica plates (Merck Art 5554) or!neutral 
aluminium plates (Merck Art 5550) and visualised under UV irradiation (254 nm), or by 
staining with either iodine or Dragendorff’s reagent (solution of bismuth nitrate and 
potassium iodide in AcOH and H2O). Preparative column chromatography was 
performed using silica gel (Merck Silica Gel 60, 230-400 mesh) or neutral alumina 
(Merck Aluminium Oxide 90, activity II-III, 70-230 mesh), with the latter pre-soaked in 
ethyl acetate overnight before use. 
 
Dialysis was performed with Float-A-Lyzer G2 filters MWCO 0.5-1 kD (Spectrum 
Laboratories, Inc) or modified benzoylated dialysis tubing MWCO 2 kD (Sigma 
Aldrich). The first type of tubing was washed thoroughly; first with a 50: 50 EtOH: H2O 
mix, and then with H2O, as per manufacturer’s advice. The second type of tubing was 
treated with a 0.3% (w/v) sodium sulfide solution at 70 °C for 1 min, washed with hot 
water (60 °C) for 2 min, acidified with 0.2% sulfuric acid, and rinsed with hot water, as 
per the manufacturer’s advice. After addition of the material to the tubing, the ends of 
the tubing were secured (using provided screw tops) and the ensemble submerged in 
stirring H2O (ca. 800 mL). The bulk H2O was exchanged 4 times over a 72 h period, to 
ensure a positive dialysis gradient was maintained. Filtering of the tubing contents and 
lyophilisation yielded the desired product. 
 
pH measurements were carried out at 295 K using a Jenway 3320 pH meter with a 
Sigma Aldrich micro-pH combination electrode. Calibration was performed using 
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commercially available buffer solutions at pH 4.00±0.02, pH 7.00±0.02, and pH 
10.00±0.02 (Sigma Aldrich). Diluted aqueous solutions of NaOD and DCl (in D2O) 
were used for pD adjustments; NaOH and HCl (in H2O) for pH adjustments. For 
measurements in D2O, the pD is calculated as pD = pH + 0.41, where pH is the meter 
reading. Protonation constants were measured at 295 K and 500 MHz using diluted 
solutions of the complex (1 mM) in D2O, unless otherwise stated. For solutions of H2O 
and mouse plasma (diluted 1:1 with Purite water), a coaxial insert containing D2O was 
used to lock the NMR instrument. The resulting curves reporting the 1H NMR chemical 
shift vs. pH were fitted by non-linear least squares iterative analysis by Boltzmann using 
Origin 8.0 software, producing estimates of the pKa values. 
 
All complex yields are omitted due to the presence of residual sodium formate from 
reverse-phase HPLC purification and subsequent neutralisation. 
  
6.1.2 Characterisation: NMR Spectroscopy 
1H, 13C and 31P NMR spectra were recorded in commercially available deuterated 
solvents on a Varian Mercury-200 (1H at 199.975, 13C at 50.289, 19F 188.179, 31P 
80.985 MHz), Varian Mercury-400 (1H at 399.960, 13C at 100.572, 19F 376.338, 31P at 
161.943 MHz), Bruker Avance-400 (1H at 400.052, 13C at 100.603, 19F 376.423, 31P at 
161.980 MHz), Varian Inova-500 (1H at 499.722, 13C at 125.671, 19F 470.253, 31P at 
202.375 MHz), Appleby VNMRS-600 (1H at 599.832, 13C at 150.828, 19F 564.385, 31P 
at 242.862 MHz), or Varian VNMRA-700 (1H at 699.731, 13C at 175.948, 19F 658.405, 
31P at 283.256 MHz) spectrometer. All chemical shifts are given in ppm and all 
coupling constants are reported in Hz, to the nearest 0.5. Where required, the operating 
temperature of the spectrometer was measured with the aid of an internal calibration 
solution of ethylene glycol. For non-deuterated solutions, a coaxial insert containing 
D2O was used to lock the NMR instrument. Measurements at 1.0 T (42.5 MHz 1H) were 
made on a Magritek Spinsolve spectrometer. The recorded free induction decays were 
processed using backward linear prediction, optimal exponential weighting, zero-filling, 
Fourier transform, phasing and baseline correction (by polynomial fitting). The signals 
were integrated by Lorentzian line fitting. 
 
1H longitudinal relaxation times were measured in dilute D2O solutions at 295 K using 
the inversion-recovery technique, on spectrometers operating at fields of 1.0, 4.7, 9.4, 
11.7, 14.1 and 16.4 T. Each relaxation time measurement was repeated three times to 
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reduce experimental error. The number of transients used in the measurements was 
determined by the signal-to-noise ratio of the sample. The signal was fully recovered 
during the inversion-recovery sequence to minimise the experimental error. Fitting 
errors were determined by calculating the standard deviation of a set of relaxation times.  
 
Relaxation rate data was fitted by Dr. Nicola Rogers at Durham University, using a 
modified algorithm originally provided by Dr. Ilya Kuprov at the University of 
Southampton. The algorithm uses the SBM equations to fit the measured relaxation rate 
data using the Matlab internal Levenberg-Marquardt minimisation of the non-linear 
squares error function and the results were analysed iteratively. Some parameters were 
used globally in the series, and others used for each lanthanide individually. Magnetic 
moments for each lanthanide(III) were taken from the literature. 
 
Concentrations of the lanthanide(III) complexes were calculated using the bulk 
magnetic susceptibility (BMS) method, using 1% tBuOH/ H2O solutions of the 
complexes, with a coaxial insert containing the same solution without the complex 
added. 
 
Water proton T1 measurements were recorded on a Bruker Minispec mq60 (60 MHz, 
310 K), and are reported as the mean value of three measurements.  The relaxivities, !!!, of the compounds were calculated as the slope of the function shown in equation 1.1 
 !!!,!"# = !!!,! + !!![!"(!!!)] (1) 
 
where T1,obs is the measured T1, T1,d is the diamagnetic contribution of the solvent 
(calculated to be 4000 ms), and [Gd.Ln] is the concentration in mM of the appropriate 
Gd(III) complex. The error for each relaxivity value was less than 0.3 mM-1 s-1. 
 
Variable temperature NMR spectroscopy was carried out using the Varian VNMRS-500 
spectrometer with the assistance of Dr. Nicola Rogers at Durham University, using the 
ethylene glycol method (mentioned above) to confirm the operating temperature of the 
spectrometer at each temperature measured. Samples were inserted at 295 K with shift 
and T1 measurements made over the range 290-315 K, using the tert-butyl chemical 
shift (T-2 shift dependence). !
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6.1.3 Characterisation: Optical Techniques 
All samples for optical analyses were contained in quartz cuvettes with a path length of 
1 cm and a polished base. Measurements were recorded at 295 K, unless stated 
otherwise. Low temperature (80 K) emission spectra were obtained with the assistance 
of Dr. Lars-Olaf Pålsson.  
 
UV/Vis absorbance spectra were measured on a Perkin Elmer Lambda 900 UV/Vis/NIR 
spectrometer, using FL Winlab software. Samples were measured relative to a reference 
of pure solvent contained in a matched cell. 
 
Emission spectra were measured on a ISA Joblin-Yvon Spec Fluorolog-3 luminescent 
spectrometer, using DataMax v2.20 software. Excitation wavelengths were selected 
according to the specific measurement of λmax. An integration time of 0.5 s, increment 
of 0.5 nm, and excitation and emission slit widths of 2.5 and 1.0 nm, respectively, were 
used throughout unless stated otherwise. 
 
Lifetime measurements were carried out using a Perkin Elmer LS55 luminescence 
spectrometer. Lanthanide excited state lifetimes were measured by excitation of the 
sample by a short pulse of light followed by monitoring the integrated intensity of light 
emitted during a fixed gate time, tg, after a delay time of td. Excitation and emission 
wavelengths were selected based upon the lanthanide(III) complex. Measurements were 
made for at least 30 delay times over a period of three or more lifetimes. A gate time of 
0.1 ms was used and the excitation and emission slits were both set to 6 nm. The 
obtained decay curves were fitted to equation 2. 
 ! = !! + !!!!!" (2) 
 
where I is the intensity at time t after the excitation pulse; A0 is the intensity after decay 
is completed; A1 is the pre-exponential factor and k is the rate constant for decay of the 
excited state. The excited state lifetime, τ, is the inverse of the rate constant, k. 
 
The inner sphere hydration number (q) was obtained by measuring the excited state 
lifetime in H2O and D2O, following D2O exchange, of a Eu(III) and/or Tb(III) complex 
(vide infra). The q value was calculated using equations 3 and 4:2 
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!!" = 1.2 !!!! − !!!! − 0.25− 0.075!   (3) 
 !!" = 5.0 !!!! − !!!! − 0.06− 0.010!   (4) 
 
where !!!! and !!!! are the rate constants for the depopulation of the lanthanide(III) 
emissive excited state in each solvent (derived as the reciprocals of the luminescence 
lifetimes of the complex in each solvent, !!!!!and !!!!, respectively, and n is the 
number of proximate carbonyl-bound amide groups. 
  
6.1.4 Characterisation: Other Techniques 
Low resolution electrospray mass spectra were obtained on a TQD mass spectrometer, 
operating in positive or negative ion mode, equipped with an Acquity UPLC, an 
electrospray ion source and an Acquity photodiode array detector (Waters Ltd, UK). 
High-resolution electrospray mass spectra were recorded on a LCT Premier XE mass 
spectrometer or a QTOF Premier mass spectrometer, both equipped with an Acquity 
UPLC, a lock-mass electrospray ion source and an Acquity photodiode array detector 
(Waters Ltd, UK). 
 
Dr. Nicholas Chilton at the University of Manchester collected EPR spectra and SQUID 
data. Q-band (~34 GHz) EPR spectra were measured with a Bruker EMX spectrometer 
(EPSRC EPR National Facility) fitted with a CF935 cryostat connected to an Oxford 
Intelligent Temperature Controller, on both solid-state and frozen glass samples (80% 
water, 20% glycerol, ~1 mM) at 5 K. Magnetic measurements were obtained using a 
Quantum Design MPMS-XL7 SQUID magnetometer on powder samples contained in 
gelatin capsules at the centre of a drinking straw. The data were corrected for the 
diamagnetism of the straw and capsule as well as that of the sample. 
 
Gel permeation chromatography (GPC) was undertaken at Smithers Rapra UK, using a 
Viscotek Model 301 TDA instrument with associated pump, autosampler, and refractive 
index detector (with differential pressure and light scattering). Agilent PLaquagel-OH 
Guard plus 2 x PLaquagel-OH Mixed-M, 30 cm, 8 µm columns were used with an 
eluent composed of 0.5 M NaNO3, 0.01 M NaH2PO4 at pH 2 at a flow rate of 1.0 
mL/min at 30°C.  The GPC system was calibrated using Pullulan polysaccharides and 
the data analysed using Malvern/Viscotek ‘OmniSec’ software. 
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Melting points were recorded using a Gallenkamp (Sanyo) apparatus and are 
uncorrected. 
 
6.1.5 HPLC Analysis 
Reverse phase HPLC was performed at 295 K using a Shimadzu system consisting of a 
Degassing Unit (DGU-20A5R), a Prominence Preparative Liquid Chromotograph (LC-
20AP), a Prominence UV/Vis Detector (SPD-20A) and a Communications Bus Module 
(CBM-20A). An XBridge C18 19 x 100 mm, 5 µm column was used to purify the 
complexes on a preparative scale (flow rate 17 mL/min) and a Shimadzu ShimPack VP-
ODS column, 4.6 x 150 mm, 5 µm (flow rate 2 mL/min) was used for analytical scale 
purifications. A gradient elution with a solvent system composed of H2O + 0.1% 
HCOOH/ MeOH + 0.1% HCOOH was performed for a total run time of 17 min. The 
separation details are reported below (Table 6.0). Fraction collection was performed 
manually. 
 
Table 6.0 Preparative procedure: flow rate = 17 mL/min; Solvent A = H2O+0.1% formic acid; Solvent B 
= MeOH+0.1% formic acid. 
 
Time (min) Solvent A (%) Solvent B (%) 
0 90 10 
3 90 10 
13 0 100 
16 0 100 
17 90 10 
 
6.1.6 Imaging Studies 
Imaging studies were carried out by Prof. Andrew Blamire, Dr. Ian Wilson and Dr. Dara 
O’Hogain at the Newcastle Magnetic Resonance Centre, using a 7 T (300 MHz) Varian 
Unity Inova microimaging/ pre-clinical system equipped with broadband capability and 
actively shielded gradients. In vitro experiments were performed with a 30 mm i.d. 
birdcage volume coil (Rapid Biomedical), and in vivo experiments were performed with 
a 39 mm i.d. birdcage volume coil. The coils were used for both signal excitation and 
reception.  
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For phantom studies, dilute aqueous samples were placed in cut-down NMR tubes and 
positioned on the axis of the coil. For in vivo studies, mice were anaesthetised with an 
oxygen/1-2% isofluorane mixture. Complexes were administered intravenously as 
saline solutions via the tail vein, with the doses quoted calculated by BMS and ICP-
OES. Sequence parameters differ and are as quoted. 
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6.2 Synthetic Procedures!
1. 1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane3 
 
 
 
Tert-butyl bromoacetate (11.5 mL, 78.3 mmol) was added to a stirred solution of 
1,4,7,10-tetraazacyclododecane (5.0 g, 29.0 mmol) and NaHCO3 (6.50 g, 78.3 mmol) in 
anhydrous MeCN (190 mL) and the resulting mixture stirred at rt for 18 h under argon. 
The reaction mixture was filtered and the solvent removed under reduced pressure. The 
resulting white residue was dissolved in a minimal amount of toluene, with heating, and 
upon cooling a white solid precipitated out of solution (6.7 g, 45%). Rf (10% 
MeOH/CH2Cl2) = 0.29; m.p. 184-185 °C (lit. m.p. 183-184 °C); 1H NMR (400 MHz, 
CDCl3) δ 10.03 (br s, 1H, NH), 3.37 (s, 4H, CH2), 3.29 (s, 2H, CH2), 3.04-3.15 (br m, 
4H, cyclen CH2), 2.78-2.98 (br m, 12H, cyclen CH2), 1.46 (s, 18H, C(CH3)3), 1.45 (s, 
9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 169.5 (CO), 168.7 (CO), 80.9 (C(CH3)3), 
80.7 (C(CH3)3), 57.2 (CH2), 50.3 (cyclen CH2), 48.2 (cyclen CH2), 46.6 (cyclen CH2), 
27.2 (C(CH3)3), 27.1 (C(CH3)3); ESI-LRMS (+) m/z 515.7 [M+H]+; ESI-HRMS (+) 
calcd for [C26H51N4O6]+ 515.3809, found 515.3804. 
 
2. 5-tert-Butyl-2-methylpyridine 
 
 
 
Copper(I) cyanide (20 mg) was added to a solution of anhydrous THF (50 mL) and 
anhydrous Et2O (100 mL) and the resulting suspension cooled to -78 oC. To this was 
added tert-butylmagnesium chloride (58 mL, 2.0 M in Et2O, 116.2 mmol) and the 
mixture was stirred at -78 oC for 20 min under an atmosphere of argon. After this, 5-
bromo-2-methylpyridine (10.0 g, 58.1 mmol) was added and the reaction mixture was 
allowed to warm to rt, where it was stirred for a further 18 h. Upon completion, 
N N
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NH4OH (sat. aq. solution, 50 mL) was added dropwise. The mixture was extracted with 
Et2O (3 × 200 mL) before the organic layers were combined, dried over MgSO4, and 
the solvent removed under reduced pressure. This partially volatile yellow liquid was 
used without further purification (6.0 g, 69%). 1H NMR (400 MHz, CDCl3) δ 8.43 (s, 
1H, H6), 7.44 (dd, 3J = 8, 4J = 2, 1H, H4), 6.95 (d, 3J = 8, 1H, H3), 2.38 (s, 3H, CH3), 
1.20 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 154.8 (C2), 146.1 (C6), 142.3 
(C5), 132.8 (C4), 122.1 (C3), 32.8 (C(CH3)3), 30.6 (C(CH3)), 20.4 (CH3); ESI-LRMS (+) 
m/z 150.1 [M+H]+; ESI-HRMS (+) calcd for [C10H16N]+ 150.1283, found 150.1270. 
 
3. 5-tert-Butyl-2-methylpyridin-1-oxide 
 
 
 
mCPBA (8.0 g, 52.3 mmol) was added to a stirred solution of 5-tert-butyl-2-
methylpyridine (6.0 g, 12.7 mmol) in anhydrous CHCl3 (100 mL). The resulting 
solution was stirred at rt for 18 h under argon, before being quenched with Na2SO4 (sat. 
aq. solution, 50 mL) and stirred for a further 10 min. The organic layer was extracted 
and washed with NaHCO3 (sat. aq. solution, 100 mL). The aqueous layer was then 
extracted with CH2Cl2 (3 × 150 mL), the organic layers combined, dried over Na2SO4 
and the solvent removed under reduced pressure. The resulting yellow oil was purified 
by silica gel column chromatography, eluting with a gradient starting from 100% 
CH2Cl2 to 2% MeOH/ CH2Cl2, to yield a pale yellow liquid (6.0 g, 90%). Rf (10% 
MeOH/ CH2Cl2) = 0.46; 1H NMR (400 MHz, CDCl3) δ 8.26 (d, 4J = 1, 1H, H6), 7.11-
7.17 (m, 2H, H3, H4), 2.44 (s, 3H, CH3), 1.25 (s, 9H, C(CH3)3); 13C NMR (101 MHz, 
CDCl3) δ 146.5 (C2), 144.8 (C6), 136.4 (C5), 124.8 (C4), 123.0 (C3), 32.6 (C(CH3)3), 
29.6 (C(CH3)), 16.4 (CH3); ESI-LRMS (+) m/z 166.1 [M+H]+; ESI-HRMS (+) calcd for 
[C10H16NO]+ 166.1232, found 166.1223. 
 
 
 
 
 
 
N
O
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4. (5-tert-Butylpyridin-2-yl)methanol 
 
 
 
Trifluoroacetic anhydride (22 mL, 156.8 mmol) was added to a solution of 5-tert-butyl-
2-methylpyridin-1-oxide (5.0 g, 30.3 mmol) in anhydrous CHCl3 (40 mL).  The 
resulting mixture was heated at 60 oC for 18 h under an atmosphere of argon. Reaction 
completion was confirmed by 1H NMR spectroscopy before the solvent was removed 
under reduced pressure. The resulting bright yellow oil was stirred in a mixture of 
EtOH (25 mL) and H2O (25 mL) for 2 h. The solution was concentrated (ca. 10 mL) 
and extracted with CH2Cl2 (3 × 100 mL).  The organic layers were combined, dried 
over MgSO4, and the solvent removed under reduced pressure. The resulting orange oil 
was purified by silica gel column chromatography, eluting with a gradient starting from 
100% CH2Cl2 to 5% MeOH/ CH2Cl2, to yield a yellow oil (4.0 g, 80%). Rf (10% 
MeOH/ CH2Cl2) = 0.46; 1H NMR (400 MHz, CDCl3) δ 8.56 (d, 4J = 2, 1H, H6), 8.35 
(dd, 3J = 8, 4J = 2, 1H, H4), 7.75 (d, 3J = 8, 1H, H3), 4.96 (s, 2H, CH2), 1.30 (s, 9H, 
C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 153.8 (C2), 150.2 (C6), 144.1 (C5), 137.8 
(C3), 124.5 (C4), 61.0 (CH2), 34.5 (C(CH3)3), 30.3 (C(CH3)); ESI-LRMS (+) m/z 166.3 
[M+H]+; ESI-HRMS (+) calcd for [C10H16NO]+ 166.1232, found 166.1231. 
 
5. (5-tert-Butylpyridin-2-yl)methyl methanesulfonate 
 
 
 
(5-tert-Butylpyridin-2-yl)methanol (1.0 g, 6.06 mmol) was dissolved in dry THF (7 
mL) and cooled to 5 oC. Triethylamine (1.3 mL, 9.08 mmol) and mesyl chloride (0.7 
mL, 9.08 mmol) were added dropwise. After addition, the reaction mixture was allowed 
to warm to rt and stirred for 30 min before the solvent was removed under reduced 
pressure. The residue was dissolved in brine (10 mL) and extracted with CH2Cl2 (2 × 
25 mL). The organic layers were combined, dried over MgSO4, and the solvent 
removed under reduced pressure to yield an orange oil, which was used immediately 
(1.1 g, 76 %). Rf (10% MeOH/ CH2Cl2) = 0.76; 1H NMR (400 MHz, CDCl3) δ 8.57 (d, 
NHO
NOS
O
O
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4J = 2, 1H, H6), 8.15 (dd, 3J = 8, 4J = 2, 1H, H4), 7.75 (d, 3J = 8, 1H, H3), 5.44 (s, 2H, 
CH2), 3.07 (s, 3H, SCH3), 1.24 (s, 9H, C(CH3)3); ESI-LRMS (+) m/z 244.3 [M+H]+; 
ESI-HRMS (+) calcd for [C11H18NO3S]+ 244.1007, found 244.1020. 
 
6. tert-Butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate 
 
 
 
A stirred mixture of 1,4,7-tris(tert-butoxycarbonylmethyl)-1,4,7,10-
tetraazacyclododecane (2.2 g, 4.19 mmol), (5-tert-butylpyridin-2-yl)methyl 
methanesulfonate (1.1 g, 4.61 mmol), and K2CO3 (1.2 g, 8.38 mmol) in anhydrous 
MeCN (15 mL) was heated at 70 oC for 18 h under argon. The reaction mixture was 
cooled and filtered, before the solvent was removed under reduced pressure. The 
resulting brown oil was purified by silica gel column chromatography, eluting with a 
gradient starting from 100% CH2Cl2 to 1% MeOH/ CH2Cl2 to yield a yellow oil (0.90 
g, 30%).  Rf (10% MeOH/ CH2Cl2) = 0.42; 1H NMR (400 MHz, CDCl3) δ 8.20 (d, 4J = 
2, 1H, H6), 7.58 (dd, 3J = 8, 4J = 2, 1H, H4), 7.02 (d, 3J = 8, 1H, H3), 3.07 (br m, 12H, 
NCH2COOtBu/cyclen CH2/NCH2py), 2.31 (br m, 12H, NCH2COOtBu/cyclen 
CH2/NCH2py), 1.42 (s, 9H, pyC(CH3)3), 1.39 (br s, 18H, COOC(CH3)3), 1.21 (s, 9H, 
COOC(CH3)3); 13C NMR (101 MHz, CDCl3) δ 171.6 (COO(CH3)3), 154.6 (C2), 144.8 
(C6), 143.3 (C5), 132.7 (C3), 121.0 (C4), 81.0 (COOC(CH3)3), 80.6 (COOC(CH3)3), 
57.3 (pyCH2), 54.3 (cyclen CH2), 50.3 (cyclen CH2), 46.5 (cyclen CH2), 32.3 
(pyC(CH3)3), 30.0 (pyC(CH3)3), 27.2 (COOC(CH3)3), 26.9 (COOC(CH3)3); ESI-LRMS 
(+) m/z 662.4 [M+H]+; ESI-HRMS (+) calcd for [C36H64N5O6]+ 662.4851, found 
662.4856. 
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7. Europium(III) complex of 1,4,7-tris(acetic acid)-10-((5-tert-butylpyridin-2-
yl)methyl)-1,4,7,10-tetraazacyclododecane, [Eu.L1(H2O)] 
 
 
tert-Butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (100 mg, 0.15 mmol) was dissolved in 
CH2Cl2 (1 mL) and to this was added TFA (1 mL). The resulting mixture was stirred at 
rt for 18 h. Excess CH2Cl2 and TFA were removed under reduced pressure and the 
resulting yellow residue was repeatedly washed with CH2Cl2 (3 x 1 mL). Deprotection 
was monitored by ESI-LRMS (+) (m/z 494.2 [M+H]+; ESI-HRMS (+) calcd for 
[C24H40N5O6]+ 494.2979, found 494.2963) and complete deprotection was confirmed 
by 1H NMR spectroscopy. The residue was dissolved in H2O (2 mL) and the pH 
adjusted to 5.5. To this was added EuCl3.6H2O (63 mg, 0.17 mmol) and the resulting 
mixture was stirred at 70 oC for 18 h, before the solvent was removed under reduced 
pressure. The resulting yellow solid was purified by reverse-phase HPLC (10-100% 
MeOH in H2O over 10 min; tR = 8.9 min) to yield a white solid (30 mg). 1H NMR (400 
MHz, D2O) δ 32.2, 29.7, 29.3, 25.3 (Hax), 13.3, 7.1, 3.7, 3.5 (Heq’), 2.1 (C(CH3)3), 1.4, -
3.5, -8.3, -14.7 (Heq), -14.0, -14.2, -17.8, -19.1 (Hax’); ESI-LRMS (+) m/z 644.0 
[M+H]+; ESI-HRMS (+) calcd for [C24H37N5O6151Eu]+ 642.1942, found 642.1935. 
 
8. [Gd.L1(H2O)] 
An analogous procedure to that described for the synthesis of [Eu.L1(H2O)] was 
followed using tert-butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (100 mg, 0.15 mmol) and GdCl3.6H2O (63 
mg, 0.17 mmol), to yield a white solid (32 mg). tR = 8.4 min; ESI-LRMS (+) m/z 648.9 
[M+H]+; ESI-HRMS (+) calcd for [C24H37N5O6155Gd]+ 646.1970, found 646.1960; r1p 
= 4.8±0.01 mM-1 s-1 (H2O, 60 MHz, 310 K).!
 
9. [Tb.L1(H2O)] 
An analogous procedure to that described for the synthesis of [Eu.L1(H2O)] was 
followed using tert-butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
N N
NN
O O
O
O
OO
N
Eu
H2O
Chapter Six: Experimental !
! 175 
tetraazacyclododecane-1,4,7-triyl)triacetate (100 mg, 0.15 mmol) and TbCl3.6H2O (63 
mg, 0.17 mmol), to yield a white solid (30 mg). tR = 9.3 min; 1H NMR (400 MHz, D2O) 
δ -11.1 (C(CH3)3); ESI-LRMS (+) m/z 651.1 [M+H]+; ESI-HRMS (+) calcd for 
[C24H37N5O6159Tb]+ 650.1997, found 650.1967. 
 
10. [Dy.L1(H2O)] 
An analogous procedure to that described for the synthesis of [Eu.L1(H2O)] was 
followed using tert-butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (100 mg, 0.15 mmol) and DyCl3.6H2O (63 
mg, 0.17 mmol), to yield a white solid (30 mg). tR = 8.9 min; 1H NMR (400 MHz, D2O) 
δ -20.1 (C(CH3)3); ESI-LRMS (+) m/z 652.3 [M+H]+; ESI-HRMS (+) calcd for 
[C24H36N5O6Na160Dy]+ 673.1815, found 673.1824.!
 
11. [Ho.L1(H2O)] 
An analogous procedure to that described for the synthesis of [Eu.L1(H2O)] was 
followed using tert-butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (100 mg, 0.15 mmol) and HoCl3.6H2O (64 
mg, 0.17 mmol), to yield a white solid (32 mg). tR = 8.3 min; 1H NMR (400 MHz, D2O) 
δ -7.2 (C(CH3)3); ESI-LRMS (+) m/z 656.0 [M+H]+; ESI-HRMS (+) calcd for 
[C24H37N5O6 165Ho]+ 656.2047, found 656.2058. 
 
12. [Er.L1(H2O)] 
An analogous procedure to that described for the synthesis of [Eu.L1(H2O)] was 
followed using tert-butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (100 mg, 0.15 mmol) and ErCl3.6H2O  (63 
mg, 0.17 mmol), to yield a white solid (29 mg). tR = 8.7 min; 1H NMR (400 MHz, D2O) 
δ 7.0 (C(CH3)3); ESI-LRMS (+) m/z 657.1 [M+H]+; ESI-HRMS (+) calcd for 
[C24H37N5O6166Er]+ 657.2047, found 657.2045. 
 
13. [Tm.L1(H2O)] 
An analogous procedure to that described for the synthesis of [Eu.L1(H2O)] was 
followed using tert-butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (100 mg, 0.15 mmol) and TmCl3.6H2O (63 
mg, 0.17 mmol), to yield a white solid (33 mg). tR = 8.6 min; 1H NMR (400 MHz, D2O) 
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δ 10.5 (C(CH3)3); ESI-LRMS (+) m/z 661.3 [M+H]+; ESI-HRMS (+) calcd for 
[C24H36N5O6NaTm]+ 682.1906, found 682.1880. 
 
14. [Yb.L1(H2O)] 
An analogous procedure to that described for the synthesis of [Eu.L1(H2O)] was 
followed using tert-butyl-2,2',2''-(10-((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (100 mg, 0.15 mmol) and YbCl3.6H2O  (63 
mg, 0.17 mmol), to yield a white solid (28 mg). tR = 8.4 min; 1H NMR (400 MHz, D2O) 
δ 124.0, 115.6, 112.8, 98.0 (Hax), 40.8, 26.6, 20.1, 19.5 (Heq), 15.4, 13.7, 11.3, 7.72 
(Hax’), 6.3 (C(CH3)3), 1.08, -1.41 (pyH), -8.84 (CHCO), -19.8 (CHCO’), -20.5, -47.2 
(CHCO), -47.5, -55.9 (CHCO’), -65.9, -67.1, -69.7, -72.3 (Heq’); ESI-LRMS (+) m/z 
665.0 [M+H]+; ESI-HRMS (+) calcd for [C24H37N5O6170Yb]+ 661.2092, found 
661.2100.  
 
15. 1,4,7,10-Tetraazacyclododecane-1,7-dicarboxylic acid dibenzyl ester4 
 
 
 
1,4,7,10-Tetraazacyclododecane (3.5 g, 20.3 mmol) was dissolved in a solution of 
distilled H2O:dioxane (50:20 mL), followed by addition of Na2HPO4 (9.8 g, 69.0 
mmol). The pH of the solution was adjusted to 2.5 by careful addition of conc. HCl 
(aq). Benzyl chloroformate (7.3 mL, 50.8 mmol) in dioxane (10 mL) was added 
dropwise over a period of 30 min and the solution left to stir for a further 18 h at rt. The 
solvent was evaporated under reduced pressure and the residue dissolved in H2O (100 
mL), followed by adjustment of the pH to 7 by addition of conc. KOH (aq). The 
aqueous phase was extracted with Et2O (2 × 100 mL), followed by CH2Cl2 (2 × 100 
mL). The organic phases were combined, dried over MgSO4, filtered, and the solvent 
removed under reduced pressure to give a clear viscous oil. The oil was dissolved in 
CH2Cl2 (10 mL) and cold Et2O (100 mL) was added, causing a white solid to 
precipitate (5.80 g, 65%). m.p. 115-117 °C (lit. m.p. 116-117 °C); 1H NMR (400 MHz, 
CDCl3) δ 7.29–7.42 (m, 10H, Ar), 5.17 (s, 4H, Cbz CH2), 3.27–4.13 (br m, 8H, cyclen 
CH2), 2.76–3.22 (br m, 8H, cyclen CH2), 1.70 (br s, 2H, NH); 13C NMR (176 MHz, 
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CDCl3) δ 156.2 (CO), 128.0 (Ar), 128.4 (Ar), 128.5 (Ar), 128.7 (Ar), 135.8 (Ar), 67.8 
(Cbz CH2), 67.9 (Cbz CH2), 49.0 (cyclen CH2), 50.5 (cyclen CH2); ESI-LRMS (+) m/z 
441.6 [M+H]+; ESI-HRMS (+) calcd for [C24H33O4N4]+ 441.2502, found 441.2514. 
 
16. 4,10-Bis-tert-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane-1,7-
dicarboxylic acid dibenzyl ester5 
 
 
 
1,4,7,10-Tetraazacyclododecane-1,7-dicarboxylic acid dibenzyl ester (5.8 g, 13.2 
mmol) and tert-butyl bromoacetate (4.5 mL, 30.4 mmol) were dissolved in anhydrous 
MeCN (70 mL), followed by the addition of Cs2CO3 (12.9 g, 39.6 mmol). The mixture 
was heated at 80 oC for 18 h. The solution was cooled and filtered, before the solvent 
was removed under reduced pressure. The resulting dark yellow oil was purified by 
silica gel column chromatography, eluting with a gradient starting from 100% CH2Cl2 
to 2% MeOH/CH2Cl2 to yield a dark yellow oil (8.0 g, 91%). Rf (10% MeOH/CH2Cl2) 
= 0.53; 1H NMR (400 MHz, CDCl3) δ 7.28-7.38 (10H, m, Ar), 5.12 (4H, s, Cbz CH2), 
3.14-3.51 (12H, cyclen CH2/CH2CO),  2.74-2.96 (8H, br s, CH2 ring), 1.42 (18H, s, 
C(CH3)3); 13C NMR (CDCl3, 101 MHz) δ 169.6 (CO), 155.5 (CO), 135.9 (Ar), 127.5 
(Ar), 127.0 (Ar), 126.9 (Ar), 80.0 C(CH3)3, 66.0 (CH2Ar), 55.0 (CH2CO), 52.9- 53.7 
(br, cyclen CH2), 45.7- 46.1 (br, cyclen CH2), 27.2 C(CH3)3; ESI-LRMS (+) m/z 669.3 
[M+H]+; ESI-HRMS (+) calcd for [C36H53O8N4]+ 669.3863, found 669.3868. 
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17. (7-tert-Butoxycarbonylmethyl-1,4,7,10-tetraazacyclododec-1-yl)-acetic acid 
tert-butyl ester5 
 
 
 
4,10-Bis-tert-butoxycarbonylmethyl-1,4,7,10-tetraazacyclododecane-1,7-dicarboxylic 
acid dibenzyl ester (2.0 g, 2.99 mmol) was dissolved in MeOH (10 mL) to which 
Pd(OH)2/C (Pd content 10%, 50 mg) was added. The vessel was then loaded onto a 
Parr hydrogenator (pressure 40 bar H2) and the reaction mixture agitated for 3 days. 
After this time, the catalyst was filtered off and the solvent removed under reduced 
pressure to yield a yellow oil (1.1 g, 89 %). 1H NMR (400 MHz, CDCl3) δ 3.28 (4H, s, 
CH2CO), 2.81 (8H, br m, cyclen CH2), 2.65 (8H, br m, cyclen CH2), 1.36 (18H, s, 
C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 170.7 (CO), 80.7 (C(CH3)3, 60.1 (CH2), 45.8, 
49.1, 51.1, 56.3 (cyclen CH2), 27.6 C(CH3)3; ESI-LRMS (+) m/z 401.3 [M+H]+; ESI-
HRMS (+) calcd for [C20H41O4N4]+ 401.3128, found 401.3109. 
 
18. tert-Butyl 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetate 
 
 
 
(7-tert-Butoxycarbonylmethyl-1,4,7,10-tetraazacyclododec-1-yl)-acetic acid tert-butyl 
ester (0.27 g, 0.67 mmol) was dissolved in anhydrous MeCN (4 mL) and to this was 
added K2CO3 (0.23 g, 1.68 mmol). The resulting mixture was stirred for 10 min under 
argon before (5-tert-butylpyridin-2-yl)methyl methanesulfonate (0.41 mg, 1.68 mmol) 
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in anhydrous MeCN (1 mL) was added dropwise. The reaction mixture was heated at 
60 oC for 18 h under argon. After this time, the solution was allowed to cool to rt and 
filtered. The resulting orange oil was purified by silica gel column chromatography, 
eluting with a gradient starting from 100% CH2Cl2 to 4% MeOH/ CH2Cl2 to yield a 
sticky brown oil (0.16 g, 13%).  Rf (10% MeOH/ CH2Cl2) = 0.38; 1H NMR (400 MHz, 
CDCl3) δ 8.37 (d, 4J = 2, 2H, H6), 7.65 (dd, 3J = 8, 4J = 2, 2H, H4), 7.08 (d, 3J = 8, 2H, 
H3), 3.68 (br s, 4H, NCH2py), 2.76 (br m, 12H, NCH2COOtBu/cyclen CH2), 2.39 (br m, 
8H, cyclen CH2), 1.29 (s, 18H, pyC(CH3)3), 1.26 (s, 18H, OC(CH3)3); 13C NMR (151 
MHz, CDCl3) δ 172.0 (COOC(CH3)3), 155.1 (C2), 146.0 (C6), 144.5 (C5), 133.7 (C4), 
122.1 (C3), 81.7 (COOC(CH3)3), 58.1 (pyCH2), 57.2 (NCH2CO), 53.4 (cyclen CH2), 
50.3 (cyclen CH2), 33.3 (pyC(CH3)3), 31.0 (pyC(CH3)3), 27.9 (COOC(CH3)3); ESI-
LRMS (+) m/z 695.3 [M+H]+; ESI-HRMS (+) calcd for [C40H66N6O4]+ 695.5224, found 
695.5232. 
 
19. Europium(III) complex of 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-
1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid, [Eu.L2(H2O)]+ 
 
 
 
tert-Butyl 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetate (17 mg, 0.02 mmol) was dissolved in HCl (6 
M, 1 mL) and heated to 90 oC for 18 h. The solvent was removed under reduced 
pressure and the resulting yellow residue was repeatedly washed with CH2Cl2 (3 × 1 
mL). Deprotection was monitored by ESI-LRMS (+) (m/z 583.3 [M+H]+; ESI-HRMS 
(+) calcd for [C32H51N6O4]+ 583.3972, found 583.3961) and complete deprotection was 
confirmed by 1H NMR spectroscopy. The residue was dissolved in H2O (2 mL) and the 
pH adjusted to 5.5. To this was added EuCl3.6H2O (10 mg, 0.03 mmol) and the 
resulting mixture was stirred at 70 oC for 18 h, before the solvent was removed under 
reduced pressure. The resulting yellow solid was purified by reverse-phase HPLC (10-
100% MeOH in H2O over 10 min; tR = 3.6 min) to yield a white solid (5 mg). 1H NMR 
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(400 MHz, D2O) δ 1.7 (C(CH3)3); ESI-LRMS (+) m/z 733.1 [M]+; ESI-HRMS (+) calcd 
for [C32H48N6O4151Eu]+ 731.2930, found 731.2906. 
 
20. [Gd.L2(H2O)]+ 
An analogous procedure to that described for the synthesis of [Eu.L2(H2O)]+ was 
followed using tert-butyl 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetate (17 mg, 0.02 mmol) and GdCl3.6H2O (10 mg, 
0.03 mmol), to yield a white solid (4 mg). tR = 3.9 min; ESI-LRMS (+) m/z 738.03 
[M]+; ESI-HRMS (+) calcd for [C32H48N6O4 154Gd]+ 734.2946, found 734.2938; r1p = 
5.8±0.02 mM-1 s-1 (H2O, 60 MHz, 310 K).!
 
21. [Tb.L2(H2O)]+ 
An analogous procedure to that described for the synthesis of [Eu.L2(H2O)]+ was 
followed using 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetic acid (17 mg, 0.02 mmol) and TbCl3.6H2O (10 
mg, 0.03 mmol), to yield a white solid (5 mg). tR = 4.5 min; 1H NMR (400  MHz, D2O): 
δ = -7.2 (C(CH3)3); ESI-LRMS (+) m/z 739.9 [M]+; ESI-HRMS (+) calcd for 
[C32H48N6O4 Tb]+ 739.2991, found 739.2985 
 
22. [Dy.L2(H2O)]+ 
An analogous procedure to that described for the synthesis of [Eu.L2(H2O)]+ was 
followed using tert-butyl 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetate (36 mg, 0.05 mmol) and DyCl3.6H2O (24 mg, 
0.07 mmol), to yield a white solid (11 mg). tR = 4.2 min; 1H NMR (400 MHz, D2O) δ -
17.9 (C(CH3)3); ESI-LRMS (+) m/z 743.7 [M]+; ESI-HRMS (+) calcd for 
[C32H48N6O4160Dy]+ 740.2989, found 740.2997. 
 
23. [Ho.L2(H2O)]+ 
An analogous procedure to that described for the synthesis of [Eu.L2(H2O)]+ was 
followed using tert-butyl 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetate (17 mg, 0.02 mmol) and HoCl3.6H2O (10 mg, 
0.03 mmol), to yield a white solid (5 mg). tR = 3.7 min; 1H NMR (400 MHz, D2O) δ -
7.0 (C(CH3)3); ESI-LRMS (+) m/z 745.0 [M]+; ESI-HRMS (+) calcd for 
[C32H48N6O4Ho]+ 745.3040, found 745.3055. 
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24. [Er.L2(H2O)]+ 
An analogous procedure to that described for the synthesis of [Eu.L2(H2O)]+ was 
followed using tert-butyl 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetate (17 mg, 0.02 mmol) and ErCl3.6H2O  (12 mg, 
0.02 mmol), to yield a white solid (5 mg). tR = 4.8 min; 1H NMR (400 MHz, D2O) δ 3.4 
(C(CH3)3); ESI-LRMS (+) m/z 747.9 [M]+; ESI-HRMS (+) calcd for 
[C32H48N6O4164Er]+ 744.3029, found 744.3038. 
 
25. [Tm.L2(H2O)]+ 
An analogous procedure to that described for the synthesis of [Eu.L2(H2O)]+ was 
followed using 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetic acid (17 mg, 0.02 mmol) and TmCl3.6H2O (10 
mg, 0.03 mmol) to give a white solid (5 mg). tR = 4.4 min; 1H NMR (400  MHz, D2O): 
δ 6.2 (C(CH3)3); ESI-LRMS (+) m/z 750.0 [M]+; ESI-HRMS (+) calcd for 
[C32H48N6O4Tm]+ 749.3079, found 749.3100. 
 
26. [Yb.L2(H2O)]+ 
An analogous procedure to that described for the synthesis of [Eu.L2(H2O)]+ was 
followed using tert-butyl 2,2'-(4,10-bis((5-tert-butylpyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,7-diyl)diacetate (17 mg, 0.02 mmol) and YbCl3.6H2O  (12 mg, 
0.02 mmol), to yield a white solid (5 mg). tR = 3.9 min; 1H NMR (400 MHz, D2O) δ 9.1 
(C(CH3)3); ESI-LRMS (+) m/z 754.1 [M]+; ESI-HRMS (+) calcd for 
[C32H48N6O4170Yb]+ 750.3085, found 750.3049. 
 
27. 1,4,7-Tri-benzyl 1,4,7,10-tetraazacyclododecane 1,4,7-tricarboxylate 
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1,4,7,10-Tetraazacyclododecane (2.5 g, 14.5 mmol) was dissolved in dry CH2Cl2 (80 
mL) and to this was added triethylamine (6.3 mL, 45.0 mmol). The resulting solution 
was stirred at 5 oC for 10 min, before the dropwise addition of a solution of benzyl 
chloroformate (6.4 mL, 45.0 mmol) in dry CH2Cl2 (20 mL). After addition, the solution 
was stirred at rt for a further 18 h. The solvent was removed under reduced pressure 
and the resulting pale yellow oil was purified by silica gel column chromatography, 
eluting with a gradient starting from 100% CH2Cl2 to 2% MeOH/ CH2Cl2 to yield a 
colourless oil (6.1 g, 73%).  Rf (10% MeOH/ CH2Cl2) = 0.54; 1H NMR (400 MHz, 
CDCl3) δ 7.22-7.33 (m, 15H, ArH), 5.00-5.06 (m, 6H, CH2O), 3.63-3.67 (m, 2H, cyclen 
CH2), 3.16-3.55 (m, 12H, cyclen CH2), 2.75-2.92 (m, 2H, cyclen CH2); 13C NMR (101 
MHz, CDCl3) δ 156.1 (CO), 136.4 (Ar), 136.3 (Ar), 128.4 (Ar), 128.3 (Ar), 127.7 (Ar), 
127.6 (Ar), 127.4 (Ar), 67.2 (CH2O), 66.8 (CH2O), 53.5 (cyclen CH2), 50.6 (cyclen 
CH2), 50.3 (cyclen CH2), 50.2 (cyclen CH2), 50.1 (cyclen CH2), 45.6 (cyclen CH2); 
ESI-LRMS (+) m/z 575.1 [M+H]+; ESI-HRMS (+) calcd for [C32H39N4O6]+ 575.2870, 
found 575.2867. 
 
28. 1,4,7-Tri-benzyl 10-tert-butyl 1,4,7,10-tetraazacyclododecane 1,4,7,10-
tetracarboxylate 
 
 
 
1,4,7-Tri-benzyl 1,4,7,10-tetraazacyclododecane 1,4,7-tricarboxylate (1.3 g, 2.26 
mmol) was dissolved in dry CH2Cl2 (15 mL) and to this was added triethylamine (0.4 
mL, 2.94 mmol). The resulting solution was stirred at rt for 10 min, before the addition 
of di-tert-butyl dicarbonate (0.64 g, 2.94 mmol). The resulting solution was stirred at rt 
for a further 18 h before the solvent was removed under reduced pressure. The resulting 
yellow oil was purified by silica gel column chromatography, eluting with a gradient 
starting from 100% CH2Cl2 to 2% MeOH/ CH2Cl2 to yield a colourless oil (1.3 g, 
85%).  Rf (10% MeOH/ CH2Cl2) = 0.69; 1H NMR (400 MHz, CDCl3) δ 7.21-7.34 (m, 
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15H, ArH), 5.06 (s, 2H, CH2O), 5.03 (s, 4H, CH2O), 3.00-3.54 (br m, 16H, cyclen 
CH2), 1.36 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 156.8 (CO), 136.4 (Ar), 
128.6 (Ar), 128.4 (Ar), 128.3 (Ar), 128.2 (Ar), 82.8 (C(CH3)3), 67.3 (CH2O), 49.9-50.7 
(br, cyclen CH2), 28.4 (C(CH3)3); ESI-LRMS (+) m/z 675.1 [M+H]+; ESI-HRMS (+) 
calcd for [C37H47N4O8]+ 675.3394, found 675.3406. 
 
29. tert-Butyl-1,4,7,10-tetraazacyclododecane carboxylate 
 
 
 
1,4,7-Tri-benzyl 10-tert-butyl 1,4,7,10-tetraazacyclododecane 1,4,7,10-tetracarboxylate 
(1.3 g, 1.93 mmol) was dissolved in MeOH (25 mL) and to this was added Pd(OH)2/C 
(~200 mg). The reaction vessel was loaded onto a Parr hydrogenator, where it was 
subject to agitation for 18 h, under a pressure of 40 bar H2. The catalyst was filtered 
through Celite and the solvent was removed under reduced pressure. The resulting solid 
was washed with a minimum amount of NaOH (aq. solution, 1 mL), and extracted into 
CH2Cl2 (3 × 30 mL), before the organic layers were combined, dried over MgSO4, and 
the solvent removed under reduced pressure to yield a pale yellow oil (0.52 g, 99%). 1H 
NMR (400 MHz, CD3OD) δ 5.03 (br s, NH), 3.52-3.60 (m, 4H, cyclen CH2), 3.22-3.27 
(m, 4H, cyclen CH2), 3.10-3.21 (m, 8H, cyclen CH2), 1.49 (s, 9H, C(CH3)3); 13C NMR 
(101 MHz, CD3OD) δ 157.5 (CO), 82.3 (C(CH3)3), 48.2 (cyclen CH2), 46.9 (cyclen 
CH2), 45.6 (cyclen CH2), 44.5 (cyclen CH2), 28.7 (C(CH3)3); ESI-LRMS (+) m/z 273.2 
[M+H]+; ESI-HRMS (+) calcd for [C13H29N4O2]+ 273.2291, found 273.2296. 
 
30. tert-Butyl-4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane-1-carboxylate 
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tert-Butyl-1,4,7,10-tetraazacyclododecane carboxylate (0.52 g, 1.91 mmol) and 
paraformaldehyde (1.15 g, 38.2 mmol) were dissolved in anhydrous THF (30 mL) and 
the resulting suspension was heated at 80 oC for 3 h. Diethyl methylphosphonite (1.7 
mL, 11.5 mmol) was added and the solution stirred at 80 oC for a further 18 h. The 
solution was cooled and filtered, before the solvent was removed under reduced 
pressure. The residual brown oil was purified by alumina gel column chromatography, 
eluting with a gradient starting from 100% CH2Cl2 to 2% MeOH/ CH2Cl2 to yield a 
yellow oil (0.4 g, 33%).  Rf (10% MeOH/ CH2Cl2) = 0.76; 1H NMR (400 MHz, CDCl3) 
δ 3.93 (q, 3JPH = 7, 6H, POCH2), 3.09-3.60 (br m, 6H, PCH2N), 2.41-3.00 (br m, 16H, 
cyclen CH2), 1.33-1.47 (m, 9H, PCH3), 1.32 (s, 9H, C(CH3)3), 1.18 (t, 3JPH = 7, 9H, 
POCH2CH3); 31P NMR (162 MHz, CDCl3) δ 52.53, 52.31, 52.22, 52.20, 52.18, 52.24, 
52.06, 51.95, 51.85, 51.85, 51.59, 51.49 (mixture of isomers); 13C NMR (176 MHz, 
CDCl3) δ 155.5 (CO), 79.5 (C(CH3)3), 59.9-60.1 (m, POCH2), 52.7-55.1 (m, cyclen 
CH2), 45.9 (PCH2N), 45.6 (PCH2N), 45.5 (PCH2N), 28.4 (C(CH3)3), 16.6 (t, 3JCP = 6, 
POCH2CH3), 13.5-13.9 (m, PCH3); ESI-LRMS (+) m/z 633.2 [M+H]+; ESI-HRMS (+) 
calcd for [C25H56N4O8P3]+ 633.3311, found 633.3312. 
 
31. Ethyl[(4,7-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane-1-yl)methyl](methyl)phosphinate 
 
 
 
tert-Butyl-4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecane-1-carboxylate (0.4 g, 0.63 mmol) was dissolved in anhydrous 
CH2Cl2 (2 mL) and to this was added TFA (2 mL). The resulting solution was stirred at 
rt for 18 h, before the solvent was removed under reduced pressure. The resulting 
yellow oil was dissolved in a minimal amount of H2O (3 mL). The pH of the water 
layer was adjusted to 12 using solid NaOH before being extracted with CH2Cl2 (4 × 10 
mL). The CH2Cl2 layers were combined, dried over MgSO4, and the solvent removed 
under reduced pressure to yield a yellow oil (0.22 g, 66%). 1H NMR (400 MHz, 
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CDCl3) δ 3.90-4.08 (m, 6H, POCH2), 2.60-3.32 (br m, 22H, cyclen CH2, PCH2N), 1.46 
(d, 2JPH = 13, 9H, PCH3), 1.25 (t, 3JPH = 7, 9H, POCH2CH3); 31P NMR (162 MHz, 
CDCl3) δ 54.2, 53.8, 53.5, 53.2, 50.4 (mixture of isomers); 13C NMR (101 MHz, 
CDCl3) δ 60.1-60.6 (m, POCH2), 56.2-56.6 (m, cyclen CH2), 55.1-55.5 (m, cyclen 
CH2), 52.5-53.2 (m, cyclen CH2), 46.8-47.3 (m, PCH2N), 16.7 (t, 3JCP = 6, 
POCH2CH3), 14.2 (t, 1JCP = 12, PCH3), 13.3 (t, 1JCP = 12, PCH3); ESI-LRMS (+) m/z 
533.1 [M+H]+; ESI-HRMS (+) calcd for [C20H48N4O6P3]+ 533.2787, found 533.2811. 
 
32. Ethyl ({4-[(5-tert-butylpyridin-2-yl)methyl]-7,10-
di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecan-1-
yl}methyl)(methyl)phosphinate 
 
 
 
Ethyl[(4,7-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecane-1-
yl)methyl](methyl)phosphinate (0.64 g, 1.20 mmol) was dissolved in anhydrous MeCN 
(7 mL) and to this was added K2CO3 (0.36 g, 2.64 mmol). (5-tert-Butylpyridin-2-
yl)methyl methanesulfonate (0.32 g, 1.32 mmol) was then added dropwise as a solution 
in anhydrous MeCN (5 mL). The resulting mixture was heated at 70 oC for 18 h, under 
argon. The reaction mixture was cooled and the inorganic salts were removed by 
centrifugation. The solvent was removed under reduced pressure and the resulting red 
oil was purified by alumina gel column chromatography, eluting with a gradient 
starting from 100% CH2Cl2 to 1% MeOH/ CH2Cl2 to yield an orange oil (0.37 g, 45%).  
Rf (10% MeOH/ CH2Cl2) = 0.70; 1H NMR (400 MHz, CDCl3) δ 8.57 (d, 4J = 2, 1H, 
H6), 7.66 (dd, 8.57, 3J = 8, 4J = 2, 1H, H4), 7.29 (d, 3J = 8, 1H, H3), 3.89-4.11 (m, 6H, 
POCH2), 3.46-3.57 (m, 8H, PCH2N, pyCH2), 2.63-3.14 (br m, 16H, cyclen CH2), 2.01 
(s, 9H, C(CH3)3),  1.41-1.60 (m, 9H, PCH3), 1.21-1.32 (m, 9H, POCH2CH3); 31P NMR 
(162 MHz, CDCl3) δ 54.0, 53.9, 53.8, 53.6, 53.2, 51.7, 51.6, 51.5 (mixture of isomers); 
ESI-LRMS (+) m/z 680.2 [M+H]+; ESI-HRMS (+) calcd for [C30H61N5O6P3]+ 
680.3825, found 680.3824. 
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33. Europium(III) complex of ({4-[(5-tert-butylpyridin-2-yl)methyl]-7,10-
di{[hydroxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecan-1-
yl}methyl)(methyl)phosphinic acid, [Eu.L3] 
 
 
 
Ethyl ({4-[(5-tert-butylpyridin-2-yl)methyl]-7,10-
di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecan-1-
yl}methyl)(methyl)phosphinate (45 mg, 0.065 mmol) was dissolved in aqueous HCl (6 
M, 2 mL) and stirred at 70 oC for 18 h. Complete ester hydrolysis was confirmed by 31P 
NMR spectroscopy ((162 MHz, D2O) δ 37.0, 34.4, 30.6), before the solvent was 
removed under reduced pressure. The resulting yellow oil was dissolved in H2O (2 
mL). The pH of the solution was adjusted to 5.5 using NaOH and EuCl3.6H2O (36 mg, 
0.098 mmol) was added. The resulting solution was stirred at 70 oC for 18 h before the 
solvent was removed under reduced pressure. The resulting yellow solid was purified 
by reverse-phase HPLC (10-100% MeOH in H2O over 10 min; tR = 8.6 min) to yield a 
white solid (15 mg). 1H NMR (400 MHz, D2O) δ 2.9 (C(CH3)3 major), 1.5 (C(CH3)3 
minor); ESI-LRMS (+) m/z 746.4 [M+H]+; ESI-HRMS (+) calcd for 
[C24H46N5O6P3151Eu]+ 745.4931, found 745.4929. 
 
34. [Gd.L3] 
An analogous procedure to that described for [Eu.L3] was followed using ethyl ({4-[(5-
tert-butylpyridin-2-yl)methyl]-7,10-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl}methyl)(methyl)phosphinate (45 mg, 0.065 mmol) and 
GdCl3.6H2O (36 mg, 0.098 mmol), to yield a white solid (15 mg). tR = 9.0 min; ESI-
LRMS (+) m/z 750.4 [M+H]+; ESI-HRMS (+) calcd for [C24H46N5O6P3154Gd]+ 
747.1870, found 747.1899; r1p = 1.5±0.04 mM-1 s-1 (H2O, 60 MHz, 310 K). 
 
35. [Tb.L3] 
An analogous procedure to that described for [Eu.L3] was followed using ethyl ({4-[(5-
tert-butylpyridin-2-yl)methyl]-7,10-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
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tetraazacyclododecan-1-yl}methyl)(methyl)phosphinate (45 mg, 0.065 mmol) and 
TbCl3.6H2O (37 mg, 0.098 mmol), to yield a white solid (16 mg). tR = 8.6 min; 1H 
NMR (400 MHz, D2O) δ -76.6 (C(CH3)3 major), -77.3 (C(CH3)3 minor); ESI-LRMS 
(+) m/z 751.8 [M+H]+; ESI-HRMS (+) calcd for [C24H46N5O6P3159Tb]+ 752.1914, 
found 752.1925. 
 
36. [Dy.L3] 
An analogous procedure to that described for [Eu.L3] was followed using ethyl ({4-[(5-
tert-butylpyridin-2-yl)methyl]-7,10-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl}methyl)(methyl)phosphinate (45 mg, 0.065 mmol) and 
DyCl3.6H2O (37 mg, 0.098 mmol), to yield a white solid (16 mg). tR = 8.7 min; 1H 
NMR (400 MHz, D2O) δ -75.1 (C(CH3)3 major), -78.7 (C(CH3)3 minor); ESI-LRMS 
(+) m/z 757.8 [M+H]+; ESI-HRMS (+) calcd for [C24H46N5O6P3160Dy]+ 753.1913, 
found 753.1926. 
 
37. [Ho.L3] 
An analogous procedure to that described for [Eu.L3] was followed using ethyl ({4-[(5-
tert-butylpyridin-2-yl)methyl]-7,10-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl}methyl)(methyl)phosphinate (45 mg, 0.065 mmol) and 
HoCl3.6H2O (37 mg, 0.098 mmol), to yield a white solid (15 mg). tR = 9.6 min; 1H 
NMR (400 MHz, D2O) δ -31.9 (C(CH3)3 major), -33.8 (C(CH3)3 minor); ESI-LRMS 
(+) m/z 758.7 [M+H]+; ESI-HRMS (+) calcd for [C24H46N5O6P3165Ho]+ 758.1964, 
found 758.1970. 
 
38. [Er.L3] 
An analogous procedure to that described for [Eu.L3] was followed using ethyl ({4-[(5-
tert-butylpyridin-2-yl)methyl]-7,10-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl}methyl)(methyl)phosphinate (45 mg, 0.065 mmol) and 
ErCl3.6H2O (37 mg, 0.098 mmol), to yield a white solid (16 mg). tR = 10.2 min; 1H 
NMR (400 MHz, D2O) δ 38.3 (C(CH3)3 major), 40.1 (C(CH3)3 minor); ESI-LRMS (+) 
m/z 758.9 [M+H]+; ESI-HRMS (+) calcd for [C24H46N5O6P3164Er]+ 757.1953, found 
757.1962. 
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39. [Tm.L3] 
An analogous procedure to that described for [Eu.L3] was followed using ethyl ({4-[(5-
tert-butylpyridin-2-yl)methyl]-7,10-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl}methyl)(methyl)phosphinate (45 mg, 0.065 mmol) and 
TmCl3.6H2O (38 mg, 0.098 mmol), to yield a white solid (16 mg). tR = 9.3 min; 1H 
NMR (400 MHz, D2O) δ 67.2 (C(CH3)3 major), 68.6 (C(CH3)3 minor); ESI-LRMS (+) 
m/z 762.5 [M+H]+; ESI-HRMS (+) calcd for [C24H46N5O6P3169Tm]+ 762.2003, found 
762.2012. 
 
40. [Yb.L3] 
An analogous procedure to that described for [Eu.L3] was followed using ethyl ({4-[(5-
tert-butylpyridin-2-yl)methyl]-7,10-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl}methyl)(methyl)phosphinate (45 mg, 0.065 mmol) and 
YbCl3.6H2O (38 mg, 0.098 mmol), to yield a white solid (15 mg). tR = 9.0 min; 1H 
NMR (400 MHz, D2O) δ 116.1, 85.7, 54.4, 51.1 (Hax), 50.7, 50.3 (Heq’), 36.2, 33.5 
(Heq), 21.1 (Heq’), 21.1 (Heq), 19.0 (pyH), 16.5 (C(CH3)3, 12.1, 6.13 (pyH), -9.13, -9.52 
(CH3), -14.1, -14.5, -18.8 (CHPO), -26.4 (CH3), -27.1, -28.4, -28.9, -30.4 (CHPO’), -
40.6, -50.1, -63.4, -76.8 (Hax’); ESI-LRMS (+) m/z 767.9 [M+H]+; ESI-HRMS (+) 
calcd for [C24H46N5O6P3170Yb]+ 763.2009, found 763.2007. 
 
41. 5-tert-Butyl-2-methyl-4-nitropyridin-1-oxide 
 
 
 
5-tert-Butyl-2-methylpyridine 1-oxide (3.20 g, 19.4 mmol) was dissolved in conc. 
H2SO4 (98%, 11.0 mL, 209.5 mmol) and stirred for 10 min at 5 oC. To this was added 
HNO3 (70%, 7.0 mL, 161.0 mmol) dropwise and the resulting mixture was heated to 
100 oC for 18 h. After this time, the solution was dropped onto ice and stirred for 1 h 
before the aqueous mixture was extracted with CH2Cl2 (3 × 150 mL). The organic 
layers were combined, dried over MgSO4 and the solvent removed under reduced 
pressure. The resulting green oil was purified by silica gel column chromatography, 
eluting with a gradient starting from 100% CH2Cl2 to 2% MeOH/ CH2Cl2, to yield a 
bright yellow oil (3.0 g, 74%). Rf (10% MeOH/ CH2Cl2) = 0.47; 1H NMR (400 MHz, 
N+
O-
NO2
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CDCl3) δ 8.76 (s, 1H, H6), 7.58 (s, 1H, H3), 2.64 (s, 3H, CH3), 1.35 (s, 9H, C(CH3)3); 
13C NMR (101 MHz, CDCl3) δ 152.5 (C2), 151.1 (C5), 142.3 (C6), 139.3 (C4), 122.6 
(C3), 35.7 (C(CH3)3), 29.9 (C(CH3)3), 17.5 (CH3); ESI-LRMS (+) m/z 211.1 [M+H]+; 
ESI-HRMS (+) calcd for [C10H15N2O3]+ 211.1083, found 211.1088. 
 
42. 4-Amino-5-tert-butyl-2-methylpyridin-1-oxide 
 
 
 
5-tert-Butyl-2-methyl-4-nitropyridin-1-oxide (1.9 g, 9.04 mmol) was dissolved in 
MeOH (50 mL) and Pd/C was added (Pd content 10 %, 190 mg). The vessel was then 
loaded onto a Parr hydrogenator (pressure 40 bar H2) and the reaction mixture was 
agitated for 18 h. After this time, the mixture was filtered before the methanolic solution 
was evaporated under reduced pressure to yield an orange oil (1.6 g, 98%). Rf (10% 
MeOH/ CH2Cl2) = 0.28; 1H NMR (400 MHz, CD3OD) δ 7.95 (s, 1H, H6), 6.68 (s, 1H, 
H3), 3.32 (s, 3H, CH3), 1.37 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CD3OD) δ 152.2 
(C2), 148.0 (C5), 138.1 (C6), 129.4 (C4), 112.2 (C3), 34.1 (C(CH3)3), 26.8 (C(CH3)3), 
16.9 (CH3); ESI-LRMS (+) m/z 181.1 [M+H]+; ESI-HRMS (+) calcd for [C10H17N2O]+ 
181.1341, found 181.1350. 
 
43.  (5-tert-Butyl-4-nitropyridin-2-yl)methanol 
 
 
 
Trifluoroacetic anhydride (20 mL, 143.0 mmol) was added to a solution of 5-tert-butyl-
2-methyl-4-nitropyridin-1-oxide (3.0 g, 14.3 mmol) in CHCl3 (40 mL). The resulting 
mixture was heated at 60 oC for 18 h under an atmosphere of argon. Reaction 
completion was confirmed by 1H NMR spectroscopy before the solvent was removed 
under reduced pressure. The resulting bright yellow oil was stirred in a mixture of EtOH 
(20 mL) and H2O (20 mL) for 2 h. The solution was concentrated (ca. 10 mL) and 
extracted with CH2Cl2 (3 × 100 mL), before the organic layers were combined, dried 
over MgSO4, and the solvent removed under reduced pressure. The resulting yellow oil 
N+
O-
NH2
NHO
NO2
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was purified by silica gel column chromatography, eluting with a gradient starting from 
100% CH2Cl2 to 1% MeOH/ CH2Cl2 to yield a yellow oil (2.2 g, 73%). Rf (10% MeOH/ 
CH2Cl2) = 0.45; 1H NMR (400 MHz, CDCl3) δ 8.78 (s, 1H, H6), 7.27 (s, 1H, H3), 4.79 
(s, 2H, CH2), 4.09 (br s, 1H, OH), 1.40 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) 
δ 160.1 (C2), 156.9 (C5), 150.3 (C6), 133.7 (C4), 114.0 (C3), 63.9 (CH2), 34.7 (C(CH3)3), 
30.5 (C(CH3)3); ESI-LRMS (+) m/z 211.52 [M+H]+; ESI-HRMS (+) calcd for 
[C10H15N2O3]+ 211.1083, found 211.1087. 
 
44. (4-Amino-5-tert-butyl-pyridin-2-yl)methanol 
 
 
 
(5-tert-Butyl-4-nitropyridin-2-yl)methanol (600 g, 2.90 mmol) was dissolved in MeOH 
(10 mL) and to this was added Pd/C (0.18 g). The reaction vessel was degassed three 
times using a vacuum and a H2 balloon, until a positive pressure of H2 was obtained. 
The resulting solution was stirred at rt for 3 h before the reaction mixture was filtered. 
The resulting yellow oil was dissolved in CH2Cl2 (10 mL), before being washed with 
H2O (3 × 10 mL). The aqueous layers were combined and the solvent removed under 
reduced pressure to yield a yellow oil (300 mg, 57 %). 1H NMR (400 MHz, CD3OD) δ 
7.88 (s, 1H, H6), 6.81 (s, 1H, H3), 4.64 (s, 2H, CH2), 1.38 (s, 9H, C(CH3)3); 13C NMR 
(101 MHz, CD3OD) δ 159.9 (C5), 152.7 (C2), 137.2 (C6), 128.6 (C4), 107.9 (C3), 60.2 
(CH2), 34.0 (C(CH3)3), 28.4 (C(CH3)3); ESI-LRMS (+) m/z 181.9 [M+H]+; ESI-HRMS 
(+) calcd for [C10H17N2O]+ 181.1341, found 181.1332. 
 
45.  (5-tert-Butyl-4-nitropyridin-2-yl)methyl methanesulfonate 
 
 
 
(5-tert-Butyl-4-nitropyridin-2-yl)methanol (0.28 g, 1.32 mmol) was dissolved in dry 
THF (5 mL) and cooled to 5 oC. Triethylamine (0.46 mL, 3.30 mmol) and mesyl 
chloride (0.26 mL, 3.30 mmol) were added dropwise. After addition, the reaction 
mixture was allowed to warm to rt and stirred for 20 min before the solvent was 
N
NH2
HO
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removed under reduced pressure. The residue was dissolved in brine (15 mL) and 
extracted with CH2Cl2 (3 × 10 mL). The organic layers were combined, dried over 
MgSO4, and the solvent removed under reduced pressure to yield an orange oil, which 
was used immediately (0.38 g, 99 %). Rf (10% MeOH/ CH2Cl2) = 0.75; 1H NMR (600 
MHz, CDCl3) δ 8.77 (s, 1H, H6), 7.28 (s, 1H, H3), 5.23 (s, 2H, CH2), 3.04 (s, 3H, CH3), 
1.32 (s, 9H, C(CH3)3); ESI-LRMS (+) m/z 289.11 [M+H]+; ESI-HRMS (+) calcd for 
[C11H17N2O5S]+ 289.0858, found 289.0854. 
 
46. tert-Butyl-2,2',2''-(10-((5-tert-butyl-4-nitropyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate 
 
 
 
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (0.61 g, 1.20 
mmol) was dissolved in anhydrous MeCN (5 mL) and to this was added K2CO3 (0.33 g, 
2.40 mmol). (5-tert-Butyl-4-nitropyridin-2-yl)methyl methanesulfonate (0.38 g, 1.32 
mmol) was added dropwise as a solution in MeCN (5 mL). The resulting mixture was 
heated at 60 oC for 18 h, under argon. The reaction mixture was cooled and filtered 
before the solvent was removed under reduced pressure. The resulting orange oil was 
purified by silica gel column chromatography, eluting with a gradient starting from 
100% CH2Cl2 to 3% MeOH/ CH2Cl2 to yield a yellow oil (0.3 g, 32%).  Rf (10% 
MeOH/ CH2Cl2) = 0.46; 1H NMR (200 MHz, CDCl3) δ 8.49 (s, 1H, H6), 7.05 (s, 1H, 
H3), 3.84 (br m, 4H, NCH2COOtBu/cyclen CH2/NCH2py), 3.04 (br m, 8H, NCH2-
COOtBu/cyclen CH2/NCH2py), 2.29 (br m, 12H, NCH2COOtBu/cyclen CH2/NCH2py), 
1.45 (s, 18H, COOC(CH3)3), 1.43 (br s, 9H, pyC(CH3)3), 1.21 (s, 9H, COOC(CH3)3); 
13C NMR (150 MHz, CDCl3) δ 173.0 (COO(CH3)3), 169.5 (COO(CH3)3), 159.6 (C5), 
156.8 (C2), 150.1 (C6), 133.2 (C4), 115.5 (C3), 82.4 (pyC(CH3)3), 82.2 (COOC(CH3)3), 
82.1 (COOC(CH3)3), 61.6 (cyclen CH2), 58.1 (pyCH2), 55.4 (cyclen CH2), 53.6 (cyclen 
CH2), 52.1 (cyclen CH2), 34.5 (pyC(CH3)3), 30.5 (COOC(CH3)3), 28.2 (COOC(CH3)3); 
N N
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ESI-LRMS (+) m/z 706.99 [M+H]+; ESI-HRMS (+) calcd for [C36H63N6O8]+ 707.4707, 
found 707.4700. 
 
47. Dysprosium(III) complex of 1,4,7-tris(acetic acid)-10-((5-tert-butyl-4-
nitropyridin-2-yl)methyl)-1,4,7,10-tetraazacyclododecane 
 
 
 
tert-Butyl-2,2',2''-(10-((5-tert-butyl-4-nitropyridin-2-yl)methyl)-1,4,7,10-
tetraazacyclododecane-1,4,7-triyl)triacetate (17 mg, 0.03 mmol) was dissolved in 
CH2Cl2 (1 mL) and to this was added TFA (1 mL). The resulting mixture was stirred at 
rt for 18 h, before the solvent was removed under reduced pressure. The resulting 
yellow residue was repeatedly washed with CH2Cl2 (3 × 1 mL). Deprotection was 
confirmed by ESI-LRMS (+) (m/z 530.02 [M+H]+; ESI-HRMS (+) calcd for 
[C24H39N6O8]+ 539.2829, found 539.2841) and 1H NMR spectroscopy. The residue was 
dissolved in H2O (2 mL) and the pH adjusted to 5.5. To this was added DyCl3.6H2O (16 
mg, 0.04 mmol) and the resulting mixture was stirred at 70 oC for 18 h, before the 
solvent was removed under reduced pressure. The resulting white solid was purified by 
reverse-phase HPLC (10-100% MeOH in H2O over 10 min; tR = 5.8 min) to yield an 
off-white solid (6 mg). 1H NMR (400 MHz, D2O) δ -28.0 (C(CH3)3); ESI-LRMS (+) 
m/z 699.5 [M+H]+; ESI-HRMS (+) calcd for [C24H36N6O8160Dy]+ 696.1847, found 
696.1860. 
 
48. Dysprosium(III) complex of 1,4,7-tris(acetic acid)-10-((5-tert-butyl-4-
dimethylaminopyridin-2-yl)methyl)-1,4,7,10-tetraazacyclododecane, [Dy.L4(H2O)] 
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The dysprosium(III) complex of 1,4,7-tris(acetic acid)-10-((5-tert-butyl-4-nitropyridin-
2-yl)methyl)-1,4,7,10-tetraazacyclododecane, 47 (6.3 mg, 0.001 mmol) was dissolved in 
dimethylamine (1 mL, 5.6 M in EtOH) and the resulting solution was stirred at 30 oC 
for 4 h. The solution was neutralised using acetic acid and the solvent was removed 
under reduced pressure. The resulting yellow glassy solid was purified by reverse-phase 
HPLC (10-100% MeOH in H2O over 10 min; tR = 5.8 min) to yield a white solid (3 
mg). 1H NMR (400 MHz, D2O) δ -8.1 (NCH3), -19.3 (NCH3), -28.4 (C(CH3)3); ESI-
LRMS (+) m/z 698.7 [M+H]+; ESI-HRMS (+) calcd for [C26H42N6O6160Dy]+ 694.2418, 
found 694.2444. 
 
49. (4-Amino-5-tert-butyl-pyridin-2-yl)methyl acetate 
 
 
 
K2CO3 (0.55 g, 4.00 mmol) was added to a stirred solution of (4-amino-5-tert-butyl-
pyridin-2-yl)methanol (0.30 g, 1.67 mmol) in H2O (3 mL). After 5 min, acetic 
anhydride (1.56 mL, 16.7 mmol) was added as a solution in dioxane (3 mL) and the 
resulting mixture was stirred at rt for 30 min. The dioxane was removed under reduced 
pressure and the aqueous layer extracted with CH2Cl2 (3 × 15 mL). The organic layers 
were combined, dried over MgSO4 and the solvent was removed under reduced 
pressure. The resulting yellow oil was purified by silica gel column chromatography, 
eluting with a gradient starting from 100% CH2Cl2 to 5% MeOH/ CH2Cl2, to yield a 
yellow oil (0.19 g, 50%). Rf (10% MeOH/ CH2Cl2) = 0.18; 1H NMR (700 MHz, CDCl3) 
δ 8.14 (s, 1H, H6), 6.67 (s, 1H, H3), 5.40 (br s, 2H, NH2), 5.07 (s, 2H, CH2), 2.09 (s, 3H, 
CH3), 1.35 (s, 9H, C(CH3)3); 13C NMR (176 MHz, CDCl3) δ 170.7 (CO), 154.2 (C4), 
150.9 (C2), 143.6 (C6), 127.1 (C5), 109.5 (C3), 64.4 (CH2), 33.1 (C(CH3)3), 28.9 
(C(CH3)3), 20.9 (CH3); ESI-LRMS (+) m/z 223.0 [M+H]+; ESI-HRMS (+) calcd for 
[C12H19N2O2]+ 223.1447, found 223.1499. 
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50. (5-tert-Butyl-4-acetamidopyridin-2-yl)methyl acetate 
 
 
 
Acetic anhydride (1.1 mL, 11.1 mmol) and triethylamine (0.56 mL, 5.05 mmol) were 
added to a stirred solution of (4-amino-5-tert-butyl-pyridin-2-yl)methyl acetate (0.19 
mg, 0.84 mmol) in anhydrous CH2Cl2 (3 mL) and the resulting solution stirred at rt for 
18 h. The mixture was washed with Na2CO3 (sat. aq. solution, 15 mL) and extracted 
with CH2Cl2 (3 × 15 mL). The organic phases were combined, dried over MgSO4 and 
the solvent removed under reduced pressure. The resulting brown oil was purified by 
silica gel column chromatography, eluting with a gradient starting from 100% CH2Cl2 
to 2% MeOH/ CH2Cl2, to yield an off-white solid (0.12 mg, 53%). Rf (10% MeOH/ 
CH2Cl2) = 0.53; m.p. 138-140 oC; 1H NMR (700 MHz, CDCl3) δ 8.53 (s, 1H, H6), 8.06 
(br s, 1H, NH), 7.50 (s, 1H, H3), 5.13 (s, 2H, CH2), 2.21 (s, 3H, NCOCH3), 2.12 (s, 3H, 
OCOCH3), 1.43 (s, 9H, C(CH3)3); 13C NMR (176 MHz, CDCl3) δ 170.7 (OCO), 167.9 
(NCO), 154.7 (C2), 148.0 (C6), 143.7 (C4), 131.9 (C5), 115.4 (C3), 66.5 (CH2), 33.2 
(C(CH3)3), 30.4 (C(CH3)3), 25.1 (NCOCH3), 20.8 (OCOCH3); ESI-LRMS (+) m/z 265.7 
[M+H]+; ESI-HRMS (+) calcd for [C14H21N2O3]+ 265.1552, found 265.1546; Anal 
Calcd (%) for C10H15INO: C, 63.62; H, 7.63; N, 10.60, found: C, 63.58; H, 7.69; N, 
10.52. 
 
51. N-[5-tert-Butyl-2-(hydroxymethyl)pyridine-4-yl]acetamide 
 
 
 
(5-tert-Butyl-4-acetamidopyridin-2-yl)methyl acetate (117 mg, 0.44 mmol) was 
dissolved in anhydrous EtOH (5 mL) and purged with argon for 10 min, before sodium 
metal (~10 mg) was added. The resulting solution was stirred at rt for 1 h, under an 
atmosphere of argon. The solvent was removed under reduced pressure and the residue 
dissolved in CH2Cl2 (10 mL). This was washed with H2O (10 mL), which was 
N
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subsequently neutralised. The aqueous layer was washed with CH2Cl2 (3 × 10 mL), 
before the organic layers were combined, dried over MgSO4 and the solvent removed 
under reduced pressure to yield a colourless oil (75 mg, 77%). 1H NMR (400 MHz, 
CDCl3) δ 8.50 (s, 1H, H6), 7.98 (br s, 1H, H3), 7.50 (br s, 1H, NH), 4.70 (s, 2H, CH2), 
2.23 (s, 3H, CH3), 1.46 (s, 9H, C(CH3)3); 13C NMR (151 MHz, CDCl3) δ 168.1 (NCO), 
158.5 (C2), 147.2 (C6), 143.7 (C4), 131.6 (C5), 113.9 (C3), 64.0 (CH2), 33.3 (C(CH3)3), 
30.6 (C(CH3)3), 25.3 (NCOCH3); ESI-LRMS (+) m/z 223.6 [M+H]+; ESI-HRMS (+) 
calcd for [C12H19N2O2]+ 223.1447, found 223.1458. 
 
52. (5-tert-Butyl-4-acetamidopyridin-2-yl)methyl methanesulfonate 
 
 
 
N-[5-tert-Butyl-2-(hydroxymethyl)pyridine-4-yl]acetamide (75 mg, 0.34 mmol) was 
dissolved in dry THF (3 mL) and cooled to 5 oC. Triethylamine (70 µL, 0.51 mmol) and 
mesyl chloride (32 µL, 0.41 mmol) were added dropwise. After addition, the reaction 
mixture was allowed to warm to rt and stirred for 30 min before the solvent was 
removed under reduced pressure. The residue was dissolved in brine (10 mL) and 
extracted with CH2Cl2 (3 × 10 mL). The organic layers were combined, dried over 
MgSO4, and the solvent removed under reduced pressure to yield an orange oil, which 
was used immediately (102 mg, quant.). 1H NMR (400 MHz, CDCl3) δ 8.35 (s, 1H, H6), 
7.60 (s, 1H, H3), 7.55 (br s, 1H, NH), 5.34 (s, 2H, CH2), 2.99 (s, SCH3), 2.21 (s, 3H, 
CH3), 1.47 (s, 9H, C(CH3)3); ESI-LRMS (+) m/z 301.0 [M+H]+; ESI-HRMS (+) calcd 
for [C13H21N2O4S]+ 301.1222, found 301.1231. 
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53. tert-Butyl-2-2’-2’’-(10-{[4-acetylamino-5-(tert-butyl)-2-pyridyl]methyl}-
1,4,7,10-tetrazacyclododecane-1,4,7-triacetate 
 
 
 
1,4,7-Tris(tert-butoxycarbonylmethyl)-1,4,7,10-tetraazacyclododecane (175 mg, 0.34 
mmol) was dissolved in anhydrous MeCN (2 mL) and to this was added K2CO3 (94 mg, 
0.68 mmol). (5-tert-Butyl-4-acetamidopyridin-2-yl)methyl methanesulfonate (102 mg, 
0.34 mmol) was then added dropwise as a solution in anhydrous MeCN (3 mL). The 
resulting mixture was heated at 70 oC for 5 h, under argon. The reaction mixture was 
cooled and filtered before the solvent was removed under reduced pressure. The 
resulting yellow oil was purified by silica gel column chromatography, eluting with a 
gradient starting from 100% CH2Cl2 to 1% MeOH/ CH2Cl2 to yield a colourless oil (87 
mg, 36%).  Rf (10% MeOH/ CH2Cl2) = 0.45; 1H NMR (400 MHz, CDCl3) δ 8.88 (br s, 
1H, NH), 8.18 (s, 1H, H6), 7.41 (s, 1H, H3), 3.17-3.91 (br m, 4H, NCH2COOtBu/cyclen 
CH2/NCH2py), 2.79-3.13 (br m, 8H, NCH2COOtBu/cyclen CH2/NCH2py), 2.37-2.77 (br 
m, 8H, NCH2COOtBu/cyclen CH2/NCH2py), 2.32 (s, 3H, CH3), 2.17-2.30 (br m, 4H, 
NCH2COOtBu/cyclen CH2/NCH2py), 1.45 (s, 9H, COOC(CH3)3), 1.37 (s, 9H, 
pyC(CH3)3), 1.35 (br s, 18H, COOC(CH3)3); 13C NMR (176 MHz, CDCl3) δ 172.4 
(COO(CH3)3), 170.1 (NCO), 156.5 (C2), 147.6 (C6), 144.4 (C5), 136.6 (C4), 121.1 (C3), 
58.4 (pyCH2), 56.6, 55.3, 53.5, 50.5 (cyclen CH2), 33.6 (pyC(CH3)3), 30.9 
(COOC(CH3)3), 28.0 (pyC(CH3)3), 27.9 (COOC(CH3)3), 24.8 (CH3); ESI-LRMS (+) 
m/z 719.0 [M+H]+; ESI-HRMS (+) calcd for [C38H67N6O7]+ 719.5071, found 719.5052. 
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54. Dysprosium(III) complex of 1,4,7-tris(acetic acid)-10-{[4-acetylamino-5-
(tert-butyl)-2-pyridyl]methyl}-1,4,7,10-tetrazacyclododecane, [Dy.L5(H2O)] 
 
 
 
tert-Butyl-2-2’-2’’-(10-{[4-acetylamino-5-(tert-butyl)-2-pyridyl]methyl}-1,4,7,10-
tetrazacyclododecane-1,4,7-triacetate (13 mg, 0.02 mmol) was dissolved in CH2Cl2 (1 
mL) and to this was added TFA (1 mL). The resulting mixture was stirred at rt for 18 h, 
before the solvent was removed under reduced pressure. The resulting residue was 
repeatedly washed with CH2Cl2 (3 × 1 mL). Deprotection was monitored by ESI-LRMS 
(+) (m/z 551.0 [M+H]+; ESI-HRMS (+) calcd for [C26H43N6O7]+ 551.3193, found 
551.3184) and 1H NMR spectroscopy. The residue was dissolved in H2O (2.5 mL) and 
the pH adjusted to 5.5. To this was added DyCl3.6H2O (9 mg, 0.02 mmol) and the 
resulting mixture was stirred at 90 oC for 18 h. The solvent was removed under reduced 
pressure and the resulting white solid was purified by reverse-phase HPLC (10-100% 
MeOH in H2O over 10 min; tR = 5.7 min) to yield an off-white solid (5 mg). 1H NMR 
(400 MHz, D2O, pD 6.7) δ -7.7 (COCH3, major), -11.4 ((C(CH3)3, minor), -23.3 
((C(CH3)3, major), -33.2 (COCH3, minor); ESI-LRMS (+) m/z 711.0 [M+H]+; ESI-
HRMS (+) calcd for [C26H40N6O7160Dy]+ 708.2211, found 708.2197. 
 
55. 1-Methoxy-2-methyl-5-tert-butylpyridinium methyl sulfate 
 
 
 
Dimethyl sulfate (2 mL, 17.1 mmol) was added slowly to 5-tert-butyl-2-methylpyridin-
1-oxide (0.85 g, 5.15 mmol). The solution was heated at 80 °C for 5 h, before being 
stirred at rt for 18 h. The solvent was removed under reduced pressure to yield a brown 
oil, which was used without purification (0.92 g, 99%). Rf (10% MeOH/ CH2Cl2) = 
0.18; 1H NMR (400 MHz, CDCl3) δ 8.71 (d, 4J = 2, 1H, H6), 8.36 (dd, 3J = 8, 4J = 2, 
1H, H4), 7.94 (d, 3J = 8, 1H, H3), 4.41 (s, 3H, OCH3), 2.83 (s, 3H, CH3), 1.40 (s, 9H, 
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C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 152.1 (C2), 150.5 (C6), 142.8 (C5), 137.2 
(C4), 130.4 (C3), 69.2 (OCH3), 34.9 (C(CH3)3), 30.2 (C(CH3)), 16.8 (CH3); ESI-LRMS 
(+) m/z 180.5 [M+H]+; ESI-HRMS (+) calcd for [C11H18NO]+ 180.1388, found 
180.1390. 
 
56. Diethyl[2-methyl-5-(tert-butyl)-6-pyridyl]phosphonate 
 
 
 
1-Methoxy-2-methyl-5-tert-butylpyridinium methyl sulfate (0.92 g, 5.10 mmol) and 
sodio-diethylphosphite (1.63 g, 10.2 mmol) were dissolved in diethylphosphite (10 mL). 
The resulting solution was heated at 60 °C for 18 h, before the solvent was removed 
under reduced pressure. The resulting yellow solid was dissolved in H2O (50 mL) and 
extracted with CH2Cl2 (3 × 50 mL). The organic layers were dried over MgSO4 and the 
solvent removed under reduced pressure. The resulting yellow oil was purified by silica 
gel column chromatography, eluting with a gradient starting from 100% CH2Cl2 to 4% 
MeOH/ CH2Cl2 to yield a pale yellow oil (170 mg, 12%).  Rf (10 % MeOH/ CH2Cl2) = 
0.64; 1H NMR (700 MHz, CDCl3) δ 7.71 (dd, 3JHH = 8, 4JHP = 8, 1H, H4), 7.14 (dd, 3JHH 
= 8, 5JHP = 3, 1H, H3), 4.22-4.26 (m, 3J = 7, 4H, PCH2), 2.52 (s, 3H, pyCH3), 1.54 (s, 
9H, C(CH3)3), 1.35 (t, 3J = 7, 6H, CH2CH3); 31P NMR (162 MHz, CDCl3) δ 11.6-11.9 
(m, 3JPH = 7); 13C NMR (176 MHz, CDCl3) δ 154.3 (d, 3JCP = 22, C2), 149.9 (d, 1JCP = 
226, C6), 148.6 (s, 2JCP = 30, C5), 135.4 (d, 3JCP = 13, C4), 124.9 (s, 4JCP = 4, C3), 62.9 
(d, 3JPH = 7, PCH2), 35.3 (C(CH3)3), 31.6 (C(CH3)), 16.4 (d, 4JPH = 7, CH3); ESI-LRMS 
(+) m/z 286.2 [M+H]+; ESI-HRMS (+) calcd for [C14H25NO3P]+ 286.1572, found 
286.1574. 
 
57. 5-(tert-Butyl)-2-methyl-4-nitropyridine 
 
 
 
5-tert-Butyl-2-methyl-4-nitropyridin-1-oxide (1.9 g, 9.04 mmol) was dissolved in 
anhydrous CHCl3 (50 mL) and PBr3 (2.6 mL, 27.1 mmol) was added dropwise. The 
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mixture was stirred at 60 oC for 18 h under argon, before the solvent was removed under 
reduced pressure. The resulting brown residue was quenched cautiously using NaOH 
(aq. 2 M, 50 mL) and the resulting solution was extracted with CH2Cl2 (3 × 50 mL). 
The organic layers were combined, dried over MgSO4 and the solvent removed under 
reduced pressure. The resulting yellow oil was purified by silica gel column 
chromatography, eluting with a gradient starting from 100% CH2Cl2 to 2% MeOH/ 
CH2Cl2 to yield a yellow oil (0.98 mg, 56%). Rf (10% MeOH/ CH2Cl2) = 0.59; 1H NMR 
(400 MHz, CDCl3) δ 8.74 (s, 1H, H6), 7.03 (s, 1H, H3), 2.59 (s, 3H, CH3), 1.41 (s, 9H, 
C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 158.3 (C2), 156.3 (C5), 150.6 (C6), 131.6 (C4), 
115.9 (C3), 34.3 (C(CH3)3), 30.4 (C(CH3)3), 23.6 (CH3); ESI-LRMS (+) m/z 195.5 
[M+H]+; ESI-HRMS (+) calcd for [C10H15N2O2]+ 195.1134, found 195.1135. 
 
58. 4-Bromo-5-(tert-butyl)-2-methylpyridine 
 
 
 
5-(tert-Butyl)-2-methyl-4-nitropyridine (300 mg, 1.55 mmol) was dissolved in acetyl 
bromide (10 mL, 140.0 mmol) and the resulting mixture was stirred at 70 oC for 18 h. 
The resulting brown solution was cooled and dropped cautiously onto cold MeOH (50 
mL). The solvent was removed under reduced pressure and the resulting brown solid 
was purified by silica gel column chromatography, eluting with a gradient starting from 
100% CH2Cl2 to 2% MeOH/ CH2Cl2 to yield an orange oil (320 mg, 91%).  Rf (10 % 
MeOH/ CH2Cl2) = 0.58; 1H NMR (400 MHz, CD3OD) δ 8.52 (s, 1H, H6), 8.25 (s, 1H, 
H3), 2.70 (s, 3H, CH3), 1.59 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CD3OD) δ 153.2 
(C5), 146.6 (C6), 144.6 (C2), 141.1 (C4), 135.6 (C3), 37.4 (C(CH3)3), 29.0 (C(CH3)3), 
18.8 (CH3); ESI-LRMS (+) m/z 228.3 [M+H]+; ESI-HRMS (+) calcd for [C10H15N79Br]+ 
228.0388, found 228.0360. 
 
59. 5-tert-Butyl-4-iodo-2-methylpyridin-1-oxide 
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To a cold solution of 4-amino-5-tert-butyl-2-methylpyridin-1-oxide (1.6 g, 8.88 mmol) 
and HBF4 (2.3 mL, 17.8 mmol) in H2O (40 mL) was added a dropwise solution of 
NaNO2 (1.2 g, 17.8 mmol) in H2O (5 mL). Potassium iodide (2.0 g, 12.4 mmol) was 
slowly added to the suspension, over several portions. The reaction mixture was allowed 
to stir at rt for 5 min before being heated at 60 oC for 30 min. The mixture was cooled to 
rt and the pH adjusted to 10 with KOH. The organics were extracted with CH2Cl2 (3 × 
100 mL) and washed with NaHCO3 (sat. aq. solution, 100 mL) before being dried over 
MgSO4 and the solvent removed under reduced pressure. The resulting brown oil was 
purified by silica gel column chromatography, eluting with a gradient starting from 
100% CH2Cl2 to 2% MeOH/ CH2Cl2 to yield an orange solid (0.8 g, 31%).  Rf (10 % 
MeOH/ CH2Cl2) = 0.37; m.p. 153-155 oC; 1H NMR (400 MHz, CDCl3) δ 8.23 (s, 1H, 
H6), 7.80 (s, 1H, H3), 2.41 (s, 3H, CH3), 1.48 (s, 9H, C(CH3)3); 13C NMR (101 MHz, 
CDCl3) δ 152.5 (C2), 146.5 (C5), 139.8 (C6), 138.4 (C4), 122.2 (C3), 35.9 (C(CH3)3), 
29.1 (C(CH3)3), 16.7 (CH3); ESI-LRMS (+) m/z 291.9 [M+H]+; ESI-HRMS (+) calcd 
for [C10H15127INO]+ 292.0198, found 292.0208; Anal Calcd (%) for C10H15INO: C, 
41.26; H, 4.85; N, 4.81, found: C, 41.11; H, 4.78; N, 4.79. 
 
60. (5-tert-Butyl-4-iodopyridin-2-yl)methyl acetate 
 
 
 
5-tert-Butyl-4-iodo-2-methylpyridin-1-oxide (0.8 g, 2.75 mmol) was dissolved in acetic 
anhydride (10 mL) and the solution was heated to 75 °C for 3 h. The solvent was 
removed under reduced pressure and the resulting orange oil was purified by silica gel 
column chromatography, eluting with a gradient starting from 100% CH2Cl2 to 2% 
MeOH/ CH2Cl2 to yield an orange oil (0.74 g, 81%).  Rf (10 % MeOH/ CH2Cl2) = 0.62; 
1H NMR (400 MHz, CDCl3) δ 8.53 (s, 1H, H6), 7.94 (s, 1H, H3), 5.11 (s, 2H, CH2), 2.16 
(s, 3H, CH3), 1.54 (s, 9H, C(CH3)3); 13C NMR (101 MHz, CDCl3) δ 170.7 (CO), 158.5 
(C2), 147.6 (C5), 145.0 (C6), 136.3 (C4), 107.0 (C3), 65.5 (CH2), 35.9 (C(CH3)3), 29.6 
(C(CH3)3), 21.0 (CH3); ESI-LRMS (+) m/z 333.8 [M+H]+; ESI-HRMS (+) calcd for 
[C12H17127INO2]+ 334.0304, found 334.0307. 
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61. [5-tert-Butyl-4-(diethoxyphosphoryl)pyridin-2-yl]methyl acetate  
 
 
 
(5-tert-Butyl-4-iodopyridin-2-yl)methyl acetate (425 mg, 1.28 mmol) was dissolved in 
triethylphosphite (10 mL, 58.3 mmol). To this was added Pd(dba)2 (73 mg, 10 mol%, 
0.128 mmol) and the resulting solution was heated at 120 oC for 18 h. The solvent was 
removed by vacuum distillation and the resulting brown oil was purified by silica gel 
column chromatography, eluting with a gradient starting from 100% CH2Cl2 to 1% 
MeOH/ CH2Cl2, to yield a yellow oil (284 mg, 65%). Rf (10% MeOH/ CH2Cl2) = 0.56; 
1H NMR (400 MHz, CDCl3) δ 8.84 (d, 4JHP = 8, 1H, H6), 7.80 (d, 3JHP = 16, 1H, H3), 
5.21 (s, 2H, CH2), 4.05-4.14 (m, 3J = 7HP, 4H, POCH2), 2.16 (s, 3H, pyCH3), 1.58 (s, 
9H, C(CH3)3), 1.31-1.37 (m, 4J = 7HP, 6H, POCH2CH3); 31P NMR (162 MHz, CDCl3) δ 
16.1-16.5 (m, 3JPH = 7); 13C NMR (101 MHz, CDCl3) δ 170.7 (CO), 153.1 (d, 3JCP = 12, 
C6), 149.2 (d, 3JCP = 13, C2), 147.7 (d, 2JCP = 11, C5), 136.8 (d, 1JCP = 179, C4), 126.5 
(d, 2JCP = 7, C3), 66.4 (CH2O), 63.8 (d, 2JPH = 6, POCH2), 36.0 (C(CH3)3), 31.6 
(C(CH3)), 21.0 (CH3), 16.3 (d, 3JPH = 6, POCH2CH3); ESI-LRMS (+) m/z 344.2 
[M+H]+; ESI-HRMS (+) calcd for [C16H27NO5P]+ 344.1627, found 344.1628. 
 
62. Diethyl [5-tert-butyl-2-(hydroxymethyl)pyridin-4-yl]phosphonate 
 
 
 
[5-tert-Butyl-4-(diethoxyphosphoryl)pyridin-2-yl]methyl acetate (300 mg, 0.87 mmol) 
was dissolved in anhydrous EtOH (4 mL) and purged with argon for 10 min, before 
sodium metal (~15 mg) was added. The resulting solution was stirred at rt for 1 h, under 
an atmosphere of argon. The solvent was removed under reduced pressure and the 
residue dissolved in CH2Cl2 (7 mL). This was washed with H2O (2 mL), before the 
aqueous layer was rewashed with CH2Cl2 (3 × 7 mL). The organic layers were 
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combined, dried over MgSO4 and the solvent removed under reduced pressure. The 
resulting brown oil was purified by silica gel column chromatography, eluting with a 
gradient starting from 100% CH2Cl2 to 2% MeOH/ CH2Cl2, to yield a yellow oil (150 
mg, 57%). Rf (10% MeOH/ CH2Cl2) = 0.48; 1H NMR (400 MHz, CDCl3) δ 8.80 (d, 4JHP 
= 8, 1H, H6), 7.79 (d, 3JHP = 15, 1H, H3), 4.80 (s, 2H, CH2), 4.07-4.14 (m, 3J = 7HP, 4H, 
POCH2), 2.58 (br s, OH), 1.59 (s, 9H, C(CH3)3), 1.35 (t, 4J = 7HP, 6H, POCH2CH3); 31P 
NMR (162 MHz, CDCl3) δ 15.8-16.2 (m, 3JPH = 7); 13C NMR (176 MHz, CDCl3) δ 
157.3 (d, 3JCP = 11, C6), 148.1 (d, 3JCP = 13, C2), 146.7 (d, 2JCP = 11, C5), 136.5 (d, 1JCP 
= 179, C4), 125.3 (d, 2JCP = 7, C3), 64.2 (CH2O), 62.7 (d, 2JPH = 6, POCH2), 35.8 (d, 
3JCP = 3, C(CH3)3), 31.6 (C(CH3)), 16.3 (d, 3JPH = 6, POCH2CH3); ESI-LRMS (+) m/z 
302.2 [M+H]+; ESI-HRMS (+) calcd for [C14H25NO4P]+ 302.1521, found 302.1519. 
 
63. [5-tert-Butyl-4-(diethoxyphosphoryl)pyridin-2-yl]methyl methane sulfonate 
 
 
 
Diethyl [5-tert-butyl-2-(hydroxymethyl)pyridin-4-yl]phosphonate (150 mg, 0.50 mmol) 
was dissolved in anhydrous THF (4 mL) and cooled to 5 oC. Triethylamine (140 µL, 
1.00 mmol) and mesyl chloride (58 µL, 0.75 mmol) were added dropwise and the 
resulting solution was stirred at rt for 30 min. The solvent was removed under reduced 
pressure before the residue was dissolved in brine (5 mL) and extracted with CH2Cl2 (3 
× 10 mL). The organic layers were combined, dried over MgSO4, and the solvent 
removed under reduced pressure to yield an orange oil, which was used immediately 
(176 mg, 93%). Rf (10% MeOH/ CH2Cl2) = 0.56; 1H NMR (400 MHz, CDCl3) δ 8.78 
(d, 4JHP = 8, 1H, H6), 7.84 (d, 3JHP = 15, 1H, H3), 5.26 (s, 2H, CH2), 4.06-4.16 (m, 3JHP 
= 6, 4H, POCH2), 3.05 (s, 3H, CH3), 1.52 (s, 9H, C(CH3)3), 1.29 (dt, 3JHP = 6, 4JHP = 1, 
6H, POCH2CH3); 31P NMR (162 MHz, CDCl3) δ 15.4-15.8 (m, 3JPH = 6); ESI-LRMS 
(+) m/z 380.5 [M+H]+; ESI-HRMS (+) calcd for [C15H27NO6PS]+ 380.1297, found 
380.1308. 
 
 
N
P
O
O OO
S
O
O
Chapter Six: Experimental !
! 203 
64. Diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-
1,4,7,10-tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}phosphonate 
 
 
 
Ethyl[(4,7-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecane-1-
yl)methyl](methyl)phosphinate (540 mg, 1.42 mmol) was dissolved in anhydrous 
MeCN (5 mL) and to this was added K2CO3 (196 mg, 1.42 mmol). [5-tert-Butyl-4-
(diethoxyphosphoryl)pyridin-2-yl]methyl methane sulfonate (500 mg, 0.94 mmol) was 
then added dropwise as a solution in anhydrous MeCN (10 mL). The resulting mixture 
was heated at 70 oC for 18 h, under argon. The reaction mixture was cooled and the 
inorganic salts were removed by centrifugation. The solvent was removed under 
reduced pressure and the resulting red oil was purified by alumina gel column 
chromatography, eluting with a gradient starting from 100% CH2Cl2 to 2% MeOH/ 
CH2Cl2 to yield an orange oil (210 mg, 27%).  Rf (10% MeOH/ CH2Cl2) = 0.65; 1H 
NMR (400 MHz, CDCl3) δ 8.73 (d, 4JHP = 8, 1H, H6), 7.88 (d, 3JHP = 16, 1H, H3), 4.09-
4.16 (m, 4H, POCH2), 3.93-4.05 (m, 6H, POCH2), 3.50-3.74 (m, 8H, NCH2), 2.53-3.49 
(br m, 16H, cyclen CH2), 1.39-1.54 (m, 18H, C(CH3)3, PCH3), 1.20-1.32 (m, 15H, 
POCH2CH3); 31P NMR (162 MHz, CDCl3) δ 53.5, 52.9, 52.5, 52.4, 52.3, 52.2, 52.0, 
51.9, 51.7, 51.5 (NCH2P, mixture of isomers), 16.6, 15.9, 14.4 (pyP, mixture of 
isomers); 13C NMR (101 MHz, CDCl3) δ 149.0 (C2), 136.2 (C5), 129.5 (C6), 127.3 (C4), 
111.7 (C3), 62.5-62.8 (m, POCH2), 59.7-60.3 (m, POCH2), 53.0-55.0 (m, PCH2N, 
pyCH2, cyclen CH2), 36.3 (C(CH3)3), 31.3 (C(CH3)3), 16.6 (d, 3JCP = 6, POCH2CH3), 
16.2 (d, 3JCP = 6, POCH2CH3), 13.0-14.9 (m, PCH3); ESI-LRMS (+) m/z 816.7 [M+H]+; 
ESI-HRMS (+) calcd for [C34H70N5O9P4]+ 816.4124, found 816.4129. 
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65. Europium(III) complex of {5-tert-butyl-2-[(4,7,10-
tri{[hydroxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecan-1-
yl)methyl]pyridin-4-yl}phosphonic acid, [Eu.L6] 
 
 
 
Diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}phosphonate (15 mg, 0.02 mmol) was 
dissolved in aqueous HCl (6 M, 2 mL) and stirred at 70 oC for 18 h. Complete ester 
cleavage was confirmed by ESI-MS (+) (LR: m/z 676.6 [M+H]+; HR: m/z calcd for 
[C24H50N5O9P4]+ 676.2559, found 676.2557). The solvent was removed under reduced 
pressure and the resulting yellow oil was dissolved in H2O (2 mL). The pH of the 
solution was adjusted to 5.5 using NaOH and EuCl3.6H2O (10 mg, 0.028 mmol) was 
added. The resulting solution was stirred at 70 oC for 18 h before the solvent was 
removed under reduced pressure. The resulting yellow solid was purified by reverse-
phase HPLC (10-100% MeOH in H2O over 10 min; tR = 7.3 min) to yield a white solid 
(5 mg). 1H NMR (400 MHz, pD 7.4, CDCl3) δ 3.1 (C(CH3)3 major), 1.4 (C(CH3)3 
minor); ESI-LRMS (+) m/z 825.8 [M+H]+; ESI-HRMS (+) calcd for 
[C24H47N5O9P4151Eu]+ 824.1523, found 824.1549. 
 
66. [Gd.L6] 
An analogous procedure to that described for the synthesis of [Eu.L6] was followed 
using diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}phosphonate (20 mg, 0.033 mmol) and 
GdCl3.6H2O (14 mg, 0.036 mmol), to yield a white solid (5 mg). tR = 7.1 min; ESI-
LRMS (+) m/z 830.4 [M+H]+; ESI-HRMS (+) calcd for [C24H47N5O9P4154Gd]+ 
827.1533, found 827.1561; r1p = 2.0±0.05 mM-1 s-1 (H2O, 60 MHz, 310 K).!
 
67. [Tb.L6] 
An analogous procedure to that described for the synthesis of [Eu.L6] was followed 
using diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
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tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}phosphonate (20 mg, 0.033 mmol) and 
TbCl3.6H2O (14 mg, 0.037 mmol), to yield a white solid (7 mg). tR = 7.3; min; 1H NMR 
(400 MHz, pD 7.4, CDCl3) δ -78.3 (C(CH3)3 minor), -83.4 (C(CH3)3 major); ESI-LRMS 
(+) m/z 832.2 [M+H]+; ESI-HRMS (+) calcd for [C24H47N5O9P4159Tb]+ 832.1578, found 
832.1562. 
  
68. [Dy.L6] 
An analogous procedure to that described for the synthesis of [Eu.L6] was followed 
using diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}phosphonate (50 mg, 0.06 mmol) and 
DyCl3.6H2O (10 mg, 0.028 mmol), to yield a white solid (20 mg). tR = 6.8 min; 1H 
NMR (400 MHz, pD 7.4, CDCl3) δ -78.3 (C(CH3)3 major), -81.0 (C(CH3)3 minor); 31P 
NMR (162 MHz, CDCl3) δ -38.2 (pyP); ESI-LRMS (+) m/z 836.4 [M+H]+; ESI-HRMS 
(+) calcd for [C24H47N5O9P4160Dy]+ 833.1576, found 833.1573. 
 
69.  [Er.L6] 
An analogous procedure to that described for the synthesis of [Eu.L6] was followed 
using diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}phosphonate (20 mg, 0.033 mmol) and 
ErCl3.6H2O (14 mg, 0.066 mmol), to yield a white solid (9 mg). tR = 7.0 min; 1H NMR 
(400 MHz, CDCl3) δ 42.5 (C(CH3)3 major), 44.2 (C(CH3)3 minor); ESI-LRMS (+) m/z 
840.1 [M+H]+; ESI-HRMS (+) calcd for [C24H47N5O9P4164Er]+ 837.1616, found 
837.1636. 
 
70. [Tm.L6] 
An analogous procedure to that described for the synthesis of [Eu.L6] was followed 
using diethyl {5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}phosphonate (50 mg, 0.06 mmol) and 
TmCl3.6H2O (14 mg, 0.066 mmol), to yield a white solid (20 mg). tR = 6.9 min; 1H 
NMR (400 MHz, CDCl3) δ 74.6 (C(CH3)3 major), 75.5 (C(CH3)3 minor); ESI-LRMS 
(+) m/z 841.9 [M+H]+; ESI-HRMS (+) calcd for [C24H47N5O9P4154Tm]+ 842.1667, 
found 842.1647. 
 
 
 
Chapter Six: Experimental !
! 206 
71. Ethyl 2-{[5-tert-butyl-2-(hydroxymethyl)pyridine-4-yl]sulfonyl}acetate6 
 
 
 
Ethyl thioglycolate (1.4 mL, 12.6 mmol) and NaH (0.3 g, 12.6 mmol) were dissolved in 
anhydrous DMF (7 mL) and stirred for 10 min at rt. (5-tert-Butyl-4-nitropyridin-2-
yl)methanol (2.2 g, 10.5 mmol) was added dropwise as a solution in anhydrous DMF (3 
mL) and the resulting solution was stirred at rt for 18 h. The solvent was removed under 
reduced pressure before the resulting red oil was dissolved in H2O (50 mL) and 
extracted with ethyl acetate (3 × 70 mL). The organic layers were combined, dried over 
MgSO4 and the solvent removed under reduced pressure. The resulting orange oil was 
purified by silica gel column chromatography, eluting with a gradient starting from 
100% CH2Cl2 to 5% MeOH/ CH2Cl2 to yield an orange oil (0.8 g, 26%).  Rf (10% 
MeOH/ CH2Cl2) = 0.32; 1H NMR (400 MHz, CDCl3) δ 8.39 (s, 1H, H6), 7.21 (s, 1H, 
H3), 4.68 (s, 2H, OCH2), 4.18 (q, 3JHH = 7, 2H, OCH2CH3), 3.78 (s, 2H, SCH2), 1.48 (s, 
9H, C(CH3)3), 1.23 (t, 3JHH = 7, 3H, CH2CH3); 13C NMR (101 MHz, CDCl3) δ 168.5 
(CO), 157.5 (C2), 147.4 (C5), 145.7 (C6), 140.5 (C4), 118.1 (C3), 64.0 (OCH2), 61.9 
(OCH2), 53.4 (SCH2), 35.1 (C(CH3)3), 29.6 (C(CH3)3), 14.0 (CH3); ESI-LRMS (+) m/z 
284.9 [M+H]+; ESI-HRMS (+) calcd for [C14H22NO3S]+ 284.1320, found 284.1330. 
 
72. Ethyl 2-({5-tert-butyl-2-[(methanesulfonyloxy)methyl]pyridin-4-
yl}sulfanyl)acetate6 
 
 
 
Ethyl 2-{[5-tert-butyl-2-(hydroxymethyl)pyridine-4-yl]sulfonyl}acetate (0.14 g, 0.49 
mmol) was dissolved in anhydrous THF (4 mL) and cooled to 5 oC. Triethylamine (90 
µL, 0.64 mmol) and mesyl chloride (50 µL, 0.64 mmol) were added dropwise and the 
resulting solution was stirred at rt for 30 min. The solvent was removed under reduced 
pressure and the residue dissolved in brine (5 mL) and extracted with CH2Cl2 (3 × 15 
mL). The organic layers were combined, dried over MgSO4, and the solvent removed 
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under reduced pressure to yield a red oil, which was used immediately (0.17 g, 96%). Rf 
(10% MeOH/ CH2Cl2) = 0.72; 1H NMR (400 MHz, CDCl3) δ 8.30 (s, 1H, H6), 7.21 (s, 
1H, H3), 5.08 (s, 2H, OCH2), 4.02 (q, 3JHH = 7, 2H, OCH2CH3), 3.68 (s, 2H, SCH2), 
2.95 (s, 3H, SCH3), 1.34 (s, 9H, C(CH3)3), 1.21 (t, 3JHH = 7, 3H, CH2CH3); ESI-LRMS 
(+) m/z 362.4 [M+H]+; ESI-HRMS (+) calcd for [C15H24NO5S2]+ 362.1096, found 
362.1114. 
 
73. Ethyl 2-({5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-
1,4,7,10-tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}sulfanyl)acetate 
 
 
 
Ethyl[(4,7-di{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecane-1-
yl)methyl](methyl)phosphinate (220 mg, 0.41 mmol) was dissolved in anhydrous 
MeCN (4 mL) and to this was added K2CO3 (113 mg, 0.82 mmol). Ethyl 2-({5-tert-
butyl-2-[(methanesulfonyloxy)methyl]pyridin-4-yl}sulfanyl)acetate (170 mg, 0.47 
mmol) was then added dropwise as a solution in anhydrous MeCN (4 mL). The 
resulting mixture was heated at 70 oC for 18 h, under argon. The reaction mixture was 
cooled and the inorganic salts were removed by centrifugation. The solvent was 
removed under reduced pressure and the resulting red oil was purified by alumina gel 
column chromatography, eluting with a gradient starting from 100% CH2Cl2 to 2% 
MeOH/ CH2Cl2 to yield an orange oil (230 mg, 61%).  Rf (10% MeOH/ CH2Cl2) = 0.64; 
1H NMR (400 MHz, CDCl3) δ 8.45, 8.31 (s, 1H, H6), 7.34, 7.13 (s, 1H, H3), 4.05-4.17 
(m, 2H, OCH2), 3.85-4.03 (m, 6H, POCH2), 3.74-3.83 (m, 2H, SCH2), 2.82-3.17 (m, 
8H, PCH2N, pyCH2), 2.06-2.80 (br m, 16H, cyclen CH2), 1.41-1.51 (m, 9H, PCH3), 
1.40 (s, 9H, C(CH3)3), 1.11-1.30 (m, 12H, POCH2CH3, OCH2CH3); 31P NMR (162 
MHz, CDCl3) δ 54.0, 53.4, 52.9, 52.7, 52.4, 52.3, 52.2, 52.1, 51.9, 51.7, 51.6, 51.2 
(mixture of isomers); 13C NMR (101 MHz, CDCl3) δ 168.6 (CH2CO), 155.5 (C2), 147.3 
(C5), 146.3 (C6), 140.6 (C4), 120.3 (C3), 61.7-61.9 (m, OCH2), 59.9-60.2 (m, POCH2, 
SCH2), 53.6-54.7 (m, PCH2N, pyCH2), 51.4-52.6 (m, cyclen CH2), 35.1 (C(CH3)3), 29.6 
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(C(CH3)3), 16.5-16.7 (m, POCH2CH3), 14.1 (OCH2CH3), 12.9-13.9 (m, PCH3); ESI-
LRMS (+) m/z 798.1 [M+H]+; ESI-HRMS (+) calcd for [C34H67N5O8P3S]+ 798.3923, 
found 798.3939. 
 
74. Gadolinium(III) complex of {[4-({5-tert-butyl-4-[(2-ethoxy-2-
oxoethyl)sulfanyl]pyridin-2-yl}methyl)-10-{[ethoxy(methyl)phosphoryl]methyl}-7-
{[hydroxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecan-1-
yl]methyl}(methyl)phosphinic acid, [Gd.L7] 
 
 
 
Ethyl 2-({5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-1,4,7,10-
tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}sulfanyl)acetate (30 mg, 0.044 mmol) 
was dissolved in aqueous HCl (6 M, 1 mL) and stirred at 70 oC for 18 h. Complete ester 
hydrolysis was confirmed by ESI-MS (+) (LR: m/z 686.2 [M+H]+; HR: m/z calcd for 
[C26H51N5O8P3S]+ 686.2671, found 686.2666). The solvent was removed under reduced 
pressure and the resulting yellow oil was dissolved in H2O (1 mL). The pH of the 
solution was adjusted to 5.5 using NaOH and GdCl3.6H2O (24 mg, 0.066 mmol) was 
added. The resulting solution was stirred at 70 oC for 18 h before the solvent was 
removed under reduced pressure. The resulting yellow solid was purified by reverse-
phase HPLC (10-100% MeOH in H2O over 10 min; tR = 9.6 min) to yield a white solid 
(12 mg). ESI-LRMS (+) m/z 840.6 [M+H]+; ESI-HRMS (+) calcd for 
[C26H48N5O8P3S154Gd]+ 837.1645, found 837.1657; r1p = 1.9 mM-1 s-1 (H2O, 60 MHz, 
310 K).!
 
75. [Dy.L7] 
An analogous procedure to that described for the synthesis of [Gd.L7] was followed 
using ethyl 2-({5-tert-butyl-2-[(4,7,10-tri{[ethoxy(methyl)phosphoryl]methyl}-
1,4,7,10-tetraazacyclododecan-1-yl)methyl]pyridin-4-yl}sulfanyl)acetate (230 mg, 0.29 
mmol) and DyCl3.6H2O (142 mg, 0.38 mmol), to yield a white solid (80 mg). tR = 9.5 
min; 1H NMR (400 MHz, CDCl3) δ -75.8 (C(CH3)3 major), -78.1 (C(CH3)3 minor); 31P 
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NMR (162 MHz, CDCl3) δ 249.5 (major), 208.2 (minor); ESI-LRMS (+) m/z 846.9 
[M+H]+; ESI-HRMS (+) calcd for [C26H48N5O8P3S160Dy]+ 843.1689, found 843.1703. 
 
76. [Dy.L7-glucosamine] 
 
 
 
To a stirring suspension of the dysprosium(III) complex of {[4-({5-tert-butyl-4-[(2-
ethoxy-2-oxoethyl)sulfanyl]pyridin-2-yl}methyl)-10 
{[ethoxy(methyl)phosphoryl]methyl}-7-{[hydroxy(methyl)phosphoryl]methyl}-
1,4,7,10-tetraazacyclododecan-1-yl]methyl}(methyl)phosphinic acid, [Dy.L7] (10 mg, 
0.012 mmol) in anhydrous DMF (0.3 mL) was added DIPEA (4 µL, 0.024 mmol) and 
after 30 min, HATU (7 mg, 0.018 mmol).  The solution was left stirring for 30 min at rt 
before glucosamine hydrochloride (4 mg, 0.018 mmol) was dissolved in a minimum 
amount of H2O (0.1 mL) and added to the reaction mixture. The mixture was left 
stirring at rt for a further 18 h, before being concentrated under reduced pressure. The 
crude material precipitated by dropping onto stirred dry diethyl ether (15 mL) and was 
isolated by centrifugation. Further impurities were triturated with MeCN, before the 
solvent was removed under reduced pressure. The crude yellow solid was purified by 
reverse-phase HPLC (10-100% MeOH in H2O over 10 min; tR = 11.6 min) to yield a 
white solid (4 mg). 1H NMR (400 MHz, D2O) δ -75.9 (C(CH3)3 major), -76.8 (C(CH3)3 
major), -78.5 (C(CH3)3 minor), -79.3 (C(CH3)3 minor); ESI-LRMS (+) m/z 1007.6 
[M+H]+; ESI-HRMS (+) calcd for [C32H59N6O12P3S160Dy]+ 1004.238, found 1004.237. 
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77. [Dy.L7-chitosan] 
 
 
 
The dysprosium(III) complex of {[4-({5-tert-butyl-4-[(2-ethoxy-2-
oxoethyl)sulfanyl]pyridin-2-yl}methyl)-10 {[ethoxy(methyl)phosphoryl]methyl}-7-
{[hydroxy(methyl)phosphoryl]methyl}-1,4,7,10-tetraazacyclododecan-1-
yl]methyl}(methyl)phosphinic acid, [Dy.L7] (10 mg, 0.012 mmol) was dissolved in 
anhydrous DMF (0.3 mL) to which DIPEA (11 µL, 0.06 mmol) and HATU (14 mg, 
0.036 mmol) were added.  The mixture was stirred at rt for 30 min under argon, before 
glycol chitosan (1.5 mg, MW ≈ 6.5 kD) dissolved in H2O (0.1 mL) was added. The 
mixture was left stirring at rt for a further 18 h, before the solution was diluted with 
H2O (5 mL) and dialysed against Purite water for 48 h (0.5 - 1 kD MWCO), with the 
bulk solvent water refreshed periodically. The solvent was removed under reduced 
pressure, before the residue dissolved in H2O and dialysed for a second time (2 kD 
MWCO) for a further 48 h. The solution was lyophilised to yield a white solid (3 mg, 
crude). 1H NMR (400 MHz, D2O) δ -75.2 (C(CH3)3 major), -76.4 (C(CH3)3 minor), -
77.8 (C(CH3)3 minor). 
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